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INTRODUCTION 
 
 Everything we do relies on the close cooperation of the nearly 100 trillion individual cells that 
make up the human body.  This cooperation is achieved through a complex network of chemical signals 
that allows cells to communicate with each other.  Each cell is wired into the network by an extensive 
repertoire of proteins in the cell membrane that sense the extracellular environment.  These receptor 
proteins recognize a specific chemical signal, or ligand, and transduce that information across the cell 
membrane to initiate the appropriate cellular response.  The responses to extracellular stimuli can include 
changes in cell growth, mobility, or metabolism, as well as changes in gene expression, the release of 
additional chemical signals, and even cell death (Fig. 1).  Disruptions in this signaling network play a role 
in every human disease, from the common cold to cancer to Parkinson’s disease, and the general question 
of how extracellular signals are converted into cellular responses is of fundamental importance in our 
efforts to understand human physiology.  My dissertation research has focused on the function of one key 
player in this process, the heterotrimeric G protein, whose history dates to the beginning of the signal 
transduction field. 
 In 1955, Earl W. Sutherland, Jr., wrote that “the precise mechanism of action of any hormone has 
not yet been clearly established” (Beavo & Brunton, 2002).  At the time, Sutherland was studying how 
the hormone epinephrine (adrenaline) activates the enzyme phosphorylase, which leads to the formation 
of glucose from the breakdown of glycogen stored in the liver.  This reaction releases additional energy 
into the bloodstream in the form of glucose in preparation for a “fight or flight” response.  The following 
year, Sutherland and colleagues demonstrated that the activity of the phosphorylase enzyme was regulated 
by the incorporation of phosphate (Wosilait & Sutherland, 1956; Rall, et al., 1956).  When studying this 
phenomenon in broken cell systems, they noted that the effects of epinephrine were lost after 
centrifugation separated the cell membranes from the cytoplasm.  In an exciting series of experiments, 
they were able to show that the membrane fraction was producing a small molecule in response to 
 xxiv
 
 
 
 
 
 
 
 
 
Figure 1 | Introduction to signal transduction  When a receptor protein embedded in the cell membrane 
is activated by a specific extracellular signal, it initiates an intracellular signaling cascade that leads to a 
cellular response.  Each cell has thousands of different receptors that activate dozens of different 
intracellular signaling pathways, all of which are interconnected.  The cell is like a sophisticated computer 
processor that integrates a variety of inputs (extracellular signals) to produce a measured response to its 
environment.    
 xxv
epinephrine, later identified as cyclic AMP, which led to the phosphorylation and activation of the 
phosphorylase enzyme in the cytoplasm (Berthet, et al., 1957).  Based on these experiments, Sutherland 
developed a model whereby epinephrine binds to the β-adrenergic receptor outside of the cell, causing 
activation of the membrane-bound enzyme, adenylyl cyclase, that makes cAMP.  The cAMP acts as the 
“second messenger” (epinephrine is the first messenger) leading to phosphorylase activation in the 
cytoplasm.  Since these early studies, the role of receptors in converting extracellular signals into cellular 
responses through intracellular second messengers has proven to be a common mechanism of signal 
transduction (Fig. 2a) and, in 1971, Sutherland was awarded the Nobel Prize in Medicine or Physiology 
for his discoveries concerning “the mechanisms of the action of hormones.”   
 In 1967, Sutherland proposed the simplest molecular explanation for the production of cAMP at 
the membrane when he wrote, “It seems likely that in most and perhaps all tissues the β receptor and 
adenylyl cyclase are the same.” (Fig. 2a) (Robison, et al., 1967).  However, in 1969, Martin Rodbell and 
Lutz Birnbaumer demonstrated that a variety of hormones could stimulate adenylyl cyclase in adipocytes.  
If each adenylyl cyclase was a distinct receptor for these various hormones, then stimulation with the 
maximal effective concentrations of multiple hormones should result in additive production of cAMP, yet 
it did not, suggesting that each receptor was activating a common pool of adenylyl cyclase (Birnbaumer 
& Rodbell, 1969).  Once radioactive ligands were developed, the interaction between receptors and their 
activators could be studied directly without relying on an indirect functional readout, like cAMP 
production.  When cell membranes were solubilized with detergent, the β-adrenergic receptor ligand 
binding activity and the cAMP production activity of adenylyl cyclase could be separated by size 
exclusion chromatography (Limbird & Lefkowitz, 1977).  This experiment definitively showed that the 
receptor and adenylyl cyclase were distinct molecular entities, begging the question, how was the receptor 
coupled to activation of adenylyl cyclase? 
 Although the next simplest model was that the receptor and adenylyl cyclase are separate proteins 
that directly interact with each other, Rodbell and colleagues demonstrated that GTP reduced the affinity 
 xxvi
of glucagon for its receptor, and that GTP was required for the activation of adenylyl cyclase in addition 
to the hormone itself (Rodbell, et al., 1971b; Rodbell, et al., 1971a).  Based on these studies, Rodbell 
suggested that the signal transduction machinery consisted of the hormone-binding receptor, an effector 
protein like adenylyl cyclase, and also a GTP-binding transducer protein connecting the two (Fig. 2b).    
Interestingly, the addition of non-hydrolysable analogs of GTP, such as Gpp(NH)p, resulted in 
the persistent stimulation of adenylyl cyclase (Londos, et al., 1974).  Based on this result, Rodbell also 
proposed that the transducer protein was a GTP hydrolase, an enzyme that could convert GTP to GDP.  
Receptor-stimulated GTPase activity was subsequently demonstrated in red blood cell membranes by 
Cassel and Selinger (Cassel & Selinger, 1976).  Additional studies showed that GTP hydrolysis does turn 
off adenylyl cyclase and that GDP can maintain adenylyl cyclase in an inactive state (Cassel & Selinger, 
1978), although at this time, Cassel and Selinger thought that the adenylyl cyclase itself was regulated by 
guanine nucleotides.  However, this work eventually provided the evidence that receptors activated 
signaling pathways by exchanging GTP for GDP bound to the transducer protein proposed by Rodbell 
(Fig. 2b). 
Proof of the three-component signaling model was provided by Al Gilman and colleagues who 
were interested in the cytocidal effects of cAMP on clonal S49 murine lymphoma cells (Daniel, et al., 
1973).  One variant of these cells, cyc−, lacked adenylyl cyclase activity despite a normal abundance of 
adrenergic receptors on the cell surface (Bourne, et al., 1975; Insel, et al., 1976).  As a first step toward 
overcoming the effects of the cyc− mutation, Gilman and Elliott Ross extracted adenylyl cyclase from 
cells lacking adrenergic receptors and reconstituted the adenylyl cyclase extract with membranes from the 
cyc− cells.  As expected, they observed hormone-induced stimulation of cAMP in the reconstituted system 
(Ross & Gilman, 1977b), however, not for the anticipated reasons.  When the adenylyl cyclase in the 
extract was heat-inactivated, they still observed undiminished hormone-sensitive cAMP production! 
(Ross & Gilman, 1977a).  Clearly, at least two proteins in the extract were necessary to couple receptor 
activation to cAMP production in the cyc− membranes, adenylyl cyclase and a novel stimulatory protein 
(Fig. 2c).  Additional experiments showed that this transducer protein was likely the hormone-sensitive 
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GTPase suggested by Rodbell (Ross, et al., 1978).  In 1980, Gilman and colleagues reported the 
purification of a 45 kDa polypeptide, which co-purified with a 35 kDa protein and an 7-8 kDa protein, 
corresponding to the α, β, and γ subunits of a heterotrimeric guanine nucleotide-binding protein, now 
known as the stimulatory G protein, Gs, which was sufficient for activation of adenylyl cyclase in cyc− 
membrane preparations (Northup, et al., 1980; Hildebrandt, et al., 1984).  For their discovery of “G 
proteins and the role of these proteins in signal transduction in cells,” Rodbell and Gilman were awarded 
the Nobel Prize in Medicine or Physiology in 1994. 
While Gilman and associates were working to purify Gs, several interesting similarities between 
the adenylyl cyclase system and the retinal phototransduction system were noted.  In the retina, light 
activates cyclic GMP phosphodiesterase, which breaks down cGMP into GMP.  In 1977, the activation of 
cGMP phosphodiesterase was shown to require GTP and, moreover, light-responsive GTPase activity 
was identified in the retina, which was necessary to shut off cGMP phosphodiesterase (Wheeler & 
Bitensky, 1977).  These observations led to the purification of transducin, or Gt, a soluble, multimeric 
protein composed of α, β, and γ subunits (Godchaux & Zimmerman, 1979; Kuhn, 1980; Fung, et al., 
1981).  Shortly thereafter, the molecular target of islet activating protein, a toxin from Bordetella 
pertussis that blocks hormone-mediated inhibition of adenylyl cyclase, was shown to be an inhibitory 
GTP-binding protein, Gi (Katada & Ui, 1982; Bokoch, et al., 1984).  At this time, it was clear that Gs, Gt, 
and Gi represented a family of structurally homologous guanine nucleotide-binding proteins with similar 
α and β subunits (Manning & Gilman, 1983).   
Today, we recognize that the family of heterotrimeric G proteins plays a critical role as molecular 
switch proteins that couple the activation of nearly 1,000 different cell surface receptors to a vast array of 
intracellular effector proteins.  These signaling systems underlie the physiological responses to hormones, 
neurotransmitters, chemokines, odorants, tastants, and light.  The receptors that activate G proteins are 
also the molecular targets of nearly 50% of all drugs currently on the market.  Tremendous progress has 
been made in the fifty years since Sutherland noted that nothing was known about the mechanism of 
 xxviii
action of any hormone, however, many important questions still remain regarding the structure and 
function of heterotrimeric G proteins. 
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Figure 2 | Discovery of heterotrimeric G proteins  (a) Sutherland was the first to propose a model of 
signal transduction whereby activation of a cell surface receptor (the β receptor in Sutherland’s work) by 
a first messenger leads to the intracellular production of a second messenger (cAMP) leading to protein 
activation (phosphorylase phosphorylation).  However, the simple model proposed by Sutherland 
suggested that the receptor and adenylyl cyclase (AC) were the same protein.  (b) Based on several lines 
of experimental evidence, Rodbell proposed the existence of a transducing protein (G) that coupled 
receptor (R) activation to adenylyl cyclase stimulation.  This protein could be activated by GTP binding 
and could hydrolyze GTP to turn off the signal.  (c) When a detergent extract of membrane proteins was 
added to so-called cyc− membranes, which were thought to lack adenylyl cyclase, epinephrine was able to 
stimulate cAMP production.  This suggested to Gilman and Ross that adenylyl cyclase had been added 
back to the deficient membranes to reconstitute the signaling pathway (left).  In the control experiment, 
where adenylyl cyclase in the protein extract had been heat-inactivated, cAMP was still produced when 
the protein extract was added to the cyc− membranes! (center).  This led to the discovery that the cyc− 
membranes did contain adenylyl cyclase, but did not contain a third component, the G protein, that was 
necessary to activate it (right) (adapted from Linder & Gilman, 1992). 
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CHAPTER I 
 
HETEROTRIMERIC G PROTEINS 
 
Introduction 
 
 Heterotrimeric guanine-nucleotide-binding proteins act as molecular switches in signaling 
pathways by coupling the activation of heptahelical receptors at the cell surface to intracellular responses.  
This role depends on the ability of G protein α subunits to cycle between a resting conformation primed 
for interaction with an activated receptor and a signaling conformation capable of modulating the activity 
of downstream effector proteins, including a variety of enzymes and ion channels.  As the primary 
intermediary between receptors and effectors, G proteins play a critical role in determining the specificity 
and temporal characteristics of the cellular responses to a diverse array of extracellular stimuli.   
G proteins are inactive in the heterotrimeric conformation where Gα binds GDP and the 
constitutive Gβγ dimer.  Extracellular stimuli, such as hormones, neurotransmitters, chemokines, light, 
odorants, and tastants, activate receptors by inducing a conformational change that permits G protein 
binding and catalyzes GDP release from Gα, thereby resulting in the formation of a stable, high-affinity 
complex between the activated receptor and the G protein.  Binding of GTP to Gα destabilizes this 
complex, leading to a structural rearrangement of Gα(GTP), Gβγ, and the receptor.  Both subunits, 
Gα(GTP) and Gβγ, go on to interact with downstream effector proteins.  The cellular response is 
terminated when Gα hydrolyzes GTP to GDP and re-associates with Gβγ, thus completing the cycle (Fig. 
3).  This chapter will serve as a review of our current understanding of the structural determinants of the 
function, specificity and regulation of heterotrimeric G proteins. 
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Figure 3 | Heterotrimeric G protein cycle  In the resting state, G proteins are heterotrimers of GDP-
bound α (blue), β (green), and γ (gold) subunits.  Agonist (yellow) binding to heptahelical receptors 
(pink) in the cell membrane results in a conformational change leading to G protein binding and, 
subsequently, GDP release from Gα.  The high-affinity, nucleotide-free complex is stable until GTP 
binding causes a structural rearrangement in R*, Gα(GTP), and Gβγ, allowing the G protein subunits to 
go on to activate a variety of downstream effector proteins (purple).  The signal is terminated upon the 
hydrolysis of GTP to GDP by Gα, which may be catalyzed by RGS proteins (red). 
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Heterotrimeric G Protein Structure 
 
Although nearly nine hundred different heptahelical receptors are known (Fredriksson & Schiöth, 
2005), they interact with a relatively small number of G proteins composed of α, β, and γ subunits.  At 
last count, there are 21 Gα subunits encoded by 16 genes, 6 Gβ subunits encoded by 5 genes, and 12 Gγ 
subunits in humans (Fig. 4) (Downes & Gautam, 1999).  
 
G protein α subunit 
Heterotrimeric G proteins are typically divided into four main classes based on the primary 
sequence similarity of the Gα subunits: Gαs, Gαi, Gαq, and Gα12 (Simon, et al., 1991).  Members of this 
family range in size from 39-52 kDa and share between 35-95% sequence identity (Fig. 3) (Downes & 
Gautam, 1999).  Many crystal structures of these proteins in a variety of conformations have been 
resolved, and these structures provide the framework for our understanding of the biomechanics of G 
protein signaling (Table 1).   
All of the Gα structures reveal a conserved protein fold composed of two domains, a GTPase 
domain and a helical domain (Fig. 5a).  The GTPase domain is structurally homologous to the family of 
monomeric G proteins, and is composed of a six-stranded β-sheet surrounded by five α-helices.  The 
most highly conserved sequences in this domain are the five loops that contain the consensus sequences 
for guanine nucleotide binding, the diphosphate-binding loop (GxGESGKS), the Mg2+-binding domain 
(RxxTxGI and DxxG), and the guanine ring-binding motifs (NKxD and TCAT).  This domain also 
contains three flexible loops near the γ-phosphate binding site, named Switches I, II, and III, where 
significant structural differences between the GDP-bound (Lambright, et al., 1994; Mixon, et al., 1995) 
and GTPγS-bound (Noel, et al., 1993; Coleman, et al., 1994a) conformations of Gα are found (Fig. 5c).  
The GTPase domain hydrolyzes GTP and contains sites for binding to the Gβγ dimer, heptahelical 
receptors and downstream effector proteins.  The helical domain is composed of six α-helices that form a
 4
  
 
Figure 4 | Primary sequence identity of G protein subunit genes  Not shown are the other splice 
variants of Gαs (3), Gαo (1) and Gβ5 (1).     
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Table 1 | Heterotrimeric G protein structures 
PDBa Complex Missing Regions (# aa) & Notes Res. (Å) Reference 
G protein subunits 
1TAG Gαt(GDP) Nb (27), C (10) 1.8 (Lambright, et al., 1994)
1GDD Gαi1(GDP) N (8), Switches II (16) & III (6) 2.2 (Mixon, et al., 1995)
1BOF Gαi1(GDP)c N (9), Switches II (14) & III (7) 2.2 (Coleman & Sprang, 1998)
1AS3 G42V-Gαi1(GDP) N (8), Switches II (10) & III (6) 2.4 (Raw, et al., 1997)
1ZCB Gαi/13(GDP) N (27), Switch II (7), α4/β6 (2), C (5); N from Gαi1 2.0 (Kreutz, et al., 2006)
1TBG Gβ1γ1 Cγ (3, F) 2.1 (Sondek, et al., 1996)
Gα complexes with GDIs 
1GOT Gαt/iβ1γ1 Heterotrimer Nα (5), Cα (7), Nγ (8), Cγ (5, F); 216-294 from Gαi1 2.0 (Lambright, et al., 1996)
1GP2 Gαi1β1γ2 Heterotrimer Nα (4), Cα (6), Nγ (7), Cγ (7, G) 2.3 (Wall, et al., 1995)
1GG2 G203A-Gαi1β1γ2 Heterotrimer Nα (4), Cα (6), Nγ (7), Cγ (7, G) 2.4 (Wall, et al., 1995)
1KJY Gαi1(GDP)·RGS14 GoLoco Nα (29), Cα (5) 2.7 (Kimple, et al., 2002)
Elements that undergo R*-mediated conformational changes 
1AQG Gαt C-terminus  aa 340-350 NMR (Kisselev, et al., 1998)
1LVZ Gαt C-terminus  aa 340-350 with K340R, C346S NMR (Koenig, et al., 2002)
1MF6 Gγ C-terminus aa 60-71, no F NMR (Kisselev & Downs, 2003)
Activated Gα subunits 
1TND Gαt(GTPγS) N (26), C (1) 2.2 (Noel, et al., 1993)
1GIA Gαi1(GTPγS) N (33), C (11) 2.0 (Coleman, et al., 1994a)
1CIP Gαi1(GppNHp) N (31), C (7) 1.5 (Coleman & Sprang, 1999)
1AS0 G42V-Gαi1(GTPγS) N (31), C (10) 2.0 (Raw, et al., 1997)
1GIL Q204L- Gαi1(GTPγS) N (33), C (11) 2.3 (Coleman, et al., 1994b)
1BH2 A326S-Gαi1(GTPγS) N (31), C (8) 2.1 (Posner, et al., 1998)
1SVS K180P-Gαi1(GppNHp ) N (31), C (7) 1.5 (Thomas, et al., 2004)
1AZT Gαs(GTPγS) N (34), C (3) 2.3 (Sunahara, et al., 1997b)
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Table 1 | Continued 
 
PDB Complex Missing Regions (# aa) & Notes Res. (Å) Reference 
Complexes with effectors and other binding proteins 
1FQJ Gαt/i(GDP·AlF4−)·RGS9·PDEγ Nα (27), Cα (6); 216-294 from Gαi1; RGS box only 2.0 (Slep, et al., 2001)
1AZS Gαs(GTPγS)·ACV/IId Nα (35), Cα (1); AC VC1 & IIC2 catalytic domains  2.3 (Tesmer, et al., 1997b)
2BCJ Gαi/q(GDP·AlF4−)·GRK2·Gβ1γ2 Nα (29), Cα (5), Nγ (3), Cγ (1, G); N from Gαi1 3.1 (Tesmer, et al., 2005)
1SHZ Gα13/i(GDP·AlF4−)·p115RhoGEF  Nα (30), Cα (5); Gα13 HD, Switches I-III; RGS only 2.9 (Chen, et al., 2005b)
2TRC Gβ1γ1·Phosducin Cγ (3, F) 2.4 (Gaudet, et al., 1996)
1A0R Gβ1γ1·Phosducin Nγ (1), Cγ (5); F is present 2.8 (Loew, et al., 1998)
1B9X Gβ1γ1·S73E-Phosducin Cγ (3, F) 3.0 (Gaudet, et al., 1999)
1B9Y Gβ1γ1·Phosducin Cγ (3, F) 3.0 (Gaudet, et al., 1999)
1OMW Gβ1γ2·GRK2 Nγ (7), Cγ (G) 2.5 (Lodowski, et al., 2003)
1XHM Gβ1γ2·SIGK peptide Nγ (6), Cγ (17, G) 2.7 (Davis, et al., 2005)
Transition-state structures in GTP hydrolysis 
1TAD Gαt(GDP·AlF4−) N (26), C (6) 1.7 (Sondek, et al., 1994)
1GFI Gαi1(GDP·AlF4−) N (32), C (9) 2.2 (Coleman, et al., 1994a)
1SVK K180P-Gαi1(GDP·AlF4−) N (32), C (9) 2.0 (Thomas, et al., 2004)
1ZCA Gαi/12(GDP·AlF4−) N (34), C (9); N from Gαi1 2.9 (Kreutz, et al., 2006)
1AS2 G42V-Gαi1(GDP·Pi) N (31), C (8) 2.8 (Raw, et al., 1997)
1GIT G203A-Gαi1(GDP·Pi) N (31), C (6) 2.6 (Berghuis, et al., 1996)
1FQK Gαt/i(GDP·AlF4−)·RGS9 Nα (27), Cα (5); 216-294 from Gαi1 2.3 (Slep, et al., 2001)
1AGR Gαi1(GDP·AlF4−)·RGS4 Nα (4) 2.8 (Tesmer, et al., 1997a)
 
a The Protein Data Bank at www.pdb.org.  
b Abbreviations: (N) residues missing from the amino terminal methionine; (C) residues missing from the C-terminus or isoprenylation site 
(Gγ); (F) farnesyl; (G) geranylgeranyl; (HD) helical domain. 
c This structure was solved in the presence of Mg2+, distinguishing it from 1GDD. 
d Additional structures of this complex have been solved with different ligands for AC: 1CJK, 1CJT, 1CJU, 1CJV (Tesmer, et al., 1999), 1CS4 
and 1CUL (Tesmer, et al., 2000). 
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lid over the nucleotide-binding site, burying bound nucleotides in the core of the protein.  Functions of the 
helical domain include increasing the affinity of Gα for guanine nucleotides (Remmers, et al., 1999; 
Warner, et al., 1998) and increasing the GTP hydrolysis activity of the protein (Markby, et al., 1993).  As 
this domain is the most divergent among Gα subunits, it may also play a significant role in coupling 
specific G proteins to specific effectors (Liu, et al., 1998). 
Less is known about the structure of two other important regions of Gα, the amino and carboxyl 
termini, because they were either removed from the protein or disordered in the crystals.  In the two 
structures of G protein heterotrimers, the N-terminus forms an α-helix that is ordered by its interaction 
with Gβ (Fig. 5a) (Lambright, et al., 1996; Wall, et al., 1995), however, its structure and location in most 
of the other conformations of the protein remain unknown.  Both termini are key determinants of receptor 
binding specificity and play a critical role in G protein activation.   
The N-terminus is also the site of the fatty acid modifications on Gα subunits that regulate G 
protein localization and protein-protein interactions.  All of these proteins, except Gαt, are modified post-
translationally with the saturated 16-carbon fatty acid palmitate, and some (Gαq, Gα11, Gα13, and Gα15) 
are palmitoylated at multiple sites.  Palmitate is attached by a reversible thioester bond to cysteines near 
the N-terminus of Gα, which is subject to regulation by protein acyltransferases and thioesterases 
(reviewed in Chen & Manning, 2001; Smotrys & Linder, 2004).  Members of the Gαi family are also 
myristoylated, which results from the co-translational addition of the saturated 14-carbon fatty acid 
myristate to an N-terminal glycine following removal of the initiating methionine residue.  Since a stable 
amide bond links the myristate to the protein, myristoylation is an irreversible modification (reviewed in 
Chen & Manning, 2001). 
Recently, we have shown that myristoylation also plays an important role in the structure of the 
N-terminal helix of Gα.  In the non-myristoylated protein, this region is dynamically disordered, and 
upon binding to Gβγ, the N-terminus becomes ordered (Medkova, et al., 2002), consistent with its 
conformation as an ordered α-helix in the crystal structures of G protein heterotrimers 
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Figure 5 | Structural features of heterotrimeric G proteins  (a) Ribbon model of the Gαt/i(GDP)β1γ1 
heterotrimer (1GOT), where α is blue, β is green, and γ is gold.  The three Switch regions in Gα are 
highlighted in yellow.  GDP (red) is buried between the GTPase and helical domains of Gα.  (b) The 
subunits have been rotated to show the intersubunit interface, which is primarily composed of the αN 
helix (truncated in this view) and Switch II on Gα and blades 1-3 on Gβ.  (c) When the GDP-bound 
(1TAG), GTPγS-bound (1TND), and heterotrimer (1GOT) structures of Gαt are aligned, significant 
conformational differences are found in the three Switch regions (compare gray and colored backbone).  
The crystal structures indicate that, upon GTP binding (green backbone), these regions collapse toward 
the γ-phosphate of GTP.  The Gα(GDP) conformation (blue backbone) is likely a short-lived transition 
state in vivo due to the large hydrophobic surface presented by this conformation of the Switch regions. 
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(Wall, et al., 1995; Lambright, et al., 1996).  However, the myristoylated N-terminus is highly ordered in 
Gα(GDP), and no further conformational changes are observed upon binding to Gβγ (Preininger, et al., 
2003).  Thus, myristoylation plays a structural role in ordering the αN helix, even in the absence of Gβγ.  
Furthermore, steady-state fluorescence and fluorescence anisotropy indicate that the myristoylated N-
terminus is less solvent exposed and less mobile than the non-myristoylated N-terminus, pointing to a 
putative intramolecular binding site in Gα(GDP) for the myristoylated N-terminus (Fig. 6) (Preininger, et 
al., 2003).  Myristoylation also affects the interactions between Gα and effectors (Gallego, et al., 1992; 
Taussig, et al., 1993; Dessauer, et al., 1998) and the soluble guanine nucleotide exchange factor, 
Resistance to inhibitors of cholinesterase 8A (Tall & Gilman, 2005). 
 
G protein βγ dimer 
 All six Gβ subunits are approximately 36 kDa, and share 50-90% sequence identity, with the long 
and short splice variants of Gβ5 being the least similar to the other four members of the family (Fig. 4) 
(Downes & Gautam, 1999).  Although not as dynamic a protein as Gα, Gβ is certainly more attractive 
with its seven-bladed β-propeller structure formed from seven WD40 sequence repeats (Fig. 5b).  Each 
blade is composed of four antiparallel β-strands, where one WD40 sequence contributes the last three 
strands in one blade and the first strand in the next blade.  Consequently, the final blade requires the N-
terminus of Gβ to contribute the fourth β-strand, and thereby close the ring.  The remaining N-terminal 
residues adopt an α-helical conformation that forms a coiled coil that is essential for interaction with Gγ 
or Gγ-like motifs and six (Fig. 5) (Sondek, et al., 1996).  All of the Gγ subunits undergo post-translational 
isoprenylation at their C-termini with a 15-carbon farnesyl (Gγ1, Gγ8, and Gγ11) or 20-carbon 
geranylgeranyl (all others) moiety.  These isoprenoids are first attached by a stable thioether bond to a 
cysteine residue located in the C-terminal CaaX sequence of Gγ.  Then the three C-terminal amino acids 
are removed, and the new prenylated C-terminus is carboxylmethylated (reviewed in Zhang & Casey, 
1996).  If the X residue in the CaaX motif is serine, methionine, glutamine, or alanine, then Gγ is 
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Figure 6 | GTP-dependent myristoyl switch  Biophysical studies using fluorescence and EPR 
spectroscopy have shown that myristoylation plays a critical role in the structure of the N-terminus (cyan) 
of Gα subunits.  In the non-myristoylated proteins, the N-terminus is disordered in both the GDP-bound 
and GTP-bound conformations.  By contrast, this helix is ordered in the myristoylated proteins.  Upon 
GTP binding to the myristoylated Gα, the N-terminus enters into a more hydrophobic environment than 
in either the Gα(GDP) or heterotrimeric conformations, suggesting that G protein activation exposes an 
intramolecular binding site for the N-terminus.  The disordered structures observed in non-myristoylated 
G proteins may reflect the transition states following activation and prior to heterotrimer formation. 
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farnesylated, while leucine at this position directs geranylgeranylation (reviewed in Higgins & Casey, 
1996).  Carboxylmethylation increases the affinity of Gβγ for the membrane by neutralizing the 
negatively charged C-terminus (Fukada, et al., 1994).   
The G protein β and γ subunits form a functional unit that is not dissociable except by 
denaturation (Schmidt, et al., 1992).  Although most β subunits can interact with most γ subunits, not all 
of the sixty possible combinations of dimers form (Clapham & Neer, 1997).  For example, Gγ1 interacts 
with Gβ1, but not Gβ2 despite its high (87%) sequence identity to Gβ1, and Gβ2 does bind to Gγ2 despite 
its similarity to Gγ1 (38% identity) (Garritsen & Simonds, 1994; Downes & Gautam, 1999; Schmidt, et 
al., 1992; Pronin & Gautam, 1992).  Substituting three consecutive residues in the middle of Gγ1 with 
homologous residues from Gγ2, including a leucine that is conserved in all Gγ subunits except for Gγ1, 
enables Gγ1 binding to Gβ2, however the reverse substitution does not allow Gγ2 to bind to Gβ2, 
suggesting that additional regions are also important for the specificity of dimer formation (Lee, et al., 
1995a).  Several different Gβγ dimers can interact with the same Gα isoform (Graf, et al., 1992), 
suggesting that differential expression or subcellular localization may be an important determinant of 
signaling specificity. 
 
Unique role of Gβ5 in complexes with RGS proteins 
Gβ5 is unique among Gβ isoforms.  While Gβ1-4 share 80-90% sequence identity and are 
ubiquitously expressed, Gβ5 shares only 50% identity and is preferentially expressed in the nervous 
system (Fig. 4) (Downes & Gautam, 1999).  Additionally, Gβ1-4 are entirely particulate proteins while 
Gβ5 is found in both the particulate and soluble fractions.  The N-terminus of Gβ5 is also significantly 
longer than the other subunits (Watson, et al., 1994).  Although this region is important for binding Gγ 
(Garritsen, et al., 1993), Gβ5 can still form dimers and functional heterotrimers, as well as interact with a 
number of effectors following receptor activation (Zhang, et al., 1996; Bayewitch, et al., 1998b; Fletcher, 
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et al., 1998; Watson, et al., 1994; Watson, et al., 1996).  Unlike the other Gβ subunits, Gβ5 can be easily 
dissociated from Gγ and is stable in solution as a monomer (Cabrera, et al., 1998; Yoshikawa, et al., 
2000).  Interestingly, free Gβ5 has been shown to form complexes with regulators of G protein signaling 
proteins, a family of GTPase activating proteins, that contain a Gγ-like domain (Levay, et al., 1999; 
Makino, et al., 1999).  The GGL domain is a 64-amino acid sequence that is found in RGS6, 7, 9, 11, and 
the C. elegans RGS protein, EGL-10 (Snow, et al., 1998).  The interaction between these RGS proteins 
and Gβ5 enhances their ability to accelerate the GTPase activity of Gα subunits (Kovoor, et al., 2000).  In 
addition, this interaction allows RGS6, 7, and 11 to selectively GAP Gαo (Snow, et al., 1998).  
These unique associations beg the question as to whether Gβ5 interacts with RGS proteins, Gγ, or 
both in vivo.  Despite the extensive in vitro biochemical evidence, there is little data to support a Gβ5γ 
complex in vivo, although this may be due to the technical difficulties resulting from the somewhat 
weaker interactions between these proteins than in other dimers (Jones, et al., 2004).  By contrast, in 
native preparations of vertebrate photoreceptors, the long isoform of Gβ5 is in a tight complex with RGS9 
(Makino, et al., 1999).  When RGS9 is knocked out, Gβ5L cannot be found in the retinal tissue of these 
animals, despite the presence of normal Gβ5 mRNA levels (Chen, et al., 2000).  The protein levels for the 
short isoform were normal in these animals, suggesting that RGS9 may be required for the stability of 
Gβ5L, while Gβ5S is stabilized by interactions with Gγ or other RGS proteins (Chen, et al., 2000).  
Similarly, the protein expression of all GGL-containing RGS proteins is eliminated or substantially 
reduced in Gβ5 knockout mice (Chen, et al., 2003).  Several other provocative questions are posed by 
these complexes, including why Gβ5 is specifically enriched in the brain, whether they can form 
functional heterotrimers in vivo and what the physiological roles of the various complexes in signal 
transduction are.  Clearly they are important for the fast inactivation of the photoreceptor response (Chen, 
et al., 2000), and roles in opioid and dopaminergic signaling pathways are emerging (reviewed in Jones, 
et al., 2004), yet we are only beginning to understand the functional consequences of these interactions. 
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Heterotrimeric G protein structure 
 Two crystal structures of G protein heterotrimers, Gαt/iβ1γ1 and Gαi1β1γ2, show two sites of 
interaction between Gα and Gβγ (Fig. 5a) (Lambright, et al., 1996; Wall, et al., 1995).  The primary 
interaction surface is between Switches I and II of Gα and residues from five of seven blades on Gβ.  
This switch interface buries approximately 1,800 Å2 of solvent-accessible surface area, and is composed 
of hydrophobic residues stabilized by hydrogen bonds and two ion pairs.  A second interaction between 
the N-terminus of Gα and blade one of Gβ buries 900 Å2 of solvent-accessible surface area.   
Neither crystal structure provides evidence for Gα-Gγ contacts, although the acylated amino and 
carboxyl termini of Gα and Gγ, respectively, would likely be in close proximity to each other, suggesting 
that their lipids insert cooperatively into the plasma membrane (Bigay, et al., 1994; Seitz, et al., 1999).  In 
addition to their membrane anchoring role, the lipid modifications have been shown to increase the 
affinity of Gα for Gβγ, and vice versa, and this effect may be independent of the presence of the 
membrane (Linder, et al., 1991; Iniguez-Lluhi, et al., 1992; Iiri, et al., 1996).  Since these modifications 
are absent from the two G protein heterotrimer crystals, additional studies are needed to understand the 
structural features of these hydrophobic moieties and their effect on Gα-Gβγ interactions. 
Comparing the structures of Gα(GDP) (Lambright, et al., 1994; Mixon, et al., 1995) and the G 
protein heterotrimers shows that Gβγ binding significantly alters the conformation of Switches I and II, 
while the rest of Gα remains relatively unperturbed (Fig. 4c).  By stabilizing these two flexible loops and, 
in the Gi1 heterotrimer, forming a new salt bridge between the P-loop and Switch I, Gβγ locks GDP into 
the nucleotide-binding pocket (Wall, et al., 1995).  This reorganization also appears to disassemble the 
binding sites for Mg2+ and the GTP γ-phosphate (Fig. 14a), explaining the observation that GTP and Gβγ 
binding to Gα are negatively cooperative (Higashijima, et al., 1987b).  In contrast to the rearrangements 
observed in Gα upon heterotrimer formation, significant structural changes are not observed in Gβγ.    
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Lipid modifications direct membrane association 
 One clear function of the fatty acid modifications on Gα and Gγ is to direct the association of the 
heterotrimer with the membrane.  For Gαi family members, both fatty acid modifications, myristoylation 
and palmitoylation, contribute to membrane localization.  Mutations that prevent palmitoylation shift the 
localization of myristoylated proteins from the membrane to the cytoplasm (Degtyarev, et al., 1994; 
Morales, et al., 1998; Mumby, et al., 1994; Wise, et al., 1997a).  Similarly, mutating the N-terminal 
glycine to block myristoylation not only increases the amount of soluble protein, but also inhibits 
palmitoylation of these proteins (Mumby, et al., 1990; Galbiati, et al., 1994; Hallak, et al., 1994; Wilson 
& Bourne, 1995).  These observations support a two-signal membrane trapping model for anchoring Gα 
to the plasma membrane (Shahinian & Silvius, 1995).  In this model, myristoylation is the first signal that 
leads to a transient interaction of Gα with the membrane.  Palmitoylation is the second signal that serves 
to securely attach the protein to the membrane.  Consistent with the requirement of two hydrophobic 
moieties for membrane localization, non-myristoylated Gαi and Gαo can be trafficked to the membrane 
by isoprenylated Gβγ, where they are subsequently palmitoylated.  Since only membranes with the 
capacity for palmitoylation can trap G proteins in this model, this modification may specifically 
concentrate the G proteins at the plasma membrane rather than at intracellular organelle membranes that 
have less palmitoyl acyltransferase activity (Chen & Manning, 2001; Morales, et al., 1998; McCabe & 
Berthiaume, 1999).  Alternatively, Gβγ may be the primary determinant of Gα localization, as a mutant 
Gβγ that targets to mitochondrial membranes will recruit Gαz to the mitochondria independent of 
palmitoylation (Fishburn, et al., 2000). 
 In the remaining Gα family members that are not myristoylated, mutations that prevent 
palmitoylation can markedly impair membrane association (Wedegaertner, et al., 1993; Degtyarev, et al., 
1993; Wise, et al., 1997b; Bhattacharyya & Wedegaertner, 2000).  For these proteins, the hydrophobic 
isoprenyl group on Gγ may act as the first signal, leading to membrane binding and palmitoylation.  
Mutants of Gαs and Gαq that could not interact with Gβγ were localized in the cytosol and were not 
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palmitoylated.  When the Gαq mutant was myristoylated, its membrane localization and palmitoylation 
were restored (Evanko, et al., 2000).  Additionally, the over-expression of Gβγ was able to rescue the 
membrane localization of Gβγ-binding deficient mutants of Gαs and Gαq in a subtype-specific manner 
(Evanko, et al., 2001).  The two signal model may also apply to the targeting of Gβγ to the plasma 
membrane as heterotrimer formation and isoprenylation appear to be required for this process (Takida & 
Wedegaertner, 2003; Evanko, et al., 2001).  Indeed, the addition of a palmitoylation site to Gγ2 as a 
putative second membrane targeting signal can recover the appropriate plasma membrane localization of 
Gβ1γ2 in the absence of Gα (Takida & Wedegaertner, 2003).    
  
Receptor-G Protein Complexes 
 
Low affinity interactions between inactive receptors and G proteins 
Early studies of receptor-G protein interactions in the visual transduction field demonstrated that 
transducin can bind to dark rhodopsin, albeit at a much lower affinity (Hamm, et al., 1987).  Pure 
phospholipid vesicles could not bind Gt, while vesicles containing rhodopsin could bind the G protein in 
both the dark and the light (Fung, 1983).  The dark membrane binding site saturated at 25% of the 
rhodopsin concentration (Liebman & Sitaramayya, 1984), and the only protein present at that 
concentration in washed rod outer segment membranes is rhodopsin (Hamm & Bownds, 1986).  
Interestingly, sulfhydryl modification with N-ethylmaleimide of what is now known to be the C-terminal 
cysteine in Gαt does not disturb the interaction between dark rhodopsin and Gt, while it completely blocks 
binding to the photoactivated receptor (Hofmann & Reichert, 1985).  More recently, surface plasmon-
waveguide resonance spectroscopy has been used to study the interaction between rhodopsin and Gt.  
These studies indicate that Gt binds to dark rhodopsin with an apparent Kd of 64 nM (Alves, et al., 2005).  
Although this is consistent with an earlier result obtained by surface plasmon resonance spectroscopy, a 
similar method (Salamon, et al., 1996), it is beyond the lower limit of the previously published values for 
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this interaction, ranging from 10-0.1 µM (Schleicher & Hofmann, 1987; Liebman & Sitaramayya, 1984).  
The affinity of Gt for light activated rhodopsin is approximately 1 nM (Bennett & Dupont, 1985; Alves, et 
al., 2005).  A high affinity interaction between rhodopsin and transducin in the dark suggests that all of 
the Gt-binding sites in ROS are constitutively saturated, which is a surprising conclusion.  Clearly 
transducin is able to interact with dark rhodopsin, however, much more work is required to explore the 
structural features and physiological consequences of this interaction.   
Similar complexes between the inactive receptor and G protein have been observed in other 
receptor systems.  For example, Gi co-purified through several steps with the α2-adrenergic receptor 
(Cerione, et al., 1986).  The antagonist-bound δ-opioid receptor has approximately 50-fold lower affinity 
for G proteins than the agonist-bound receptor, as shown by PWR.  Interestingly, GTPγS did not cause 
dissociation of the antagonist- or inverse agonist-bound δ-opioid receptor-G protein complexes, 
suggesting that these are complexes with the GDP-bound heterotrimer (Alves, et al., 2003).  Additional 
support for the formation of these complexes is also provided by kinetic studies of rhodopsin-catalyzed 
nucleotide exchange in Gαt, where a distinct R·Gα(GDP)βγ complex is required to fit the double 
displacement (ping-pong) mechanism described (Heck & Hofmann, 2001).  In hormone-sensitive cells 
that contain only a few thousand receptors, preformed receptor-G protein complexes could have a major 
impact on the kinetics of intracellular events (Hamm, et al., 1987). 
 
Receptor activation exposes the high-affinity G protein binding site 
 G protein-coupled receptors have a common body plan with seven transmembrane-spanning α-
helices with an extracellular N-terminus, intracellular C-terminus and three interhelical loops on each side 
of the membrane (Fig. 7).  The C-terminal tail contains an eighth α-helix and palmitoylation sites that 
create a fourth intracellular loop (Palczewski, et al., 2000).  Although the overall sequence homology 
between receptors is low, there are several highly conserved microdomains including helix VIII and the 
palmitoylation sites, as well as the D(E)RY and NPxxYx5F motifs, which are near the intracellular face of 
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the receptors and play an important role in receptor and G protein activation (Fig. 7) (reviewed in 
Kristiansen, 2004).  Despite extensive effort, the dark (inactive) conformation of rhodopsin remains the 
only receptor for which crystal structures have been solved (Palczewski, et al., 2000; Teller, et al., 2001; 
Okada, et al., 2002; Okada, et al., 2004; Li, et al., 2004).  Although these structures shed little light on the 
G protein coupling mechanism, they have provided a useful framework for the interpretation of numerous 
biophysical studies on the conformational changes associated with receptor activation (reviewed in 
Hubbell, et al., 2003).  Extensive site-directed spin-labeling studies of rhodopsin have shown that 
photoactivation primarily results in an outward movement of helix VI, thereby opening a crevice in the 
intracellular face of the receptor (Fig. 7) (Farrens, et al., 1996).  This outward movement appears to be 
essential for G protein activation as disulfide and metal-ion cross-links between helices III and VI prevent 
light-stimulated nucleotide exchange in Gt (Farrens, et al., 1996; Sheikh, et al., 1996).  A similar 
movement has also been observed in other receptors, suggesting that it is an important component of the 
conformational change leading to G protein binding (reviewed in Gether, 2000; Gether, et al., 2002). 
   
Receptor-G protein interaction surface 
The newly formed pocket in the cytoplasmic face of the receptor forms the binding site for the C-
terminus of Gα (Janz & Farrens, 2004), which is the best characterized receptor contact site in G proteins.  
Structural information for this region is lacking from G protein crystal structures, however, as these 
residues are either absent or disordered in most of them (Table 1).  Upon binding light-activated 
rhodopsin, eleven amino acid C-terminal peptides from Gαt form an αL-type C-cap motif (Fig. 9) (Dratz, 
et al., 1993; Kisselev, et al., 1998; Koenig, et al., 2002).  Interestingly, the structure of the activated 
rhodopsin-bound peptide was similar to that observed in the Gαi1(GDP·AlF4−)·RGS4 structure (Tesmer, et 
al., 1997a; Kisselev, et al., 1998).  The angle between the axis of the helix with respect to the membrane 
normal was determined to be approximately 40° based on the combination of transfer nuclear Overhauser 
effect and residual dipolar coupling nuclear magnetic resonance data (Koenig, et al., 2002).  This same 
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Figure 7 | Heptahelical receptor structure  (a) Cartoon model of dark (inactive) bovine rhodopsin 
(1U19), showing the seven transmembrane-spanning α-helices (red to blue) and 11-cis-retinal (gray 
spheres).  Conserved residues important for receptor and G protein activation are shown (magenta 
spheres), including the DRY motif on helix III (yellow) and NpxxYx5F motif on helices VII and VIII 
(blue and purple).  (b) The extracellular and intracellular faces of rhodopsin are shown.  Receptor 
activation results in an outward movement of helix VI (yellow arrow), which opens a gap in the 
cytoplasmic face of the receptor, exposing residues critical for G protein activation, such as the DRY 
motif on helix III (yellow). 
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peptide stabilizes the metarhodopsin II signaling conformation of rhodopsin, and will compete with the Gt 
heterotrimer for binding to the receptor (Hamm, et al., 1988; Aris, et al., 2001).  Screening a 
combinatorial library for peptides that could stabilize Meta II demonstrated that the C-terminal seven 
amino acids of Gαt are the most important for this interaction (Martin, et al., 1996).  Several mutations in 
this region have been shown to uncouple G proteins from their receptors, including an arginine-to-proline 
mutation in Gαs, first identified in the unc clone of S49 murine lymphoma cells, that has since been 
associated with Albright’s hereditary osteodystrophy (Sullivan, et al., 1987; Schwindinger, et al., 1994; 
Osawa & Weiss, 1995).  Similarly, the pertussis toxin-catalyzed ADP-ribosylation of the C-terminal 
cysteine in Gαi family members also uncouples signaling through Gi-coupled receptors (West, et al., 
1985).  This cysteine can only be substituted with other hydrophobic residues (Aris, et al., 2001), 
evidence that it is binding to a hydrophobic pocket in the activated receptor.   
A number of residues in the α4/β6 loop at the C-terminus of Gα have also been implicated in 
receptor contact by alanine-scanning mutagenesis (Fig. 8) (Onrust, et al., 1997), chimeric studies (Bae, et 
al., 1997; Bae, et al., 1999), sequence analysis of conserved residues in Gα subclasses (Lichtarge, et al., 
1996a), chemical cross-linking (Cai, et al., 2001), and tryptic proteolysis (Mazzoni & Hamm, 1996).  
Five residues in the α3/β5 loop of Gαs, when replaced with the homologous amino acids in Gαi2, 
decrease receptor-mediated GTP binding while increasing receptor affinity (Fig. 8) (Grishina & Berlot, 
2000).  The αN helix also interacts with the receptor, as shown by peptide competition (Hamm, et al., 
1988), mutagenesis (Onrust, et al., 1997), chemical cross-linking (Taylor, et al., 1994; Itoh, et al., 2001), 
and Gα chimeras (Ho & Wong, 2000) (Fig. 8). 
The Gβγ subunit also binds receptors and is required to stabilize the receptor-Gα interface.  The 
C-terminal sixty amino acids of Gβ can be cross-linked to a peptide corresponding to the third 
intracellular loop of the α2-adrenergic receptor (Fig. 8) (Taylor, et al., 1994; Taylor, et al., 1996).  
Alanine-scanning mutagenesis in Gβ identified several mutants with normal heterotrimer formation, but 
defective receptor-mediated GTPγS uptake, indicating a role for Gβγ in this process, either directly or  
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Figure 8 | Receptor contact sites on the G protein  Ribbon diagram of the heterotrimeric G protein 
(1GOT) with the C-terminal tail of Gαt attached (1AQG).  The G protein has been rotated toward the 
viewer from the putative receptor-binding orientation to visualize the receptor contact sites (magenta).  
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indirectly through stabilization of the Gα subunit (Ford, et al., 1998).  A farnesylated C-terminal twelve 
amino acid peptide of Gγ1 will stabilize Meta II (Kisselev, et al., 1995).  This Gγ peptide forms an 
amphipathic helix upon interaction with activated rhodopsin (Kisselev & Downs, 2003).  Other 
mutational, peptide mapping, and biophysical studies have also demonstrated regions of Gβγ that interact 
with receptors (Kisselev, et al., 1999; Phillips, et al., 1992; Kisselev & Gautam, 1993; Kisselev, et al., 
1994; Azpiazu, et al., 1999).   
Although there is extensive data describing the receptor-binding surface on G proteins, somewhat 
less is known about the specific point-to-point interactions between these proteins.  Generally, the 
membrane-proximal sections of intracellular loops 2, 3, and 4 form the primary interaction surface on the 
receptor.  Additional contact sites in the transmembrane helices may also be formed as the Gα C-terminus 
enters deeply into its binding pocket in the activated receptor (Janz & Farrens, 2004).  Peptides 
corresponding to IC loops 2, 3, and 4 block the stabilization of Meta II by Gαt (Konig, et al., 1989; 
Marin, et al., 2000).  A reverse substitution approach, where each intracellular loop was first substituted 
with polyalanine sequences and then individual alanine residues were mutated back to the native amino 
acid, demonstrated that residues adjacent to the transmembrane helices in these loops were the most 
important for G protein activation (Natochin, et al., 2003).  Chemical cross-linking experiments between 
rhodopsin and Gαt indicate that residue 240 in IC 3 of rhodopsin is near the amino and carboxyl termini 
of Gα, as well as the α4/β6 loop (Fig. 8a) (Cai, et al., 2001; Itoh, et al., 2001).  Five residues at the C-
terminus of Gα were shown to specifically interact with four noncontiguous residues in IC 3 (Liu, et al., 
1995).  Peptides corresponding to IC 3 also cross-link to the N-terminus of Gα and the C-terminus of Gβ 
(Taylor, et al., 1996; Taylor, et al., 1994).  Recently, the binding site for the C-terminal peptide of Gα 
was mapped to a hydrophobic patch on the inner face of helix VI in Meta II based on the ability of the 
tryptophan-labeled peptide to quench the fluorescence of bimane labels on the receptor (Janz & Farrens, 
2004), and both the Gα and Gγ C-termini of Gt interact with IC 4 of rhodopsin (Ernst, et al., 2000).  
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These data provide important information about specific contacts between receptors and G proteins, 
however, more constraints are needed to improve our current model of the receptor-G protein interface.  
 
Structural determinants of receptor-G protein specificity 
Relatively few types of G proteins transduce signals from a vast number of heptahelical receptors, 
thus each member of the G protein family must be capable of interacting with many different receptors.  
Furthermore, many receptors are capable of activating multiple G protein signaling pathways.  Regulating 
the specificity of these interactions is important for proper signal transduction.  Therefore, the receptor-G 
protein interface must also encode important information that determines which G proteins can interact 
with a particular receptor.  Even after identifying many of the contact sites that comprise this interface, 
the connections that define the coupling between receptors and specific G protein family members remain 
unclear.   
Each of the contact sites described in the previous section has been shown to contribute to 
coupling specificity.  Carboxyl terminal chimeras of Gα subunits have been frequently used to switch 
receptor-effector coupling.  For example, replacing the C-terminus of Gαq with that of Gαi results in a G 
protein that is activated by Gi-coupled receptors, but stimulates phospholipase C, a Gαq effector (Conklin, 
et al., 1993).  Many mutations in this region have also been shown to alter receptor-G protein coupling 
(Blahos, et al., 1998; Kostenis, et al., 1997c; Conklin, et al., 1996; Natochin, et al., 2000), including 
single point mutations (Kostenis, et al., 1997a).  The C-terminal eleven amino acids in Gαt and Gαi are 
nearly identical, yet the 5HT1B-serotonin receptor activates only Gi through a specific interaction with two 
amino acids in the α4 helix of this protein (Bae, et al., 1999).  Other key specificity determinants in Gα 
are the N-terminus (Kostenis, et al., 1997b; Kostenis, et al., 1998), αN/β1 loop (Blahos, et al., 2001), 
α2/β4 loop (Lee, et al., 1995b), and the α3/β5 loop (Grishina & Berlot, 2000), and studies suggest that 
coupling selectivity involves subtle and cooperative interactions among all of these various domains 
(Slessareva, et al., 2003).  Interestingly, mutations in the α2/β4 and α4/β6 loops in Gαs do not affect 
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binding to the β2-adrenergic receptor, while mutations in the α3/β5 loop increase receptor binding affinity 
(Grishina & Berlot, 2000).  This may suggest differential determinants of G protein coupling in different 
G protein families.  Recently, a mutation in a highly conserved glycine in Linker 1 of Gα was shown to 
increase the activation of Gαq by Gi- and Gs-coupled receptors, demonstrating that sites distant from the 
receptor-G protein interface may also be important for controlling coupling (Heydorn, et al., 2004).  
Further, coupling specificity may involve cooperative interactions between Linker 1 and the C-terminus 
(Kostenis, et al., 2005). 
In addition to the structural determinants on Gα, specific isoforms of Gβ and Gγ have been 
shown to preferentially interact with specific receptors.  For example, both Gβ1γ2 and Gβ5γ2 can couple 
Gαq to endothelin B and M1-muscarinic receptors, however only Gβ1γ2 promotes Gαi binding to the 
endothelin B receptor (Lindorfer, et al., 1998).  Additional work showed that Gβ5γ2 specifically couples 
Gαq to receptors (Fletcher, et al., 1998).  Similarly, the M2-muscarinic receptor interacts with Gαo 
heterotrimers with Gβ4γ2, but not Gβ1γ2 (Hou, et al., 2001).  The A1-adenosine receptor couples equally 
well to Gαi1 heterotrimers containing Gβ1γ2, Gβ1γ3, Gβ2γ2, and Gβ2γ3 (Figler, et al., 1996), however, Gβ1 
dimers with Gγ2 and Gγ3 had a much faster receptor-catalyzed nucleotide exchange rate as compared to 
dimers with Gγ1 (Figler, et al., 1997).  A similar study measuring the ability of each of the five Gβγ2 
dimers to couple to the β1-adrenergic and A2a-adenosine receptors found that Gβ4 coupled the best while 
Gβ5 coupled the worst.  Interestingly, although Gβ1 had a similar potency to Gβ4 in coupling to the β1-
adrenergic receptor, its potency was 20-fold lower when coupling to the adenosine receptor (McIntire, et 
al., 2001). 
The Gγ subunit also plays an important role as a determinant of receptor-G protein coupling 
specificity.  Coupling of Gαi1 to the α2a-adrenergic receptor was significantly affected depending on 
which of the eight different Gγ subunits studied was used to form the heterotrimer (Richardson & 
Robishaw, 1999).  Similarly, the M2-muscarinic receptor does not interact with Gαo heterotrimers 
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containing Gβ1γ2, although Gβ1γ5 and Gβ1γ7 could mediate binding to this receptor (Hou, et al., 2000), 
and several other studies offer additional examples of Gγ-directed coupling specificity in other receptor 
systems (Lim, et al., 2001; Jian, et al., 1999; Butkerait, et al., 1995).  The principal determinant of this 
specificity is likely the primary sequence of the C-terminal third of Gγ, independent of the type of lipid 
modification, as shown by studies with chimeric Gγ subunits (Jian, et al., 2001; Myung, et al., 2005).  
However, the type of lipid modification also has an effect on receptor coupling, as a geranylgeranyl 
moiety on Gγ1 or Gγ2 increases the affinity of the G protein for rhodopsin (Jian, et al., 2001) and the A1-
adenosine receptor (Yasuda, et al., 1996), respectively.  
Much of the difficulty in understanding coupling specificity between receptors and G proteins 
arises from the poor sequence homology of the intracellular loops that comprise the G protein binding site 
(reviewed in Wess, 1998).  Even closely related receptors that activate the same G protein can have 
dissimilar intracellular loops, making coupling determinations based on primary structure impossible 
(Hedin, et al., 1993), although a recently described statistical approach may help to overcome this 
difficulty (Muramatsu & Suwa, 2006).  Extensive studies have shown that IC 2 and 3 are the most 
common selectivity determinants in receptors, while occasionally, IC 1 and 4 modulate receptor-G protein 
interactions (reviewed in Wess, 1997).  Frequently, mutations in other regions of the receptor distant from 
the G protein binding site can affect coupling, suggesting that the global conformation of the receptor or 
changes in its dynamics may be just as important as specific side chain interactions in determining 
receptor-G protein selectivity (Gilchrist, et al., 1996; Perez, et al., 1996).   
Indeed, the observation that different agonists can affect which G proteins are activated by a 
given receptor supports a model where specific receptor conformations may be more or less favorable for 
coupling to specific G proteins (reviewed in Kenakin, 2003; Perez & Karnik, 2005).  In one recent 
example of ligand-directed signaling, structurally different ligands of the CB1-cannabinoid receptor 
differentially regulated the binding of the three homologous Gαi proteins to the receptor.  Interestingly, 
while one ligand was shown to behave as an agonist for Gi1 and Gi2 and as an inverse agonist for Gi3, 
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another ligand was shown to behave exactly opposite, as an inverse agonist of Gi1 and Gi2 and as an 
agonist for Gi3 (Mukhopadhyay & Howlett, 2005).  Similarly, the functional responses of protease-
activated receptor 1 activation differ whether the receptor is activated by thrombin or an agonist peptide.  
Mathematical modeling of the downstream signaling pathways indicates that the peptide may favor Gαq 
activation over Gα12/13 activation by 800-fold, while thrombin-mediated activation of PAR1 does not 
discriminate between the G proteins (McLaughlin, et al., 2005).  Clearly, specific receptor-G protein 
coupling results from a complex relationship between specific side chain interactions as well as the 
agonist-induced tertiary structure of the G protein binding site. 
 
Models of the receptor-G protein complex 
Recently, computational techniques have enabled investigators to apply this extensive amount of 
biochemical and biophysical information to the high resolution structures of rhodopsin and Gt to develop 
a molecular model of the receptor-G protein complex (Fig. 9) (Slusarz & Ciarkowski, 2004; Fotiadis, et 
al., 2004; Ciarkowski, et al., 2005).  Currently, the building blocks available for this complex are the 
inactive structure of rhodopsin (Teller, et al., 2001), the GDP-bound transducin heterotrimer (Lambright, 
et al., 1994), and the NMR structures of the C-termini of Gαt and Gγ1 (Kisselev, et al., 1998; Kisselev & 
Downs, 2003).  The first step in the modeling process is to “activate” the receptor to provide a binding 
site for Gt.  Two different techniques have been used to develop models of activated rhodopsin.  In the 
first, simplified energy calculations were used to find sterically and energetically reasonable arrangements 
of the transmembrane helices around all-trans retinal.  Of these, the arrangement that agreed most well 
with the conformation suggested by SDSL studies of rhodopsin was selected and the non-transmembrane 
structural elements were reconstructed (Nikiforovich & Marshall, 2003).  The second technique used 
target-driven molecular dynamics simulations to forcefully modify the cytoplasmic side of rhodopsin to 
meet the experimentally derived distances from SDSL (Slusarz & Ciarkowski, 2004).  Both of these 
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methods resulted in reasonable working models for activated rhodopsin that are consistent with 
experimental evidence. 
Since a critical receptor-binding site, the C-terminus of Gα, is absent in both structures of the 
heterotrimer (Lambright, et al., 1996; Wall, et al., 1995), it must be attached using the NMR structure of 
the C-terminal peptide bound to activated rhodopsin (Kisselev, et al., 1998).  Next, the G protein was 
visually docked onto a model of the activated receptor.  The topology and electrostatic potential of the 
binding site significantly limit the possible orientations between the receptor and G protein.  This 
particular model highlights three clusters of conserved interactions between the Gα C-terminus and the 
receptor, suggesting that the conserved residues in these proteins form a core interaction surface that may 
be shared among different receptor-G protein complexes (Slusarz & Ciarkowski, 2004).   
According to this model, the cytoplasmic surface of the receptor is not large enough to 
accommodate both the Gα C-terminus in its binding pocket and the Gγ C-terminus (Fig. 9a) (Slusarz & 
Ciarkowski, 2004).  One possible resolution is that receptors function as dimers, and increasing 
experimental evidence suggests that this is the case (reviewed in Javitch, 2004; Milligan, 2004), including 
the demonstration by neutron scattering of an R2·Gαβγ assembly between a leukotriene B4 receptor, 
BLT1, dimer and Gi (Baneres & Parello, 2003).  Rhodopsin also seems to be arranged in paracrystalline 
rows of dimers in native disk membranes as shown by atomic force microscopy (Fotiadis, et al., 2003; 
Fotiadis, et al., 2004; Liang, et al., 2003).  A model of the rhodopsin dimer was constructed by packing 
the rhodopsin crystal structure into the unit cell constraints determined by AFM (Liang, et al., 2003; 
Fotiadis, et al., 2004).  The interface between the two rhodopsin monomers is between helices IV and V 
in this model, as other orientations were excluded due to geometrical or energetic limitations.  The 
outward movement of helix VI during receptor activation was modeled as a 90° rotation of the helix about 
its long axis perpendicular to the membrane, which swings the intracellular half of this kinked helix away 
from the transmembrane bundle.  After adding the missing termini onto the G protein, the G protein was 
docked on a rhodopsin dimer where one monomer had been “activated”.  In the resulting structure, the 
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Gα C-terminus is inserted into the pocket formed upon receptor activation, the N-terminal helix of Gα 
occupies a groove that runs between the two monomers and the farnesyl group at the C-terminus of Gγ 
interacts with the inactive receptor in the dimer (Fig. 9b) (Fotiadis, et al., 2004).  An alternative model 
based on a different orientation of rhodopsin monomers within the rows of dimers was also proposed 
(Ciarkowski, et al., 2005).  However, the issue of the dimerization of rhodopsin-like heptahelical 
receptors remains a contentious one, where some maintain that receptor monomers are the functional unit 
in G protein coupling (Chabre & le Maire, 2005).    
The structural complementarity between the cytoplasmic face of dark rhodopsin and Gt was also 
recently explored using computational techniques to sample the rotational and translational space of 
several models of Gt with respect to rhodopsin (Fanelli & Dell'Orco, 2005).  The best 4000 solutions were 
winnowed down based on broad distance constraints from experimental data and then the remaining 
solutions were subjected to cluster analysis followed by energy minimization of the representative models 
in each cluster.  All of the parameters converge on the same rhodopsin-Gt complex, placing the Gαt C-
terminus in a shallow pocket at the center of the transmembrane helices where it is almost accessible to 
the conserved arginine in the D(E)RY motif that is important for G protein activation.  Interestingly, the 
architecture of the best complex between monomeric rhodopsin and Gt was also one of the best-scored 
solutions when Gt was docked to models of rhodopsin dimers or oligomers (Liang, et al., 2003).  The 
authors go on to propose that Gt may catalyze the structural changes from metarhodopsin I to Meta II, and 
that activation of both of these proteins may be concurrent processes in a supramolecular complex 
(Fanelli & Dell'Orco, 2005). 
Although a provocative model, the physiological implications of this supramolecular complex in 
phototransduction are less clear.  In the typical operating range of rhodopsin, with approximately one 
photoactivated receptor per disc membrane, the probability of hitting a preformed complex would be only 
10%, and stimulation of a preformed complex would only seem to activate one G protein.  In order to 
achieve the tremendous amplification of the visual signal, a sufficiently fast exchange 
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Figure 9 | Models of the receptor-G protein complex  Two representations of receptor-G protein 
complexes are shown.  (a) The R*·Gα(O)βγ complex was created by manually docking the G protein 
onto an activated receptor model based on the rhodopsin crystal structure (1GZM).  Sites on Gα that 
cross-link to residue S240 (cyan sphere) on the receptor are highlighted (cyan).  This type of data will be 
critical for improving models of the receptor-G protein complex, as it provides constraints for the location 
of IC 3 relatively to Gα.  In this model, the nucleotide-binding pocket is some 30 Å away from the 
receptor-binding surface.  (b) The model of an R2·Gα(O)βγ complex is based on coordinates generously 
provided by K. Palczewski (published in Fotiadis, et al., 2004). 
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G proteins on rhodopsin seems necessary for the efficient excitation of the photoresponse (Hamm, et al., 
1987). 
Current molecular models of the receptor-G protein complex meet most of the important 
experimental constraints cited above, and therefore provide a reasonable framework for the design and 
interpretation of future studies.  Particularly important information will come from additional distance 
constraints between the receptor and G protein, such as novel cross-links or interprobe measurements 
from fluorescence or electron paramagnetic resonance spectroscopy.  Also, models of the complex were 
first assembled from models of the components, the inactive receptor and C-termini of Gα and Gγ, and 
any improvement in the determination of these structures will enhance our ability to model the complex.  
Finally, the modeling process does not yet take into account conformational changes in the G protein, 
which are necessary to cause GDP release from Gα, because little is known about specific receptor-
mediated structural rearrangements in this protein. 
 
Sequential interactions may form the receptor-G protein complex 
An alternative hypothesis to account for the widely separated receptor binding sites on the C-
termini of Gα and Gγ is that these regions interact sequentially with the activated receptor (Herrmann, et 
al., 2004).  Kinetic light scattering was used to follow the association of maltose-binding protein-tagged 
peptides to photolyzed rhodopsin.  The peptide sequences used corresponded to the wild type Gαt C-
terminus, two high-affinity homologues of this peptide, and the farnesylated Gγ1 C-terminus.  The binding 
of the Gαt and Gγ1 constructs was mutually exclusive, and free Gα peptide could compete off MBP-Gγ 
and vice versa.  In the holo G protein, at least one lipid modification was necessary for rhodopsin binding 
and no binding was observed in the absence of lipid modifications, despite binding of the MBP-Gα C-
terminal peptide.  When the C-terminus of Gα was replaced with a high-affinity sequence, the authors 
noted the same kinetics of complex formation.  Combined with the previous observation that the C-
terminus of Gα cannot confer binding to the non-acylated heterotrimer, the authors conclude that the Gα 
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C-terminus is not involved in the initial encounter between the receptor and G protein.  They propose a 
model where Gβγ shields the Gα C-terminus until the farnesylated C-terminus of Gγ interacts with the 
receptor.  Once the C-terminus of Gα is exposed, it interacts with the receptor, leading to GDP release.  
This sequential fit mechanism is compatible with receptor dimers, but it does not require dimerization in 
order to explain previous observations about receptor contact sites on the G protein. 
 
Molecular Basis for G Protein Activation 
 
Activated receptors catalyze GDP release from G protein heterotrimers.  This is the rate-limiting 
step in G protein activation and, consequently, the activation of all downstream signaling proteins 
(Higashijima, et al., 1987b).  Until GTP binds, a high-affinity complex between the receptor and G 
protein is formed (Rodbell, et al., 1971b; Emeis, et al., 1982; Bornancin, et al., 1989).  Based on the 
current models of this interaction, the nucleotide-binding pocket is some 30 Å away from the nearest 
receptor contact site (Fig. 9a) (Bourne, 1997; Hamm, 1998; Slusarz & Ciarkowski, 2004; Fotiadis, et al., 
2004; Ciarkowski, et al., 2005).  Thus, the receptor must induce a conformational change in the G protein 
to cause GDP release over this distance.  Several potential mechanisms for receptor-catalyzed GDP 
release have been proposed, mainly based on the effects of various mutations on the basal and receptor-
catalyzed nucleotide exchange rates of the G protein.  To date, there is little direct evidence of specific 
receptor-mediated conformational changes in G proteins, and the molecular mechanism of receptor-
catalyzed nucleotide exchange remains one of the most important unanswered questions in the field of G 
protein signaling. 
 
Potential mechanisms of receptor-catalyzed GDP release 
 Tracing structural elements from known receptor contact sites to the nucleotide-binding pocket 
highlights several potential routes that may transmit the conformational changes causing GDP release 
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(Fig. 10).  Perhaps the most obvious connection is the α5 helix, which links the C-terminus of Gα to the 
β6/α5 loop containing the guanine ring-binding TCAT motif.  Mutations in this motif greatly enhance 
spontaneous GDP release (Iiri, et al., 1994; Posner, et al., 1998; Thomas, et al., 1993), including the 
activating mutation in Gαs, A366S, that causes pseudohypoparathyroidism and gonadotropin-independent 
precocious puberty in male patients (Iiri, et al., 1994).  A homologous mutation in Gαi1 also greatly 
enhances GDP release (Posner, et al., 1998).  No significant structural differences were observed in the 
crystal structure of the Gαi1-A326S heterotrimer compared to the wild type protein, but the GDP-binding 
site was only partially occupied.  The authors suggest that GDP release can occur without large 
conformational changes in Gα (Posner, et al., 1998).  However, inspection of the crystal structures seems 
to require a significant structural rearrangement to free the GDP buried between the GTPase and helical 
domains.  Unfortunately, crystallography cannot elucidate the structural transition that occurred to release 
GDP from ~70% of heterotrimers in this crystal.  The crystal lattice could be working to reinforce the 
more stable, GDP-bound conformation in the nucleotide-free heterotrimers, which is why no significant 
structural differences were observed.    
Several mutagenesis studies have implicated the α5 helix in receptor-catalyzed nucleotide 
exchange.  Alanine-scanning mutagenesis of Gαt identified three residues on the inward face of the helix 
with substantially increased rates of basal and receptor-catalyzed exchange, and several residues on the 
outward face of this helix that decreased catalyzed exchange (Marin, et al., 2001b).  A similar study based 
on proline-scanning mutagenesis of the α5 helix generally resulted in mutants with increased rates of 
basal exchange and decreased rates of catalyzed exchange (Marin, et al., 2002).  A flexible five-glycine 
linker inserted between the extreme C-terminus and the α5 helix only modestly decreased binding to the 
receptor, but severely reduced receptor-mediated nucleotide exchange, possibly due to disruption of the 
connection between the receptor contact site and GDP-binding pocket.  Doubling the length of the α5 
helix by repeating its sequence generated a mutant whose receptor coupling was only modestly reduced.  
This mutant argues that preserving the rigid connection between the C-terminus and GDP-binding pocket 
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is important for exchange, and further, that the α5 helix may be sufficient for coupling, as extending the 
helix increases the distance between the receptor and the protein core of Gα, thereby disrupting other 
potential receptor contacts (Natochin, et al., 2001).  Recently, an isoleucine-to-proline mutation at the C-
terminus of the α5 helix has been shown to reduce the stimulatory activity of a D2-dopamine receptor 
mimetic peptide on nucleotide exchange in Gi (Nanoff, et al., 2006).  In addition to providing a direct 
connection between the Gα C-terminus and the β6/α5 loop, receptor-induced perturbations in the α5 
helix may be transmitted to the GDP-binding pocket via the α1 helix and β2 and β3 strands, as suggested 
by mutagenesis and computational studies (Marin, et al., 2001b; Ceruso, et al., 2004).  Using SDSL, we 
have been able to observe receptor activation-dependent conformational changes in the α5 helix at sites 
distant from the receptor contact surface.  The five-glycine linker uncouples these conformational changes 
from receptor binding (Chapter III). 
Similar to the α5 helix, the β6 strand may connect receptor binding of the α4/β6 loop to the 
binding pocket at the β6/α5 loop (Fig. 10).  Several alanine mutations in this region demonstrated 
reduced receptor-catalyzed activation, despite normal receptor binding (Onrust, et al., 1997).  The α3/β5 
loop in Gαs appears to be a receptor contact site (Grishina & Berlot, 2000) that may transmit a 
conformational change along the α3 helix to Switch III.  Interactions between Switch III and the αD/αE 
loop at the domain interface have been implicated in receptor-mediated activation of Gαs (Grishina & 
Berlot, 1998).  Disruption of these interactions may open the gap between the helical and GTPase 
domains to release GDP.  Interestingly, an arginine-to-glutamate mutation in Switch III has recently been 
shown to stabilize the nucleotide-free conformation of Gαt and, excitingly, this mutant blocks the 
rhodopsin-catalyzed activation of wild type Gt (Pereira & Cerione, 2005).  If applicable in other systems, 
this dominant negative mutant will be extremely valuable for the investigation of G protein coupling.   
Several intramolecular contacts with the N-terminal region have also been implicated in 
nucleotide exchange (Fig. 10).  Carboxyl terminal truncations in Gαo and Gαi2 resulted in reduced affinity 
for GDP because of impaired interactions with the β1 and β3 strands 
 34
  
 
 
 
 
 
 
 
 
 
Figure 10 | Structural elements connecting receptor contacts to the GDP-binding pocket  The α5 
helix and β6 strand connect the C-terminus and α4/β6 loop to the nucleotide binding pocket at the β6/α5 
loop (orange).  The α3/β5 loop is connect to Switch III by the α3 helix (lime).  Perturbations in Switch III 
may be communicated across the interdomain interface through its interactions with the αD/αE loop 
(lime).  The αN helix is connected to the P-loop and Switches I and II through its interactions with β 
strands 1-3 (teal).  Additionally, these β strands also interact with the α5 helix (orange) and may 
participate in front-to-back communication between these elements. 
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(Denker, et al., 1995; Denker, et al., 1992).  A hydrophobic interaction between the β1 strand and α5 
helix in Gαt stabilizes the GDP-bound conformation (Natochin, et al., 2000).  The mutations described in 
these studies perturb the hydrophobic core of the Gα subunit, which may account for their effects on 
nucleotide exchange more than any specific side chain interactions.  However, through its interactions 
with the αN helix and αN/β1 loop, the activated receptor may similarly disturb these key stabilizing 
interactions, reducing the protein’s affinity for GDP.  Conformational changes in these regions could also 
affect β strands 1-3, and thereby alter Switches I, II and the P-loop, all of which form important 
interactions with GDP. 
Two models for receptor-mediated GDP release require that the receptor change the relative 
orientation of the Gα and Gβγ subunits (Fig. 11).  In the first model, the receptor uses the N-terminal 
helix of Gα as a lever-arm to pull Gβγ away from Gα.  This would pry Switches I and II away from the 
nucleotide-binding pocket, resulting in GDP release (Iiri, et al., 1998).  In support of this hypothesis, 
shortening the αN helix by f four amino acids at its C-terminus to mimic the putative orientation induced 
by the receptor allows Gβγ to act as an exchange factor for Gαs (Rondard, et al., 2001).  The second, gear-
shift, model proposes that the receptor uses the αN helix to force Gβγ into Gα, allowing the N-terminus 
of Gγ to engage the helical domain of Gα.  This interaction may cause the interdomain gap between the 
helical and GTPase domains of Gα to open, leading to GDP release (Cherfils & Chabre, 2003).   
These models propose that Gβγ plays a homologous role to the guanine nucleotide exchange 
factors for monomeric G proteins, and that the interaction between Gα and Gβγ plays a critical role in G 
protein activation.  Indeed, several alanine mutations at the switch interface of Gβ are defective in 
receptor-catalyzed nucleotide exchange despite normal heterotrimer formation (Ford, et al., 1998).  
Furthermore, mutations in the C-terminus of Gγ have been shown to increase receptor-catalyzed 
nucleotide exchange (Azpiazu & Gautam, 2001).  A small peptide has also recently been shown to 
increase spontaneous nucleotide exchange in Gαi1.  Structural studies indicate that this peptide 
dramatically displaces Switch II away from the nucleotide- binding pocket, presumably leading to GDP 
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Figure 11 | Two hypotheses on the role of Gβγ in GDP release  In the lever-arm model, the receptor 
uses the αN helix (cyan) as a lever to pull Gβγ away from Gα, thereby prying Switch II (yellow) away 
from the nucleotide binding pocket and causing GDP release (red arrow).  The alternative, gear-shift, 
model requires that the receptor push Gβγ closer to Gα.  This allows the N-terminus of Gγ (gold) to 
engage the helical domain (purple), thus forcing the binding pocket due to the reorientation of the two 
domains. 
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release, although the nucleotide remains bound in the crystal structure of the complex (Johnston, et al., 
2005).  This study supports the lever-arm mechanism of nucleotide exchange.  With direct examination of 
the Gα-Gβ interface using SDSL, we observe only subtle R*-mediated conformational changes in Switch 
II, but significant decreases in the mobility of labeled side chains in Switch I (Chapters IV and V).  
Additional studies are necessary to test the catalytic role of Gβγ in receptor-catalyzed GDP release.     
Bound GDP is buried between the GTPase and helical domains of Gα (Fig. 5), although the 
direct interactions are formed by the GTPase domain.  In order for GDP to be released, some of the 
contacts between these two domains may likely be broken.  Several mutagenesis studies have implicated 
these contacts in nucleotide exchange, however, the results seem to differ depending on the Gα subunit 
involved.  In Gαs and Gαi1, disrupting these interactions resulted in increased rates of basal or decreased 
rates of receptor-catalyzed exchange (Marsh, et al., 1998; Warner, et al., 1998; Grishina & Berlot, 1998; 
Warner & Weinstein, 1999).  The former indicating that an opening of the interdomain cleft reduces GDP 
affinity, and the latter indicating that the receptor may induce conformational changes across the domain 
interface through these interactions.  However, these connections do not seem to be important for 
regulating the basal and catalyzed exchange rates in Gαt (Marin, et al., 2001a).  Thus, the role of 
interdomain interactions in G protein activation remains unclear, but inspection of the crystal structure 
seems to require a movement of these two domains relative to each other in order to release GDP.  
Indeed, an interdomain reorientation has been suggested by molecular dynamics simulations of Gαt 
(Ceruso, et al., 2004) and glycine-to-proline mutations in each of the interdomain linkers enhances the 
basal nucleotide exchange rate of Gα (Majumdar, et al., 2004). 
Although each of the conformational changes described above is supported by mutagenesis and 
biochemical data, additional information is needed to understand the structural basis of receptor-mediated 
G protein activation.  Certainly, a high resolution crystal structure would answer many questions about 
the orientation of these two proteins, the sites of interaction between them and the activating 
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conformational changes that lead to complex formation and trigger GDP release.  Unfortunately, this 
complex has proven exceedingly difficult to crystallize, and its structure may not be solved in the near 
future.  In the meantime, different experimental approaches must be employed to refine current molecular 
models of the receptor-G protein complex and characterize the conformational changes leading to GDP 
release.   
Some knowledge about the nature of conformational changes in the G protein also enables 
speculation about the molecular trigger causing a particular type of change.  Site-directed mutagenesis of 
residues on the side of the α5 helix opposite the β6 strand significantly increase the basal nucleotide 
exchange rate of Gα (Marin, et al., 2001b).  Perhaps the receptor disrupts these interactions in a similar 
manner.  Assuming the general mechanism of receptor-catalyzed GDP release is conserved among 
receptor-G protein couplings, sequence analysis of conserved residues in these proteins may further serve 
to illustrate the important interactions for this process.  One model suggests that there is a conserved 
binding site between the α5 helix and the adjacent β2/β3 loop for the conserved arginine in the D(E)RY 
motif of receptors, and that this interaction may underlie the mechanism for R*-mediated conformational 
changes in Gα (Oliveira, et al., 1999).  Much work remains to be done, however, to identify the structural 
basis of G protein activation, characterize the nucleotide-free conformation of the G protein and 
incorporate these data into improved models of the receptor-G protein complex.      
 
GTP-mediated alteration of the receptor-G protein complex 
Physiologically, the receptor-G protein complex is transient due to rapid binding of GTP, the 
concentration of which exceeds that of GDP by several-fold in cells.  Binding of GTP to the Gα subunit 
causes a structural rearrangement of Gα(GTP), Gβγ and the receptor that permits effector interactions.  A 
comparison between the Gα(GDP) (Lambright, et al., 1994; Mixon, et al., 1995) and Gα(GTPγS) (Noel, 
et al., 1993; Coleman, et al., 1994a) crystal structures reveals conformational changes in the three Switch 
regions (Fig. 5c).  This structural rearrangement eliminates the Gβγ binding surface, mediating subunit 
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separation.  The overall similarity of these crystal structures suggests that separation from the receptor is 
likely due to a reversal of the conformational changes that led to GDP release.  GDP can also cause 
complex dissociation (Birnbaumer, et al., 1972), and shares a similar affinity as GTP for the receptor-
bound nucleotide-free Gα (Heck & Hofmann, 2001).  Thus, irreversible G protein activation relies on the 
greater concentration of GTP within the cell and a structural rearrangement of Gα and Gβγ following its 
binding.  However, there is little direct experimental evidence describing the GTP-induced 
conformational changes in the receptor-G protein complex.   
Studies of G protein activation in cells suggest that the receptor and G protein subunits may 
remain closely associated following receptor activation in vivo (Bunemann, et al., 2003), so questions as 
to the structural consequences of GTP binding to this complex remain unanswered.  Recent evidence 
suggests that Gβγ may be necessary to cause the dissociation of Gα from the receptor (Herrmann, et al., 
2004).  A mutant Gαt that has a C-terminal sequence with an increased affinity for Meta II can bind 
independently of its GDP- or GTP-bound conformational state, but dissociates like the native protein only 
in the presence of Gβγ.  One explanation for this observation is that the G protein may proceed through a 
reversed sequence of interactions from those described above, leading to complex dissociation, which 
would require Gβγ (Herrmann, et al., 2004).   
In addition to the conformational changes observed in the Switch regions, GTP binding also 
causes a conformational change in the myristoylated N-terminus of Gα.  Site-directed fluorescence 
labeling indicates that, while the non-myristoylated N-terminus returns to its dynamically disordered 
conformation, the myristoylated N-terminus moves into an even more hydrophobic environment in the 
Gα(GTP) state than in either the Gα(GDP) or heterotrimeric conformations (Fig. 6).  These data suggest 
that the conformational changes associated with GTP binding expose an intramolecular binding site for 
the N-terminus (Preininger, et al., 2003).  Heterotrimeric G proteins may undergo a GTP-dependent 
myristoyl switch causing subunit dissociation similar to that described for the small GTPase ARF, where 
nucleotide exchange is coupled to a conformational change that leads to dissociation from the membrane 
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(Goldberg, 1998).  The disordered state of the non-myristoylated N-terminus of Gα(GTP) may reflect the 
transition state leading to intramolecular binding (Fig. 6) (Preininger, et al., 2003).  Additional studies are 
necessary to identify the binding site for the N-terminus, such as crystallization of myristoylated Gα or 
biophysical distance measurements.  Also, the structural consequences for the N-terminus of non-
myristoylated Gα subunits remain unexplored. 
 
Activation of Downstream Effector Proteins 
 
Following subunit dissociation, Gα(GTP) and Gβγ each go on to activate specific downstream 
effector proteins (Table 2).  Several crystallographic studies provide significant insight into the structural 
basis of G protein-effector interactions (Fig. 12).   
 
Gα interactions with effectors 
The first structural information concerning the mechanism of effector activation came from a 
comparison of the Gα(GTPγS) (Noel, et al., 1993; Coleman, et al., 1994a) and Gα(GDP) (Lambright, et 
al., 1994; Mixon, et al., 1995) structures.  Significant structural differences were identified in three 
flexible loops, Switches I-III, near the γ-phosphate binding site.  Upon GTP binding, these flexible loops 
become ordered in a structural rearrangement that disrupts the Gβγ-binding site to form a new surface for 
effector interactions.  Although the crystal structures suggest that GTP binding orders the Switch regions, 
SDSL studies of Switch II indicate that this region is flexible in both conformations and that GTP binding 
actually increases its dynamics (see Chapter IV). 
Each Gα family member interacts with effector proteins in a highly specific manner.  Classical 
Gα effectors include photoreceptor cGMP phosphodiesterase (Gαt sequesters the inhibitory PDEγ 
subunit), adenylyl cyclase (Gαs activates, Gαi inhibits), phospholipase C β (Gαq), and p115RhoGEF 
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Table 2 | Effector proteins of heterotrimeric G protein subunits  (Adapted from Kristiansen, 2004)   
 
Family Subunit Effector Regulation Reference 
Gs αs AC1-9 Stimulates (Pierce, et al., 2002)
  c-Src Stimulates (Cabrera-Vera, et al., 2003)
  RGS-PX1 Stimulates 
  Tubulin Stimulates GTPase activity 
 αolf ACS Stimulates 
Gi αt1 PDE6 Stimulates (Mochizuki, et al., 1999)
 αt2 PDE6 Stimulates (Pierce, et al., 2002)
 αgust PDE Stimulates (Cabrera-Vera, et al., 2003)
 αi1-3,o AC5, 6 Inhibits 
  c-Src Stimulates 
  Rap1GAP Sequesters 
  Ca2+ channels Inhibits (αo) 
  GIRK channels Stimulates (αi) 
  Tubulin Stimulates GTPase activity 
  GRIN1, 2 Unknown 
 βγ PI3Kβ, γ Stimulates (Pierce, et al., 2002)
  AC2a, 4a, 7 Stimulates (Cabrera-Vera, et al., 2003)
  AC1 Inhibits (Willets, et al., 2003)
  PLCβ1-3 Stimulates (Preininger, et al., 2006)
  PLD Inhibits (Spiegelberg & Hamm, 2005)
  GRK2, 3 Recruits to membrane (Gerachshenko, et al., 2005)
  GIRK1, 2, 4 Stimulates  
  ATP-sensitive K+ channels Stimulates  
  Rho, Rac Recruits to membrane  
  Bruton’s tyrosine kinase Stimulates  
  Tsk tyrosine kinase Stimulates  
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Table 2 | Continued 
 
Family Subunit Effector Regulation Reference 
Gi βγ PKD Stimulates  
  Calmodulin Inhibits calmodulin kinase  
  Tubulin Stimulates GTPase activity  
  Dynamin I Stimulates GTPase activity  
  Shc Stimulates (MAPK)  
  HDAC5 Inhibits  
  SNAP-25 Inhibits exocytosis  
  Ras GEF CDC25Mm Stimulates (Ras)  
Gq αq,11,14,16 PLCβ1-4 Stimulates (Pierce, et al., 2002)
  LARG  Stimulates (Rho) (Cabrera-Vera, et al., 2003)
  GRK2, 3 Stimulates (Willets, et al., 2003)
  Bruton’s tyrosine kinase Stimulates (p38 MAPK)  
G12 α12,13 p115-, PDZ-, LA-RhoGEF Stimulates (Rho; stress fibers) (Jiang, et al., 1998)
  Ras GAP GAP1m Stimulates (Ras) (Pierce, et al., 2002)
  E-cadherin Stimulates (β-catenin release)  
 
a AC2 and AC4 are activated synergistically by Gαs and Gβγ. 
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(Gα13).  Structures of representative effector complexes from each Gα subfamily have been solved, 
Gαs·AC (Tesmer, et al., 1997b), Gαt·PDEγ·RGS9 (Slep, et al., 2001), Gα13·p115RhoGEF (Chen, et al., 
2005b), and Gαq·GRK2·Gβγ (Tesmer, et al., 2005), demonstrating a localized effector binding surface on 
Gα (Fig. 12).  In each complex, hydrophobic side chains from the effector insert into a pocket formed 
between the N-termini of the α2 (Switch II) and α3 helices (Fig. 12a).  Additional contacts are made 
between the C-termini of these helices and the α2/β4 and α3/β5 loops that determine effector specificity.  
The tertiary structures of these interacting regions are well conserved, with the exception of the α3/β5 
loop in Gαs, suggesting that in most subfamilies effector specificity is determined by the primary 
sequence of the Gα subunit (Tesmer, et al., 2005).  The specificity of Gαs is regulated by backbone 
conformation as well as primary sequence (Sunahara, et al., 1997b).  The recently solved structure of the 
Gαq·GRK2·Gβγ complex also reveals an interesting 105° rotation of Gαq that brings Switch I, Switch II, 
Linker 1, and the αB/αC loop in closest proximity to the membrane surface 30 Å away (Fig. 12c) 
(Tesmer, et al., 2005).  Both the Gαt·PDEγ·RGS9 and Gα13·p115RhoGEF structures would allow a 
similar reorientation of Gα, but the Gαs·AC structure would not.   
Unfortunately, the N-terminal helix of Gαq is disordered in this structure, and its role in complex 
formation is unclear.  Myristoylation of the N-terminus of Gαi1 is important for the inhibition of AC 
(Gallego, et al., 1992; Taussig, et al., 1993; Dessauer, et al., 1998) and at least one N-terminal cysteine in 
Gαq is necessary for normal activation of PLCβ1 (Wedegaertner, et al., 1993) regardless of its 
palmitoylation state (Hepler, et al., 1996).  Additional studies are needed to dissect the role of the N-
terminus and its fatty acid modifications in the modulation of effector interactions.  In addition to the 
effector binding site illustrated by the crystal structures, several studies indicate that the α4/β6 loop of Gα 
is important for PDEγ binding to Gαt (Rarick, et al., 1992; Liu, et al., 1999) and the activation of AC by 
Gαs (Berlot & Bourne, 1992).   
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 The structural features of these interactions also underlie several other observations regarding 
effector activation.  First, the GDP-bound Gα subunit has some ability to interact with effectors, although 
with 20-100-fold reduced potency than the GTP-bound protein (Skiba, et al., 1996; Sunahara, et al., 
1997a).  These data suggest that reassociation of Gα with Gβγ is required for the complete termination of 
G protein signaling.  Second, even closely related Gα subunits activate unique complements of effector 
proteins.  For example, Gαi2 and Gαi3 specifically inhibit only the forskolin- or Gαs-stimulated activation 
of AC, respectively (Ghahremani, et al., 1999).  Similarly, the α1-adrenergic receptor elevates 
intracellular Ca2+ through two distinct mechanisms by coupling to Gαq and Gα11 (Macrez-Lepretre, et al., 
1997).  Finally, some Gα subunits have only one identified effector, like Gαt (PDEγ), while some couple 
to several effector proteins, like Gα12 [several RhoGEFs, PLCε, and protein phosphatase 5, among others 
(reviewed in Riobo & Manning, 2005)].  Certainly not all Gα effectors have been identified, and the 
search for novel proteins that interact with Gα subunits is an active area of research. 
 
Gβγ interactions with effectors and regulatory proteins 
Initially, Gβγ was thought to facilitate the termination of the G protein signal by passively 
binding to Gα and hastening the return of the heterotrimer to the plasma membrane, thereby reducing 
spontaneous activation of Gα in the absence of receptor stimulation (Neer, 1995).  This perspective 
changed when Gβγ was shown to activate a K+-selective ion channel in cardiac atrial cells (Logothetis, et 
al., 1987).  Since that time, many other effectors of Gβγ have been identified (Table 2), including PLCβ2 
and β3 (Katz, et al., 1992; Li, et al., 1998), AC (Tang & Gilman, 1991), β-adrenergic receptor kinase 
(Pitcher, et al., 1992), phosphoinositide-3-kinase (Stephens, et al., 1994), mitogen-activated protein 
kinase pathway components (Inglese, et al., 1995), and K+ and Ca2+ ion channels (Logothetis, et al., 1987; 
Reuveny, et al., 1994; Ikeda, 1996; Herlitze, et al., 1996).  More novel effectors are being discovered all 
the time (Dell, et al., 2002; Spiegelberg & Hamm, 2005; Blackmer, et al., 2001; Blackmer, et al., 2005; 
Gerachshenko, et al., 2005).   
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Many mutational and structural studies demonstrate that effector proteins share unique, but 
overlapping binding sites on Gβγ (Fig. 12b).  Alanine-scanning mutagenesis in Gβ identified several 
residues that mediate interactions with PLCβ2, ACII, βARK, and ion channels (Ford, et al., 1998; 
Panchenko, et al., 1998; Li, et al., 1998).  For example, the ACII interaction surface maps roughly to 
blades 2, 3, and 5, while the N-terminal interface of Gβ interacts with G protein-activated inwardly 
rectifying K+ (GIRK) channels 1 and 4 (Ford, et al., 1998).  Point mutations in blades 1-4 or the outer 
loops of blades 2, 6, and 7 inhibit PLCβ2 binding (Ford, et al., 1998; Panchenko, et al., 1998), whereas 
the interaction between PLCβ3 and Gβγ is blocked by point mutations within blades 2 and 5 (Li, et al., 
1998).  Crystal structures of Gβγ in complex with the regulatory protein phosducin (Gaudet, et al., 1996; 
Loew, et al., 1998), the effector, GRK2, (Lodowski, et al., 2003; Tesmer, et al., 2005) and a small peptide 
that blocks these interactions (Davis, et al., 2005), as well as competition studies using Gβ peptides that 
block the interaction between Gβγ and the receptor for activated C kinase 1 (Chen, et al., 2005a), further 
demonstrate that Gβγ-binding proteins use a unique complement of residues within a common binding 
surface to mediate binding (Davis, et al., 2005).  Moreover, this surface is also the binding site for the 
Switch II region in Gα subunits, and thus, Gα subunits are effective inhibitors of Gβγ-effector 
interactions. 
The overall structure of Gβγ is preserved in all of the crystal structures solved thus far, although 
the interstrand loops move significantly upon complex formation to form an appropriate binding site for 
specific interacting proteins.  The dynamics of these loops probably enable Gβ to bind to such a variety of 
structurally diverse targets.  An additional structural change is observed in Gβ1γ1·phosducin structures 
(Gaudet, et al., 1996; Loew, et al., 1998; Gaudet, et al., 1999), where a cavity is introduced between 
blades 6 and 7 that may represent a putative farnesyl-binding pocket for Gγ C-terminus  (Loew, et al., 
1998).  Phosducin sequesters Gβ1γ1 away from the membrane in photoreceptor cells to attenuate G protein 
signaling, and this phosducin-induced switch in the Gγ farnesyl moiety provides the structural basis for 
membrane dissociation.  This structural change in Gβγ may be a general mechanism by which Gβγ-
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Figure 12 | Subunit interactions with effector proteins  (a) Surface rendering of Gαt(GTPγS) with the 
PDEγ binding site highlighted (purple).  In all of the effector-Gα crystals that have been solved to date, 
the effector proteins interact with a hydrophobic pocket (yellow asterisk) lined by the α2 (Switch II) and 
α3 helices (adapted from Tesmer, et al., 2005).  (b) Surface renderings of Gβ1γ1 (1GOT) highlighting the 
unique, but overlapping binding sites of several interacting proteins.  The surfaces in the top row were 
determined by crystallography, and the surfaces in the bottom row were determined by alanine-scanning 
mutagenesis in Gβ1 as well as peptide competition studies (RACK1).  (c) The recently solved structure of 
the Gαi/q·GRK2·Gβ1γ2 complex (2BCJ) clearly demonstrates illustrates the structure of subunit-effector 
interactions.  Moreover, this complex suggests the importance of macromolecular complexes for 
organizing signal transduction pathways in vivo.   
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binding proteins regulate the localization of Gβγ and attenuate signaling through Gα subunits, however, it 
has not been observed in other complexes. 
Downstream signaling through Gβγ may also be regulated through the specific composition of the 
dimer.  All of the possible dimers formed from combinations of Gβ1 or Gβ2 with Gγ1, Gγ2, Gγ3, Gγ5, or 
Gγ7 could activate PLCβ isoforms except the retinal-specific dimer, Gβ1γ1 (Iniguez-Lluhi, et al., 1992; 
Ueda, et al., 1994).  Similarly, Gβ1γ1 was less effective at stimulating ACII and inhibiting ACI than other 
dimer combinations (Iniguez-Lluhi, et al., 1992; Ueda, et al., 1994).  Comparing Gβ1γ2 with Gβ5γ2 
demonstrates that Gβ5γ2 is a much weaker inhibitor of ACI, ACV, and ACVI, and Gβ1γ2 stimulates ACII 
while Gβ5γ2 inhibits it (Bayewitch, et al., 1998b; Bayewitch, et al., 1998a).  Later studies showed that the 
remaining Gβ subunits activate ACII with a potency similar to Gβ1, and Gβ2 and Gβ4 inhibited ACI as 
well as Gβ1, while Gβ3 was 10-fold less potent (McIntire, et al., 2001).  Interestingly, the specificity of 
these subtype interactions differ among effectors, as both Gβ1γ2 and Gβ5γ2 activate PLCβ2 with similar 
potency and efficacy (Zhang, et al., 1996).  Additionally, the potency of Gβγ inhibition of voltage-
dependent N-type Ca2+ currents differs depending on the identity of the Gβ subunit in the dimer (Ruiz-
Velasco & Ikeda, 2000).  Similarly, GRK2 can be recruited to the plasma membrane by Gβ1 and Gβ2, but 
not Gβ3, to initiate receptor desensitization (Daaka, et al., 1997).  Together, these data indicate that the 
Gβ isoform is a major determinant of effector coupling specificity. 
In addition, the Gγ isoform and, in particular, its lipid modification has been shown to affect 
effector coupling.  The native geranylgeranylated Gβ1γ2 is more effective in activating PLCβ than 
farnesylated Gβ1γ1 and Gβ1γ11 (Myung, et al., 1999).  If the prenyl groups are reversed on these proteins, 
farnesylated Gβ1γ2 becomes less able to activate PLCβ, while the activity of the geranylgeranylated Gβ1γ1 
and Gβ1γ11 increases (Myung, et al., 1999).  Similarly, farnesylation of Gβ1γ2 decreased its ability to 
activate ACII, but geranylgeranylation of Gβ1γ1 and Gβ1γ11 was unable to restore their activity, suggesting 
that the primary sequence as well as the prenyl modification are important determinants of effector 
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activation (Myung, et al., 1999).  Altering the position of the geranylgeranyl by insertions, deletions, or 
mutations in the C-terminus of Gγ5 also disrupted its interactions with PLCβ (Akgoz, et al., 2002).  Most 
recently, studies with Gγ chimeras have shown that the N-terminus of Gγ2 is a better activator of ACII 
than the N-terminus of Gγ1.  Also, the geranylgeranylated C-terminus of Gγ2 is a more potent activator of 
PLCβ2 and a more potent inhibitor of ACI than the geranylgeranylated C-terminus of Gγ1 or farnesylated 
C-terminus of Gγ2 (Myung, et al., 2005).  Clearly, the composition of the Gβγ dimer plays an important 
role in coupling to specific effectors.  Areas of future research include identifying the structural features 
responsible for this specificity and characterizing many of these interactions in systems in vivo. 
 
G Protein Inactivation 
 
Intrinsic GTPase activity of Gα 
Termination of the G protein signal is achieved upon the intrinsic hydrolysis of GTP to GDP by 
the Gα subunit and reassociation of the heterotrimer (Fig. 13).  Structural insight into the mechanism of 
GTP hydrolysis in Gα subunits was provided by crystal structures of Gα(GDP) bound to aluminum 
fluoride (Sondek, et al., 1994; Coleman, et al., 1994a).  Aluminum fluoride is a strong activator of Gα 
and binds with GDP in the active site as a tetracoordinate AlF4− ion (Sondek, et al., 1994; Coleman, et al., 
1994a).  In the crystal structures of Gα(GDP·AlF4−), the fluoroaluminate is in a square planar 
configuration, with the oxygen of the β-phosphate and a water molecule as transaxial ligands, forming a 
tetragonal bipyramid (Sondek, et al., 1994; Coleman, et al., 1994a; Sprang, 1997).  Inspection of this 
transition state active site reveals the functional roles of several residues important for GTPase activity, 
including a conserved glutamine that polarizes and orients the nucleophilic water molecule and a 
conserved arginine that stabilizes the developing negative charge on the leaving group to facilitate its 
release (Fig. 13a) (Noel, et al., 1993; Coleman, et al., 1994a).  Due to its important role in GTP 
hydrolysis, ADP-ribosylation of this arginine by cholera toxin abolishes the GTPase activity of Gαs and 
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Gαt (Freissmuth & Gilman, 1989; Van Dop, et al., 1984), as do mutations of this residue (Coleman, et al., 
1994a; Landis, et al., 1989; Sprang, 1997).  Mutations that slow GTP hydrolysis lead to constitutive 
activation of Gα, which has been shown to cause sporadic endocrine tumors (Lyons, et al., 1990) and 
McCune-Albright syndrome (Weinstein, et al., 1991).  Two mutations in the nucleotide-binding pocket, a 
glycine-to-valine substitution in the P-loop and a glycine-to-alanine mutation in Switch II, stabilize a 
Gαi1(GDP·Pi) complex that is associated with a substantial conformational change in Switch II (Fig. 13a) 
(Berghuis, et al., 1996; Raw, et al., 1997).  An additional lysine-to-proline mutation in Switch I 
accelerates a conformational change in the Switch regions, but decreases the rate of GTP hydrolysis, 
suggesting that this transition is an obligatory step leading to bond breakage (Thomas, et al., 2004).  
Thus, the dynamics of the Switch regions may be critical for GTP hydrolysis.   
Recently, structures of Gα12(GDP·AlF4−) and Gα13(GDP) highlight a novel conformational 
change that is likely coupled to GTP hydrolysis in this family of Gα subunits (Fig. 13c) (Kreutz, et al., 
2006).  A comparison of these two structures indicates that the αD/αE1 loop puckers upon binding AlF4−, 
and that a glutamate residue in this loop acts as a spring to rotate the helical domain away from the 
GTPase domain upon GTP hydrolysis.  This conformational change may facilitate dissociation of these 
Gα subunits from effector proteins or influence the rates of nucleotide exchange or hydrolysis, however, 
additional studies are needed to appreciate the consequences of this unique structural feature of the Gα12 
family.   
The intrinsic GTP hydrolysis activity varies among Gα family members, where the Gαs (3.5 min-
1 at 20 °C) and Gαi (1.8-2.4 min-1 at 20 °C) family members have higher GTPase activity than members 
of the Gαq (0.8 min-1 at 30 °C) or Gα12 (0.2 min-1 at 30 °C) families (except Gαz, 0.05 min-1 at 30 °C).  
The structural reasons for this difference are not clear, but may include differences in the helical domains, 
N- and C-termini, or subtle fluctuations in backbone dynamics (Cabrera-Vera, et al., 2003; Fields & 
Casey, 1997).  The mechanisms responsible for the variations have not been studied in detail, but rather, 
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Figure 13 | Mechanisms of GTP hydrolysis by Gα  (a) Crystallographic snapshots of GTP hydrolysis.  
Four important residues for stabilizing the transition state are shown (yellow side chains), including the 
highly conserved arginine (Arg) and glutamine (Gln) residues.  In the Gα(GTP) conformation (1GIA), 
serine (Ser) and threonine (Thr) coordinate Mg2+, and the nucleophilic water molecule is observed 
approaching the γ-phosphate (loop between Arg and Thr is removed in subsequent panels for clarity).  
Prior to bond breakage, a conformational change occurs in Switches I and II that orients Gln and Arg 
toward the γ-phosphate (based on Gαt(GDP); 1TAG) in a pre-transition state complex.  The transition 
state is stabilized by Gln and Arg (1GFI), and a conformational change in Switch II is observed in 
Gα(GDP·Pi) following bond breakage (1AS2).  The switch regions are disordered in Gαi1(GDP) (1GDD), 
and Gβγ binding significantly remodels the nucleotide binding pocket (1GP2).  (This series of snapshots 
was based on the discussion presented in Thomas, et al., 2004).  (b) Structure of the RGS9 RGS domain 
binding to Gαt(GTP·AlF4−) (1FQK).  The RGS proteins enhance the basal GTP hydrolysis rate of Gα 
subunits by stabilizing the transition state.  Structures of these complexes indicate that the RGS domain 
itself does not directly interact with the nucleotide, unlike the GAPs of monomeric G proteins.  (c) The 
recently solved structures of Gαi/12(GTP·AlF4−) (1ZCA) and Gαi/13(GDP) (1ZCB) suggest that GTP 
hydrolysis leads to an 8.5° rotation of the helical domain away from the GTPase domain in this family of 
Gα subunits (arrow).  This rotation is apparently due to an activation dependent “spring” in the αD/αE 
loop mediated by a glutamate residue (stick side chains) unique to the Gα12 family.  In the active 
conformation, this glutamate (green) puckers the αD/αE loop.  Following GTP hydrolysis, this residue 
forms a salt bridge with an adjacent lysine across the binding pocket (yellow). 
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research in this area has focused on the identification and characterization of the increasing number of 
proteins that regulate the intrinsic GTPase activity of Gα subunits. 
 
GTPase activating proteins 
Initially, the hydrolysis of GTP was thought to be an unregulated function of Gα subunits that 
offered intrinsic control of the duration of the G protein signal.  However, it was soon noted that the 
intrinsic GTPase activity of many purified Gα subunits in vitro was much slower than the deactivation 
rates of G protein signaling processes in vivo, suggesting that some GTPase accelerating factor was lost 
during purification (reviewed in Ross & Wilkie, 2000).  The first two GAPs identified were the Gα 
effectors PLCβ1 (Gαq) and PDEγ (Gαt) (Berstein, et al., 1992; Arshavsky & Bownds, 1992).  More 
recently, it has been demonstrated that ACV is a GAP for Gαs (Scholich, et al., 1999).  Thus, there is a 
common paradigm that effectors, after activation by Gα, can negatively regulate the amplitude and 
duration of the G protein signal. 
In addition to effector-mediated feedback inhibition, another class of GAPs has been identified, 
the RGS proteins.  These proteins share a common 120-amino acid RGS domain that forms a bundle of 
nine α-helices that binds to the Switch regions on Gα.  This domain enhances the GTPase activity of Gα 
by stabilizing the transition state conformation and orienting the Gα backbone to stabilize the 
nucleophilic water molecule (Fig. 13b) (Slep, et al., 2001; Tesmer, et al., 1997a).  However, the RGS 
domain itself does not directly take part in the chemistry of hydrolysis, unlike the GAPs for small G 
proteins that contribute an extrinsic catalytic arginine residue to the active site (reviewed in Sprang, 
1997).  The molecular mechanism for effector-mediated GAP activity has not been clearly determined.  
These proteins may also stabilize the transition state, but differences in activity between effector GAPs 
and RGS GAPs have been observed.  For example, RGS4 produces a two-fold greater activation of GTP 
hydrolysis in Gαq over PLCβ, but PLCβ is 100 times more potent than RGS4 (Mukhopadhyay & Ross, 
1999).  However, Gβγ can inhibit the GAP activity of both of these proteins (Chidiac & Ross, 1999), 
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consistent with the idea that Gβγ, effectors and RGS proteins all compete for binding to Gα.  This effect 
may also be due to Gβγ-mediated stabilization of Gα(GDP), which binds poorly to effectors and RGS 
proteins.  Regardless, RGS proteins could inhibit effector activation in addition to accelerating GTP 
hydrolysis.  Alternatively, the Gαt effector, PDEγ, enhances the GAP activity of RGS9 on Gαt by 
increasing its affinity for the protein (Skiba, et al., 1999; Skiba, et al., 2000), and structural studies 
indicate that the effectors and GAPs may have evolved to interact with non-overlapping binding sites 
(Tesmer, et al., 2005).   
Again, the N-terminal domain of Gα is an important, but uncharacterized, regulator of Gα-GAP 
interactions (Ross & Wilkie, 2000).  Proteolysis, phosphorylation, and palmitoylation (Wang, et al., 1998; 
Tu, et al., 1997; Glick, et al., 1998) have all been shown to decrease the affinity of Gα for GAPs by 100-
fold, while myristoylation increases the affinity of this interaction (Tu, et al., 1997).  Mutations in the αN 
helix reduce the basal GTP hydrolysis rate of Gαz, suggesting that its role may be to maintain the 
structure of the active site (Wang, et al., 1999).  The helix may also contribute to the binding site for the 
GAP, although this type of interaction is not observed in either crystal structure (Slep, et al., 2001; 
Tesmer, et al., 1997a).  Other regions in both proteins outside of the known molecular interface have also 
been shown to influence Gα-GAP interactions.  For example, the helical domain of Gαt is a key 
molecular determinant of RGS9 selectivity of Gαt over Gαi (Skiba, et al., 1999), and flanking regions of 
RGS4 are important for binding to Gαq, but not Gαi.  Along with their role as key desensitizers of 
heterotrimeric G protein signaling, RGS proteins are recognized as important scaffolds that facilitate the 
rapid and specific activation and termination of signal transduction pathways mediated by heptahelical 
receptors (reviewed in McCudden, et al., 2005; Ross & Wilkie, 2000).  
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Novel Regulation of G Protein Signaling 
 
The basic model of G protein signaling can be expanded to include two additional regulatory 
mechanisms, non-receptor GEFs and guanine nucleotide dissociation inhibitors (GDIs).  Several proteins 
have been identified that increase GTPγS binding to Gα subunits, including GAP-43, β-APP, presenilin 1, 
RKIP, Ric-8A, and AGS1 (reviewed in Sato, et al., 2006).  These proteins appear to be selective for the 
Gαi family, although Ric-8A can also activate Gαq in vitro (Tall, et al., 2003).  Additional work remains 
to be done before the regulation of the GEF activity of these proteins and its functional consequences are 
completely understood, although Ric-8A has been shown to play a critical role in asymmetric cell division 
during embryogenesis in C. elegans (reviewed in McCudden, et al., 2005) and AGS1 is important for 
processing signals in the suprachiasmatic nucleus during the circadian cycle (reviewed in Sato, et al., 
2006).   
By contrast to the soluble GEFs, which cause GDP release, the class of GDI proteins inhibit GDP 
dissociation from Gαi family members, which can dampen signaling through Gα or prolong signaling 
through Gβγ (reviewed in McCudden, et al., 2005; Sato, et al., 2006).  The GDI proteins have been 
implicated as crucial players in asymmetric cell division during embryogenesis (reviewed in McCudden, 
et al., 2005; Willard, et al., 2004; Sato, et al., 2006).  Most of these proteins contain one or more GoLoco 
motifs (reviewed in Willard, et al., 2004).  The GoLoco domain is a 19-amino acid sequence that slows 
spontaneous GDP release from Gα(GDP) and prevents its interaction with Gβγ.  A crystal structure 
shows that the N-terminus of the GoLoco domain of RGS14 forms an α-helix that is sandwiched between 
Switch II and the α3 helix of Gαi(GDP) (Kimple, et al., 2002).  The GoLoco peptide extends to the 
helical domain, and contacts Switch I and GDP.  Perturbation of Switch II would preclude coincident 
binding of Gβγ to this complex.  The arginine in the highly conserved DNR sequence in GoLoco motifs, 
inserts into the nucleotide binding pocket and interacts with the α- and β-phosphates of GDP and the 
bridging oxygen atom between them.  GoLoco binding also results in the formation of a salt bridge 
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between the P-loop and Switch I that is also observed in the structure of the Gi heterotrimer (Wall, et al., 
1995), which locks GDP into the binding pocket.  These two new stabilizing interactions provide the 
structural basis for the GDI activity of GoLoco-containing proteins (Kimple, et al., 2002).   
 
Novel Approaches to Study G Protein Structure and Function 
 
Nuclear magnetic resonance spectroscopy 
Recently, the high yield expression and purification of an isotopically-labeled Gαt chimera has 
been reported, thereby greatly facilitating the study of this protein with NMR (Abdulaev, et al., 2005b).  
The two-dimensional 1H-15N heteronuclear single-quantum correlation (15N-HSQC) spectrum of 
Gα(GDP) is relatively well dispersed and 340 of 397 cross-peaks are readily identifiable.  Upon the 
addition of AlF4−, many of the amide resonances in the spectrum shift, particularly the indole 1HN and 15N 
resonances of two tryptophan residues in Switch II and the adjacent α3 helix, consistent with the crystal 
structures of the protein in these conformations (Sondek, et al., 1994; Lambright, et al., 1994).  After this 
initial study, the authors measured the 15N-HSQC spectrum of a reconstituted heterotrimer (Abdulaev, et 
al., 2005a).  Interestingly, the chemical shifts observed upon Gβγ binding are generally similar to those 
observed in the spectra for the AlF4−- and GTPγS-bound Gα subunit, specifically for the three tryptophan 
residues and C-terminal phenylalanine for which definitive assignments were made, suggesting that these 
two protein conformations are also similar.  A model is proposed whereby Gβγ organizes the C-terminus 
of Gα and the nucleotide-binding pocket for binding to R* and GTP, respectively.  In order to reconcile 
the NMR results with the crystal structures of these conformations, the authors point out that the 
conformation of Gα(GDP·AlF4−) can be modeled into the structure of the heterotrimer with minimal 
changes in the interfacial contacts between the proteins.  This model rotates the helical domain of Gα 
closer to the N-terminus of Gγ, similar to the gear-shift model described above, and it is not inconsistent 
with the structural heterogeneity observed between the crystal structures of G protein heterotrimers (Wall, 
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et al., 1995; Lambright, et al., 1996).  However, it seems extremely unlikely that AlF4− can bind in the 
presence of Gβγ as this event is highly dependent on a structural rearrangement of Switch II. 
This approach has also been used to monitor conformational changes associated with receptor-
catalyzed GTPγS binding (Ridge, et al., 2006).  In this study, the authors found that R*-generated 
Gα(GTPγS) was more conformationally dynamic than that generated independently of R*, suggesting 
that the increase in protein dynamics may be due to interactions with R* and Gβγ.  Changes in the NMR 
spectra during R*-catalyzed exchange continued several hours after GTPγS binding appeared to be 
complete, which the authors suggest is due to slow dissociation of Gα(GTPγS) and Gβγ.  Support for this 
hypothesis comes from the observation that a soluble receptor mimic that does not catalytically activate 
the G protein (Abdulaev, et al., 2000) is found to form a stable complex with a GTPγS-bound 
heterotrimer (Ridge, et al., 2006).  The C-terminus, which displays two conformational states in the 
heterotrimer (Abdulaev, et al., 2005a), is found exclusively in an “activated” conformation in the putative 
R*·Gα(GTP)βγ complex and the Gα(GTPγS) conformation (Ridge, et al., 2006). 
Although complete assignment of the cross-peaks and analysis of the solution structures will be 
necessary before the differences between the crystal structures and the NMR data are completely 
understood, the current analysis raises some questions.  For example, it seems unlikely that the dynamics 
of a tryptophan residue in Switch II, a region that contributes significantly to the Gβγ-binding surface 
(Lambright, et al., 1996; Wall, et al., 1995), would increase upon heterotrimer formation.  Indeed, these 
flexible loops are absent in the structure of Gαi1 that lacks either crystal contacts or Gβγ to stabilize this 
region (Mixon, et al., 1995).  Our own SDSL studies indicate that Gβγ dampens the backbone dynamics 
of Switch II (Chapter IV).  Also, the authors suggest that Gβγ pre-organizes the nucleotide-binding site 
for GTP, but this role is difficult to reconcile with the well-established negative cooperativity between 
heterotrimer formation and GTP binding (Higashijima, et al., 1987b), as is the observation that the 
heterotrimer dissociates slowly following GTP binding.  Certainly this effort is in the initial stages, but it 
has already raised some provocative issues concerning the dynamics of G protein signaling.  Moreover, it 
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is on a trajectory to provide the first high resolution structural information for the nucleotide-free Gα, 
which would hopefully lend further insight into the molecular mechanism of GDP release.   
 
Studies of G protein function in living cells 
 Much of our understanding of G protein structure and function is the result of a vast number of 
biochemical experiments conducted in vitro where the constituents of an assay can be carefully controlled 
and manipulated.  Although this reductionist approach is often the only way to dissect a particular 
experimental question, it does set aside the basic fact that the G protein cycle runs inside of cells in the 
presence of a variety of regulatory and scaffolding proteins that almost certainly influence every one of 
the reactions and interactions that have been carefully described in vitro.  Recently, several groups have 
adopted fluorescence-based approaches to study G proteins in living cells (reviewed in Hebert, et al., 
2006).  One method is based on the nonradiative energy transfer from Renilla reniformis luciferase 
attached to the C-terminus of the receptor to a blue-shifted variant of Aequorea victoria green fluorescent 
protein attached to one of the three G protein subunits (Gales, et al., 2005).  Upon degradation of its 
substrate, luciferase emits light at a wavelength that will excite GFP when the two molecules are within 
100 Å of each other.  This bioluminescence resonance energy transfer approach detected basal coupling 
of receptors and G proteins, rapid ligand-induced increases in the association of receptors and G proteins, 
as well as a slow decrease in BRET reflecting receptor desensitization.  Interestingly, the agonist-
promoted increase in BRET was highly dependent on the Gα isoform present in the complex, suggesting 
that this assay provides a new tool to assess the specificity of receptor-G protein interactions in vivo.   
 Fluorescence resonance energy transfer is similar to BRET, where the energy donor is a 
fluorescent protein that is excited by an external light source rather than a chemical reaction.  Receptor 
activation increases FRET between fluorescent proteins attached to the Gαi helical domain and the N-
terminus of Gγ, reaching maximum in 1-2 s, which is five times slower than the rate of receptor activation 
(Bunemann, et al., 2003).  Somewhat surprisingly, the increase in FRET indicates that the fluorescent 
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proteins are coming closer together following receptor activation, not moving farther apart as would be 
expected if the subunits dissociated following activation.  Energy transfer between Gα and a Gγ subunit 
tagged at the C-terminus decreased after receptor stimulation, further supporting a conformational 
rearrangement in the heterotrimer rather than subunit dissociation.  This observation runs contrary to 
biochemical experience, as well as an earlier study using this technique to study G protein activation in 
yeast (Janetopoulos, et al., 2001), which support the subunit dissociation hypothesis.  Recent evidence 
suggests that the discrepancy may be due to the identity of the Gα subunit.  Upon extending the FRET 
studies to include all members of the Gαi family, Gαo was the only member to exhibit a receptor 
activation-dependent decrease in FRET, suggesting subunit dissociation.  When a region of the helical 
domain containing αB/αC loop in Gαi was replaced with the homologous sequence from Gαo, the mutant 
Gαi demonstrated a decrease in FRET, suggesting that this region was critical for preventing subunit 
dissociation following activation (Frank, et al., 2005).   
 These fluorescence-based techniques have raised some provocative questions regarding G protein 
activation in intact cells.  Unfortunately, the fluorescent protein tags are relatively large, and may have a 
substantial impact on the structure and dynamics of the system under study.  Fortunately, new 
technologies are being developed that allow the use of a small molecule as an energy donor, rather than a 
bulky fluorescent protein, and this approach has been used to explore conformational changes in receptors 
while preserving downstream signaling (Hoffmann, et al., 2005).  Additional studies seem to be necessary 
before the structural changes responsible for the differences in energy transfer are truly understood.  
Perhaps these in vivo systems might benefit from a brief return to the test tube, where much more detailed 
biochemical analyses may be carried out to assess the impact of the intracellular milieu and the 
fluorescent tags on G protein activation and subunit dissociation.   
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Summary 
 
Many of the unanswered questions about the structural basis for function in heterotrimeric G 
proteins can be framed in terms of what is not known from the many crystal structures of these proteins in 
a variety of conformations and complexes.  For example, the amino and carboxyl termini of Gα play key 
functional roles in mediating its interaction with regulatory proteins, yet limited structural information for 
these regions is available from crystallographic studies.  Furthermore, answers to some of the most 
important questions in G protein signaling await a better understanding of the structure of the receptor-G 
protein complex, including agonist-mediated conformational changes in receptors, point-to-point 
interactions between the receptor and G protein, the transition leading to GDP release, the structural 
determinants of R*-G protein specificity, and the functional role of receptor dimerization in G protein 
activation.  Unfortunately, this complex has been exceedingly difficult to crystallize despite the extensive 
efforts of a number of investigators.  In the interim, alternative biophysical approaches can be combined 
with the currently available structural information to develop increasingly better models for the structural 
basis of receptor-catalyzed G protein activation.  Additionally, these biophysical approaches can provide 
important information on the dynamics of proteins that is unavailable from crystal structures.  The 
dynamic nature of proteins is critical for normal enzymatic function, interaction with effector proteins, 
and binding of chemical ligands.  Thus, studies of G protein dynamics, such as those described here, will 
complement the extensive structural data to improve our understanding of the biomechanics of 
heterotrimeric G protein signaling. 
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CHAPTER II 
 
APPROACH TO THE STUDY OF G PROTEIN DYNAMICS 
 
Research Goals 
 
 As described in Chapter I, a great deal is known about the structure of heterotrimeric G proteins 
from x-ray crystallography, providing insight into GTP-induced conformational changes, how these 
conformational changes allow interaction with effector proteins, and the mechanism of GTP hydrolysis.  
However, despite the fundamental importance of receptor-catalyzed G protein activation in cellular 
signaling, relatively little is known about this process as compared to the other regulatory events in the G 
protein cycle.   
 When heptahelical receptors embedded in the cell membrane are activated by an extracellular 
agonist, they undergo a conformational change that allows G protein binding (Farrens, et al., 1996).  This 
interaction leads to GDP release from the Gα subunit, which is the rate-limiting step in the activation of 
all downstream signaling pathways (Higashijima, et al., 1987b).  Subsequently, a high-affinity complex 
between the activated receptor and nucleotide-free conformation of the G protein is formed, which is 
stable in the absence of guanine nucleotides (Rodbell, et al., 1971b; Emeis, et al., 1982; Bornancin, et al., 
1989).  Biochemical studies described in the previous chapter suggest that GDP is bound nearly 30 Å 
distant from the nearest receptor-contact site on the G protein (Bourne, 1997; Hamm, 1998), suggesting 
the hypothesis that the receptor must induce some sort of conformational change in the G protein to 
cause GDP release over this distance.  The primary goal of my dissertation research has been to 
determine the structural mechanism by which an activated receptor causes GDP release through the 
approach described by the following specific aims:  
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Specific Aim 1:  Identify regions of Gα that undergo receptor activation-dependent 
conformational changes. 
 
Specific Aim 2:  Specifically define the nature of the conformational changes in these 
regions. 
 
Specific Aim 3:  Determine the functional role of these conformational changes in 
mediating GDP release. 
 
 
Each of these specific aims relies on site-directed spin-labeling and EPR spectroscopy, which 
allow us to directly monitor the dynamics of specific regions within the G protein.  As discussed in 
Chapter I, many biochemical studies provide indirect evidence for a variety of routes from receptor 
contact sites to the nucleotide binding pocket.  In Specific Aim 1, several of these regions were tested for 
receptor activation-dependent conformational changes using EPR, including the α5 helix and Switches I 
and II (Chapters III-V), among others (Chapter VI).  The activation-dependent conformational changes 
observed in the α5 helix were chosen for additional studies comprising Specific Aims 2 and 3.  With this 
work, we were able to show that a specific rigid-body movement of the α5 helix couples receptor binding 
to GDP release (Chapter III). 
In addition to receptor activation-dependent conformational changes, our experimental approach 
enables the examination of each structural transition throughout the G protein activation pathway from 
heterotrimer formation to GTP binding.  As a result, a secondary goal of my research has been to 
characterize these transitions in terms of changes in protein dynamics with respect to the differences 
observed in the crystal structures of G proteins in various conformations.  While EPR is very useful for 
exploring protein conformations for which structural data is limited, such as the receptor-bound G protein, 
it also provides valuable information about how the protein behaves in solution, which may be different 
than predictions based on crystallized proteins.  For example, in the GTP-bound conformation, Switch II 
adopts a highly flexible backbone conformation, a result that is the opposite of previous predictions based 
on the crystal structures of these two conformations (Chapter IV).  Essentially, the overall goal of this 
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work was to animate the crystallographic snapshots of heterotrimeric G proteins at all points of the G 
protein cycle to learn more about how these proteins function in solution.   
 
Experimental Strategy 
 
 Our lab has adopted a site-directed spin-labeling approach to study G protein dynamics with EPR 
spectroscopy.  This approach relies on the incorporation of a thiol-reactive paramagnetic probe at a 
specific site in the protein to serve as a reporter of local structure and dynamics.  Structural changes can 
be identified as differences in the EPR spectra recorded for different conformations of the G protein (Fig. 
14a). 
 
Electron paramagnetic resonance spectroscopy 
 Electron paramagnetic resonance spectroscopy measures the absorption of microwave radiation 
by an unpaired electron oriented in a magnetic field.  This is very similar to nuclear magnetic resonance 
spectroscopy, which measures the absorption of radiofrequency radiation by spin-active nuclei.  In either 
method, the electron or nucleus is extremely sensitive to its local environment, enabling the spectrum to 
provide detailed structural information.  Indeed, a continuous-wave EPR spectrum provides information 
about mobility, solvent accessibility, and distances between paramagnetic centers (reviewed in Hubbell, 
et al., 2000).   
 The thiol-reactive methanethiosulfonate spin label is the most commonly used paramagnetic 
probe in biophysical studies of proteins (Fig. 14b).  This label reacts with cysteine residues in proteins to 
generate the nitroxide side chain R1, and the dynamics of the nitroxide on the nanosecond time scale can 
be determined by spectral lineshape analysis (Budil, et al., 1996).  In helices and loops, at sites where the 
nitroxide does not contact other residues, the internal motion of R1 is dominated by torsional oscillations 
of dihedrals χ4 and χ5 (Mchaourab, et al., 1996; Langen, et al., 2000; Columbus, et al., 2001), giving rise 
to a characteristic anisotropic motion of the nitroxide (Columbus, et al., 2001).  This inherent motion is 
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Figure 14 | Site-directed spin-labeling and EPR spectroscopy  (a) Site-directed cysteine mutagenesis 
provides a reactive thiol group for the specific incorporation of the paramagnetic nitroxide probe.  Local 
structural changes in the labeled region can be identified by comparing the EPR spectra recorded for 
different conformations of the protein (red and black traces).  (b) The methanethiosulfonate spin label 
reacts with a cysteine residue in the protein to generate the paramagnetic side chain, R1. 
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modulated by backbone motion on the nanosecond time scale, and variations in motion of R1 at different 
sites within helices reflect variations in local backbone motions (Columbus & Hubbell, 2004; Columbus 
& Hubbell, 2002).  The internal motion of R1 is also modulated by weak interactions of the nitroxide, a 
situation readily recognized in the lineshape by the appearance of features corresponding to reduced 
amplitudes and/or rates of motion.  This property confers spectral sensitivity to the local structure of the 
protein (Fig. 15) (Mchaourab, et al., 1996; Hubbell, et al., 2000).  Thus, the EPR spectra of R1 at a 
selected set of sites can be used to gain information on both local backbone dynamics and conformation.  
Additionally, conformational exchange on the micro- to millisecond time scale is slow on the X-band 
EPR time scale and, in principle, the presence of multiple protein conformations in exchange can be 
recognized by multiple components in the spectrum. 
 Although spectral lineshape analysis is the predominant means of analysis in our studies, EPR 
can also be used to determine the distance between the R1 side chain and another paramagnetic center, 
such as a metal ion or second spin label.  Conventional, continuous-wave EPR can accurately measure 
distances between 8-20 Å (Rabenstein & Shin, 1995), while pulsed techniques, such double electron-
electron resonance EPR, can potentially extend that distance to approximately 70 Å (Pannier, et al., 
2000).  This latter method uses the dipolar coupling between the paramagnetic centers to measure the 
distance, similar to two-dimensional NMR experiments that measure the dipolar coupling between 
adjacent nuclei. 
 Site-directed spin-labeling has become a powerful tool in the study of protein structure and 
function because it offers several advantages over traditional approaches.  In contrast to NMR, EPR is not 
restricted by the size of the protein because only the paramagnetic centers are spectroscopically visible.  
Additionally, membrane proteins and large protein complexes have proven difficult to crystallize, 
however, these systems are amenable to study with SDSL.  Indeed, extensive spin-labeling studies of 
rhodopsin were the first to reveal the conformational changes that accompany receptor activation 
(Farrens, et al., 1996).  However, EPR is unable to provide the structural resolution attainable by NMR 
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Figure 15 | EPR spectra are sensitive to protein structure  Models of the R1 side chain at several sites 
in the α subunit of the Gi1 heterotrimer (1GP2) are shown together with the corresponding EPR spectra.  
Each spectrum is a fingerprint of the local environment of the spin label, and these four spectra are 
characteristic of R1 side chains in loops, α-helices, sites of tertiary contact, and buried sites.  As the 
mobility of the side chain decreases, the spectra become broader and the intensity of the low-field peak 
increase (blue arrow).  If a conformational change in the protein decreases the mobility of the spin label 
at one site, similar changes are observed in its EPR spectrum.  In this way, changes in the EPR spectrum 
can be interpreted in terms of changes in the mobility of the spin-labeled side chain.   
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and x-ray crystallography, and perturbations in the structure due to incorporation of the probe, although 
small, are also a concern (Langen, et al., 2000).  Fortunately, we have been able to interpret the results of 
our SDSL studies in terms of the numerous G protein crystal structures.  By combining static, high 
resolution structural data with dynamic, low resolution EPR data, we can enhance our understanding of G 
protein function beyond the information provided by either method alone. 
 
Site-directed spin-labeling in the G protein α subunit 
In order to begin these studies, a cysteine-depleted Gαi1 base mutant was constructed so that 
cysteines could be introduced at specific locations for labeling with a fluorophore or paramagnetic probe.  
The Gαi1 protein was selected as the template for the base mutant since it is more easily expressed in 
bacteria than transducin, and can interact with rhodopsin nearly as well (Medkova, et al., 2002).  Since 
these two Gα subunit family members share 80% sequence similarity (Gilman, 1987), and both interact 
with rhodopsin, the conformational changes observed in the Gαi1 background are likely to be a good 
approximation of those in Gαt.  Rhodopsin will be used as the receptor in this system because it can be 
easily purified in large quantities from bovine retina.  Moreover, much of what is known about GPCR 
structure and function comes originally from studies on rhodopsin that have since been extended to other 
receptors.  
The base mutant was generated by substituting six solvent-accessible cysteines (of ten total 
cysteines) with conservative amino acids.  These mutations were C3S, C66A, C214S, C305S, C325A, 
and C351I.  The substituted amino acid was chosen based on the specific environment of the native 
cysteine, where serine was placed at more polar sites and alanine was chosen for less polar sites.  The 
isoleucine substitution at C351 at the extreme C-terminus of Gα was critical for maintaining normal 
interactions with the receptor as serine and alanine substitutions prevented receptor-catalyzed GTPγS 
binding.  The base mutant expresses well, is folded properly, and has rates of receptor-catalyzed 
[35S]GTPγS binding and GTP hydrolysis similar to wild type Gαi1 (Medkova, et al., 2002).   
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Once the endogenous reactive cysteines were removed, site-directed cysteine mutagenesis in the 
base mutant allowed us to specifically incorporate paramagnetic labels to monitor local conformational 
changes virtually anywhere in the protein.  To date, the lab has generated nearly sixty single (Fig. 16) and 
twenty double cysteine mutants of the base mutant, most of which express functional protein for labeling 
and study with EPR spectroscopy (Appendix A).      
A typical EPR experiment begins by recording an EPR spectrum for the purified, labeled Gα 
subunit, which can be compared to the location of the labeled side chain in the G protein structure.  Next, 
each limit conformation of Gα is examined by recording EPR spectra after the addition Gβ1γ1, dark 
(inactive) rhodopsin in urea-washed rod outer segment membranes, light, and finally, GTPγS (Fig. 17).  
Conformational changes are identified by comparing the EPR spectra recorded for any two states of the G 
protein.  For example, the receptor activation-dependent conformational changes in Gα leading to GDP 
release can be observed by comparing the EPR spectra recorded before and after photoactivation of the 
receptor (Fig. 17).  In this way, we have mapped the dynamics of each structural transition along the 
activation pathway of Gα for numerous sites in the protein. 
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Figure 16 | Summary of site-directed cysteine mutants  Many single cysteine mutations have been engineered into the base mutant background.  
Most of the mutants have been successfully labeled for study with EPR spectroscopy (green spheres), although some did not express (red 
spheres).  So far, the lab has focused on the αN helix (Medkova, et al., 2002; Preininger, et al., 2003), the α5 helix and β6 strand (Chapter III) and 
Switches I and II (Chapters IV and V).  Certainly other interesting regions of the molecule remain to be explored. 
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Figure 17 | Typical EPR experiment  Beginning with the purified, labeled GDP-bound Gα subunit, each limit conformation of Gα is explored 
by EPR.  Conformational changes are identified by comparing the EPR spectra recorded for any two conformations.  In this example, there is a 
receptor activation-dependent decrease in the mobility of the spin-labeled side chain (compare black and red traces). 
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Materials and Methods 
 
 Since most of the methods used to obtain the data presented in the subsequent chapters are the 
same (Fig. 18), I will include a description of the common methods used in this work here, and address 
unique approaches in the appropriate sections. 
 
Materials 
GDP, GTP, and GTPγS were purchased from Sigma-Aldrich, Inc. (St. Louis, MO).  The 
methanethiosulfonate spin label reagent, S-(1-oxy-2,2,5,5-tetramethylpyrrolinyl-3-methyl) 
methanethiosulfonate, was purchased from Toronto Research Chemicals, Inc. (North York, Ontario, 
Canada).  All other reagents and chemicals were of the highest purity available. 
 
Construction, expression and purification of Gα subunits 
An expression vector containing the Gαi1 cDNA sequence with a hexahistidine tag between 
amino acid residues M119 and T120 in the helical domain was generously provided by Dr. Maureen 
Linder (Washington University, St. Louis, MO).  All mutations were made in this construct using the 
Quickchange® Site-directed Mutagenesis kit (Stratagene, La Jolla, CA), where the Gαi1 expression vector 
is PCR-amplified with two antiparallel primers (Integrated DNA Technologies, Inc., Coralville, IA) 
containing the mutant codon sequence with Pfu DNA polymerase according to the manufacturer's 
protocol.  The parent plasmids are degraded by DpnI endonuclease, and the mutant plasmid is 
transformed into Epicurian coli XL1-Blue supercompetent cells (Stratagene, La Jolla, CA).  The plasmid 
is isolated using the Wizard® Plus SV Minipreps DNA Purification System (Promega Corp., Madison, 
WI) and sequenced to verify the mutation (Vanderbilt DNA Sequencing Core, Nashville, TN). 
Expression and purification were conducted essentially as previously described (Medkova, et al., 
2002).  Mutant plasmid DNA is transformed into BL21-Gold (DE3) Escherichia coli (Stratagene, La 
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Jolla, CA) for protein expression.  These cells are grown at room temperature to an OD600 of 0.3-0.6 units 
and then induced with 100 µM IPTG for 12-16 h.  Post-induction cell pellets from a 1 L culture are 
resuspended in 40 mL of Buffer A (50 mM NaH2PO4, pH 8.0, 300 mM NaCl) containing 20 µM GDP, 10 
mM β-mercaptoethanol, 5 mM imidazole, 100 mM PMSF and 1 µg/mL each of the protease inhibitors 
pepstatin A, leupeptin, and aprotinin.  Cells are disrupted by sonication, and then high-speed 
centrifugation separates the soluble and particulate fractions.  The recombinant proteins are then purified 
on a HIS-Select™ column (Sigma-Aldrich, Inc., St. Louis, MO) according to the manufacturer’s 
instructions with minor variations.  The cytosolic fraction is incubated with 5 mL of a 50% slurry of 
nickel affinity resin for 1 h at 4 °C and poured into a column.  The unbound proteins are removed by 
washing with 20 mL of Buffer A containing 5 mM imidazole.  Mutant Gα is eluted with 8 mL of Buffer 
A containing 40 mM imidazole and dialyzed against Buffer B (50 mM Tris, pH 8.0, 50 mM NaCl, 2 mM 
MgCl2) with 20% glycerol, 20 µM GDP, 10 mM βME, 100 µM PMSF and 1 µg/mL each of pepstatin A, 
leupeptin, and aprotinin overnight at 4 °C.  The dialysate is then loaded onto a 5 mL Source™ 15Q 
column (Amersham Biosciences, Piscataway, NJ).  The sample is chromatographed at 150 psi on a 
Beckman System Gold® HPLC system (Beckman Coulter, Fullerton, CA) with a linear gradient from 50 
to 200 mM NaCl in buffer B, and the Gαi1 mutant subunit elutes at approximately 150 mM NaCl.  The 
protein is concentrated and exchanged into Buffer B with 100 µM GDP and 10% glycerol.  After anion 
exchange, purification typically results in 1-5 mg of greater than 85% pure protein as estimated by 
Coomassie blue staining of SDS-polyacrylamide gels.  Protein concentrations are determined by the 
Coomassie blue method using bovine serum albumin as a standard (Pierce Biotechnology, Inc., Rockford, 
IL).  
 
Preparation of ROS membranes, Gαt, and Gβ1γ1 from bovine retina 
ROS membranes were prepared from bovine retinas as previously described and stored at -80 ºC 
in buffer containing 10 mM MOPS, pH 8.0, 90 mM KCl, 30 mM NaCl, 2 mM MgCl2, 0.1 mM EDTA, 1 
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mM DTT, and 50 µM PMSF (Mazzoni, et al., 1991).  Urea-washed ROS membranes were stripped with 4 
mM urea as previously described (Yamanaka, et al., 1985).  Rhodopsin concentration was determined by 
measuring the absorbance of solubilized ROS membrane suspensions at 500 nm before and after 
bleaching.   
Bovine Gαt and Gβ1γ1 were extracted from unwashed ROS membranes as described (Mazzoni, et 
al., 1991).  Briefly, ROS membranes were washed four times with isotonic buffer (5 mM Tris, pH 8.0, 
120 mM KCl, 0.6 mM MgCl2, 1 mM DTT, 0.1 mM EDTA, and 0.1 mM PMSF) and twice with hypotonic 
buffer (0 mM KCl).  Transducin was eluted from the membranes by washing twice with hypotonic buffer 
containing 0.1 mM GTP.  The two subunits were then resolved with a HiTrap™ Blue HP blue sepharose 
column (Amersham Biosciences, Piscataway, NJ) on a Biologic LP system (Bio-Rad Laboratories, Inc., 
Hercules, CA) at 4 ºC after the addition of 40 mM MgSO4 to encourage subunit dissociation.  Gβγ does 
not bind to the blue sepharose and elutes in the flow-through in Buffer C (10 mM Tris, pH 7.5, 20 mM 
MgSO4, 1 mM EDTA, 10% glycerol, and 14.3 mM βME) containing 150 mM NaCl.  The Gβγ subunit is 
concentrated and exchanged into storage buffer (10 mM Tris, pH 7.5, 100 mM NaCl, 5 mM βME, and 
10% glycerol) and placed at -80 ºC.  Gαt begins to elute at approximately 500 mM NaCl in Buffer C.  The 
Gαt subunit is concentrated and exchanged into storage buffer containing 10 µM GDP.  All urea-washed 
ROS and Gβ1γ1 samples were buffer exchanged into Buffer D (20 mM MES, pH 6.8, 100 mM NaCl, 2 
mM MgCl2, and 10% glycerol) prior to EPR experiments. 
 
Intrinsic fluorescence activity assay 
In order to ensure that the mutant proteins are folded properly, have GDP bound and can undergo 
a GTP-dependent conformational change, a minimum 40% increase in the intrinsic fluorescence of W211 
must be measured following the addition of AlF4−.  The fluorescence of 100 nM of the Gα subunit is 
monitored in Buffer B by excitation at 300 nm and emission at 345 nm before and after the addition of 
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AlF4− (10 mM NaF and 50 µM AlCl3) using a Varian Cary Eclipse fluorescence spectrophotometer 
(Varian, Inc., Mulgrave, Victoria, Australia).  
 
Nucleotide exchange assay 
The basal rate of GTPγS binding is determined by monitoring the relative increase in the intrinsic 
fluorescence (λex 300 nm, λem 345 nm) of Gα (500 nM) in Buffer G (10 mM MOPS, pH 7.2, 130 mM 
NaCl, 2 mM MgCl2) for 40 min at 15 ºC following the addition of 10 µM GTPγS. Similarly, the receptor-
catalyzed rate is measured by monitoring the increase in the intrinsic fluorescence of Gα reconstituted 
with Gβ1γ1 (500 nM) in the presence of 100 nM rhodopsin at 15 ºC for 40 min following the addition of 
GTPγS. The data are normalized to the baseline (0%) and the fluorescence maximum (100%). The 
exchange rate is determined by fitting the data to the exponential association equation,  
 Fl = Flmax (1-e−kt) (Eq. 1) 
where Fl is the percent of the maximum fluorescence (Flmax) at time t seconds and k is the catalytic 
activation rate constant of GTPγS binding in s-1.  These data are typically presented as bar graphs of the 
GTPγS binding rate (k) (Fig. 18).     
 
Rhodopsin binding assay 
The ability of the mutant Gα subunits to bind to rhodopsin in urea-washed ROS membranes was 
determined by incubating spin-labeled Gα mutants (10 µM) with Gβ1γ1 (10 µM) and rhodopsin (100 µM) 
in Buffer B in the light ± GTPγS (100 µM).  Following a 30 min incubation at 20 °C, the membranes 
were pelleted by centrifugation at 20,000 × g for 1 hour, and the supernatants were resolved by SDS-
PAGE, visualized with Coomassie blue and quantified by densitometry (Molecular Imager ChemiDoc™ 
XRS System, Biorad, Hercules, CA).  The percent bound is calculated form the equation,
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 (Eq. 2) 
 
where Gα L and Gα G are the amount of Gα in the light and GTPγS supernatants, respectively (Fig. 18).   
 
Electron paramagnetic resonance spectroscopy 
All EPR measurements were performed in collaboration with Wayne L. Hubbell, Ph.D. and Ned 
Van Eps, Ph.D. in the Departments of Chemistry & Biochemistry and Ophthalmology at the Jules Stein 
Eye Institute, the University of California, Los Angeles.   
For the labeling reaction, MTSSL was added at a 1:1 molar ratio to the cysteine mutants (50 µM) 
in Buffer D containing 50 µM GDP, and incubated at room temperature for 5 min.  Non-covalently bound 
probe was removed by extensive washing with Buffer D.  Gβγ and rhodopsin are exchanged into the same 
buffer prior to the EPR measurements. 
For EPR spectroscopy, a series of spectra were recorded for each spin-labeled mutant.  First, 
cysteine mutants (30 µM) were loaded into a sealed quartz flat cell and spectra were recorded at room 
temperature on a Bruker E580 spectrometer using a high-sensitivity resonator (HS0118) at X-band 
microwave frequencies (Bruker BioSpin Corp., Billerica, MA).  Each spectrum was collected using a 100 
G field scan at a microwave power of 19.92 mW.  Optimal field modulation amplitudes were selected to 
give maximal signal intensity without lineshape distortion.  The data were typically averages of 20-50 
scans.  After collecting each Gα spectrum, Gβγ was added in a 1:1 molar ratio to form heterotrimers.  The 
diluted samples were concentrated to the same concentration as the initial Gα mutants.  The EPR spectra 
of each heterotrimer was recorded both alone in solution and upon addition of urea-washed ROS in the 
dark (150 µM).  For each mutant, a dark spectrum was recorded and the sample was subsequently 
irradiated for 30 s using a tungsten lamp (cutoff filter; λ > 500 nm).  The EPR spectra were collected 
immediately after bleaching. Finally, GTPγS (200 µM) was added to the samples to form activated Gα.   
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Fitting of spectra to the MOMD model of Freed and coworkers followed previously published 
methods (Columbus, et al., 2001) using principle values for the A and g tensors of Axx = Ayy = 6 G, Azz = 
37 G, gxx = 2.0078, gyy = 2.0058 and gzz = 2.0023.  Qualitative analysis of spectra in terms of nitroxide 
mobility is as described in the literature (20, 28).  The fitting procedure gives values for the order 
parameter and the diffusion tensor of the nitroxide, Dxx, Dyy, Dzz.  The correlation time is defined as, 
     (Eq. 3)  
 
 
Four-pulse DEER distance measurements 
The spin-labeled heterotrimeric proteins were mixed with dark-adapted ROS (both in 10% 
glycerol) and flash frozen in the dark in quartz capillaries in a liquid-solid slush of Freon-22 at 127 K.  
DEER measurements were performed at 50 K on a Bruker Elexsys 580 spectrometer with a 2 mm split-
ring resonator (Bruker BioSpin Corp., Billerica, MA).  Four-pulse DEER was carried out as previously 
described (Pannier, et al., 2000) with the π pump pulse (16 ns) positioned at the absorption maximum of 
the center line and the observer π (16 ns) and π/2 (8 ns) pulses at the absorption maximum of the low-
field line.  After acquiring dark state data, the samples were thawed, illuminated with light (cutoff filter; λ 
> 500 nm), and refrozen for a second DEER measurement.  Distance distributions were obtained from the 
raw dipolar time evolution data by the program Deer Analysis 2004 (Jeschke, et al., 2002; Weese, 1992).   
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Figure 18 | Biochemical characterization of mutants  (a) Nucleotide exchange rates for Gαi1.  The 
increase in the intrinsic fluorescence of Gα alone (●) or in the presence of Gβ1γ1 and photolyzed 
rhodopsin (●) is monitored following the addition of GTPγS.  These traces are fit to an exponential 
association curve to determine the exchange rate.  (b) In the rhodopsin binding assay, Gα is incubated 
with Gβ1γ1 and rhodopsin under three conditions: dark, light, and light with GTPγS.  The samples are 
centrifuged and the membrane fraction (P) and supernatant fraction (S) are analyzed by SDS-PAGE.  
Upon light activation, the G protein moves from the supernatant to the membrane, and it is released upon 
the addition of GTPγS.  (See Appendix B for summary of biochemical data.) 
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CHAPTER III 
 
MECHANISM OF RECEPTOR-CATALYZED GDP RELEASE 
 
Introduction 
 
A variety of extracellular signals activate G protein-coupled receptors, which initiate intracellular 
signaling by catalyzing GDP release from the α subunit of heterotrimeric G proteins (Cabrera-Vera, et al., 
2003).  GDP release is the rate-limiting step in G protein activation (Higashijima, et al., 1987a), and 
results in the formation of a high-affinity complex between the activated receptor and a nucleotide-free 
conformation of the G protein (Rodbell, et al., 1971b; Emeis, et al., 1982; Bornancin, et al., 1989).  
Despite its crucial role in cell signaling, this complex is the only major G protein conformation for which 
structural information is lacking, and much remains to be discovered about the mechanism of receptor-
mediated GDP release. 
Previous research has identified several important receptor contact sites on the G protein, 
including the N- and C-termini of Gα (Hamm, et al., 1988; Itoh, et al., 2001; Onrust, et al., 1997; Cai, et 
al., 2001; Dratz, et al., 1993; Kisselev, et al., 1998), the α4/β6 loop of Gα (Cai, et al., 2001; Mazzoni & 
Hamm, 1996; Onrust, et al., 1997) and the C-termini of Gβ and Gγ (Taylor, et al., 1996; Kisselev, et al., 
1994).  Although these studies have outlined the receptor contact surface on the G protein, they provide 
little insight into the molecular mechanism of R*-catalyzed nucleotide exchange because GDP is bound 
nearly 30 Å away from this interaction surface (Bourne, 1997; Hamm, 1998).  Thus, the receptor must 
induce some conformational change in the G protein to cause GDP release over this distance.  The most 
apparent route from a receptor contact site to the nucleotide binding pocket is the α5 helix, which 
connects the Gα C-terminus to the β6/α5 loop at the nucleotide binding pocket (Fig. 19).  Previous 
studies have provided indirect evidence that the α5 helix may play a role in R*-catalyzed nucleotide 
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Figure 19 | Summary of mobility changes observed for sites near the α5 helix  Ribbon model of the 
Gi1 heterotrimer, showing the α subunit (cyan) with part of the C-terminal fragment of Gαt 
(corresponding to Gαi1 residues 347-354) from the NMR structure (1AQG) attached, juxtaposed with the 
rhodopsin structure (1GZM) (green).  The α5 helix and β6 strand (salmon) connect known receptor 
contact sites at the C-terminus and α4/β6 loop (pink) to the nucleotide binding pocket at the β6/α5 loop 
some 30 Å away.  The residues selected for site-directed spin-labeling are represented by spheres at their 
α-carbon, and are colored according to their change in mobility following receptor activation (inset, lower 
left).  Several sites undergo a dramatic immobilization upon binding to R*, thereby outlining the R*-
interacting surface (dashed line).  The pattern of mobility changes observed in labeled residues in the α5 
helix suggest that R* induces a rotation and translation of the α5 helix toward the β6 strand (arrow), 
disrupting the nucleotide-binding pocket at the β6/α5 loop.   
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exchange.  Many alanine and proline point mutations in this helix alter basal and/or receptor-catalyzed 
GTPγS binding (Marin, et al., 2001b; Marin, et al., 2002).  Additionally, the insertion of a flexible five-
glycine linker between the Gα C-terminus and the α5 helix severely reduces R*-catalyzed nucleotide 
exchange while only modestly decreasing receptor binding (Natochin, et al., 2001). 
In the present study, we used site-directed spin-labeling and electron paramagnetic resonance 
spectroscopy to directly examine the structural changes in the α5 helix during R*-mediated GDP release.  
Since this technique monitors side chain and backbone dynamics, each labeled residue serves as a local 
reporter of conformational changes (Hubbell, et al., 2000).  When interpreted in terms of the Gi1 crystal 
structure (Wall, et al., 1995), the R*-dependent conformational changes observed in the α5 helix provide 
the first direct evidence for the structural mechanism of R*-catalyzed G protein activation. 
 
Results 
 
Characterization of spin-labeled mutants 
 Site-directed mutagenesis was performed on a cysteine-depleted Gαi1 mutant (Medkova, et al., 
2002) to introduce cysteines, one at a time, at sites along the α5 helix (330, 331, 333, 334, 340, 342), on 
an adjacent loop between the β2 and β3 strands (191, 194), in the β2 strand (187), in the β6 strand (318, 
320, 321), in the C-terminal tail (344, 349) and near the nucleotide-binding pocket (273) (Fig. 19).  One 
double cysteine mutation, 187-333, was also constructed.  These mutants were expressed in E. coli, 
purified and labeled with a thiol-selective paramagnetic probe to generate a nitroxide side chain 
designated R1.  All of the spin-labeled mutants demonstrated R*-catalyzed increases in GTPγS binding 
and the ability to form stable R*-G protein complexes in the absence of nucleotide (Fig. 20).  
Interestingly, increased basal exchange rates were observed for labeled sites where the native side chain 
faces the contact surface between the α5 helix and the β2/β3 loop (191R1, 194R1, 333R1, 340R1, 
344R1), while decreased basal exchange rates were observed for mutants facing the β6 strand (331R1, 
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Figure 20 | Biochemical characterization of mutants near the α5 helix  (a) Nucleotide exchange 
assay.  Data represent the mean ± s.e.m. of 4-6 independent experiments.  (b) Rhodopsin binding assay.  
Data represent the mean ± s.e.m. of 3 independent experiments.  
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334R1, 342R1).  Overall, this pattern suggests that displacing the α5 helix away from the β2/β3 loop by 
disrupting stabilizing interactions between these structures can increase nucleotide exchange on Gα.  
Alternatively, placing a spin label on the opposite side of the helix may slow nucleotide exchange by 
sterically inhibiting this movement.   
 
Conformational changes distant from receptor contacts 
Following biochemical characterization, EPR spectra of the R1-labeled Gα mutants reconstituted 
with Gβ1γ1 and rhodopsin in native disc membranes were recorded before and after photoactivation of the 
receptor (Fig. 21).  As shown in previous work, such spectra are fingerprints for local secondary and 
tertiary structure (Mchaourab, et al., 1996; Langen, et al., 2000), and changes in the spectra following 
receptor activation reflect alterations in the mobility of the R1 side chain due to structural differences 
between the heterotrimeric and R*-bound conformations of Gα.  Indeed, the EPR spectrum of 273R1, 
which makes direct contact with GDP (Fig. 22c), reflects an increase in mobility following receptor 
activation, consistent with the formation of a nucleotide-free state of Gα and the concomitant loss of 
constraints on the motion of the R1 side chain at this position.    
R*-mediated changes in EPR spectra are also found at sites near the N-terminus of the α5 helix.  
Prior to receptor activation, the spectra of 330R1, 331R1, 333R1 and 334R1 are characteristic of the 
nitroxide side chain at the solvent-exposed surface of an ordered α-helix, where the nitroxide has weak to 
zero interactions with the protein (Columbus & Hubbell, 2004) (Fig. 21, black traces), consistent with the 
location of these sites in the crystal structure and models of R1 (Fig. 22).  Upon photoactivation and 
formation of the R*-G protein complex, a pattern of spectral changes occurs that suggests a structural 
rearrangement of the helix.  For example, decreased mobility of R1 is reflected in the spectra of 330R1, 
331R1 and 334R1, indicating that these residues establish new contact interactions absent in solution, 
while 333R1 in this helix shows no changes upon interaction with R* (Fig. 21, red traces).  Importantly, 
the absence of changes for 333R1 strongly suggests a simple rigid-body movement that does not involve 
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Figure 21 | Receptor activation-dependent conformational changes in the α5 helix  Spectra for each 
of the spin-labeled mutants in solution with Gβγ and rhodopsin were recorded before (black traces) and 
after (red traces) photoactivation of the receptor.  Differences in EPR lineshape reflect conformational 
changes observed at the individual sites.  The arrows indicate the position of a spectral component 
corresponding to an immobile state of R1 that increases in several residues following receptor activation.  
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changes in the secondary structure of the α5 helix.  Furthermore, the lack of change shows that residue 
333R1 cannot participate in the R*-binding interface, indicating that the conformational changes observed 
at 330R1, 331R1 and 334R1 must be transmitted from a distant receptor contact site.   
The extreme C-terminus of Gα (residues 344 to 354) is a known receptor contact site that 
undergoes an R*-mediated conformational change, wherein residues disordered or absent in crystal 
structures of the protein are induced to form an αL-type C-cap motif upon R* binding (Coleman, et al., 
1994b; Coleman, et al., 1994a; Wall, et al., 1995; Dratz, et al., 1993; Kisselev, et al., 1998).  The EPR 
spectra for residues 344R1 and 349R1 in this region reflect a moderate and high degree of mobility, 
respectively, prior to receptor activation.  This result is consistent with the environment of these residues 
in the crystal structure of Gα; residue 344 is located at the C-terminus of the ordered α-helix, α5, while 
residue 349 is in the flexible C-terminal tail.  Upon binding to R*, the changes in the spectra indicate an 
overall immobilization of R1 consistent with the expected interactions at the R*-G protein interface.   
Similarly, decreases in R1 mobility were observed at nearby residues 194R1, 318R1 and 342R1, 
where the nitroxide side chains point toward the receptor, suggesting that these sites may also contribute 
to the R*-binding surface (Fig. 22a).  Prior to receptor activation, the spectrum for 318R1 reflects a rapid 
isotropic motion characteristic of a disordered structure, a result anticipated from the high thermal factor 
for this residue at the N-terminus of the β6 strand (Fig. 22a) (Wall, et al., 1995).  Spectra for sites 194R1 
and 342R1, however, reflect complex multi- component states characteristic of R1 at sites where the 
nitroxide interacts with nearby structures,   giving rise to an immobilized component (Langen, et al., 
2000; Mchaourab, et al., 1996).  Following receptor activation, the spectra for 194R1, 318R1 and 342R1 
exhibit an increase in the amplitude of the immobilized component, with a concomitant decrease in the 
intensity of the mobile component (Fig. 21).   
By mapping these changes to models of the R1 side chain in the Gi1 crystal structure, the apparent 
receptor contact surface on Gα can be delineated (Fig. 19, dashed line).  Together with the absence of 
spectral change at 333R1, these data indicate that the contact interface does not extend further toward the 
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Figure 22 | Models of the R1 side chain at sites near the α5 helix  Models of R1 are based on rotamer 
conformations observed in crystal structures.  The side chains are color-coded according to the change in 
mobility observed upon receptor activation as in Figure 19.  (a) The strong immobilization of residues 
194R1, 318R1, 344R1 and 349R1, and possibly 320R1 and 342R1, are likely due to their proximity to 
known receptor contact sites.  The gradient of mobility changes observed for residues 330R1, 331R1, 
333R1 and 334R1 suggest a rotation of the α5 helix (c, arrow), while the differences at residues 191R1, 
340R1, as well as 320R1, indicate an additional translational component of this motion by the helix 
toward the β6 strand (b, arrow). 
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nucleotide-binding pocket than a surface described by residues 194R1, 318R1 and 342R1 (Fig. 22).  
Thus, the mobility changes observed at the N-terminus of the α5 helix must arise from conformational 
changes in Gα transmitted from a distant R* contact site.    
 
Conformational changes couple R* binding to GDP release 
Although it is clear that binding to R* induces a structural change in the α5 helix, its role in GDP 
release is unclear.  Several mutations in the Gα subunit that uncouple G protein activation from receptor 
activation have been described in the literature.  The best characterized mutation is a flexible five-glycine 
linker inserted between the R*-binding C-terminus and the α5 helix, which results in a mutant Gα that 
still binds to photolyzed ROS membranes, but has a critical defect in R*-catalyzed nucleotide exchange 
(Natochin, et al., 2001).  A substitution in the C-terminus of Gαs, R385H (K345H in Gαi1), uncouples β-
adrenergic receptor stimulation from adenylyl cyclase activation in patients with Albright’s hereditary 
osteodystrophy (Schwindinger, et al., 1994).  Another famous mutation in Gαs, R389P (K349P), was 
discovered in the unc clone of S49 murine lymphoma cells (Sullivan, et al., 1987).  Finally, two proline 
mutations in the α5 helix of Gαt, V338P (V342P) and I339P (I343P), had impaired receptor-catalyzed 
nucleotide exchange (Marin, et al., 2002).  Although all of these mutations had decreased receptor-
catalyzed GTPγS binding, the ability of the mutant to bind to the receptor had only been investigated for 
the 5G mutant. 
These six mutations were created in the base mutant background to evaluate their ability to bind 
to activated rhodopsin without being activated.  First, the basal and R*-catalyzed rates of nucleotide 
exchange were measured.  In the cysteine-depleted background, the V342P and K345H mutations had 
little effect on the rate of R*-catalyzed nucleotide exchange, while catalyzed exchange was impaired in 
the remaining mutants.  The ability of the remaining mutants to bind to activated rhodopsin in ROS 
membranes was evaluated, and consistent with the previous study, the 5G mutant bound to R* very well, 
however, the other mutants did not.  Together, these results indicate that the 5G mutation may uncouple 
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receptor binding from nucleotide exchange (Fig. 23), while the reduced receptor-catalyzed exchange rates 
for the other mutants are likely due to impaired receptor binding. 
Using the uncoupling 5G mutation, we introduced spin labels into the C-terminus (5G-349R1) 
and the α5 helix (5G-330R1) of Gα (Fig. 23a).  Interestingly, the five-glycine insertion increased the 
dynamics at both sites (compare Fig. 21 and Fig. 23c, black traces).  While the increase in mobility of 
5G-349R1 is expected based on the increased length of the C-terminal tail extending from the protein 
core, the increase observed for 5G-330R1 is surprising, and suggests that the N-terminus of the α5 helix 
is sensitive to perturbations made at the C-terminus of the helix.  Additionally, the amplified dynamics of 
5G-330R1 may explain the substantial increase in the basal nucleotide exchange rate for the five-glycine 
insertion (Natochin, et al., 2001).   
Upon receptor activation, 5G-349R1 exhibits a striking decrease in side chain mobility, similar to 
349R1 in the coupled protein, consistent with its location at the R*-G protein interface.  However, 
receptor activation-dependent conformational changes are no longer observed in 5G-330R1, despite 
normal binding (Fig. 23).  Together with the biochemical phenotype of this mutation, these data indicate 
that the conformational change leading to GDP release is propagated along the α5 helix to the nucleotide-
binding pocket, and without movement of the α5 helix, GDP is not released.  
 
Modeling the structural change 
 To further characterize the conformational change in the α5 helix, R1 was also introduced at an 
interior site in the middle of the helix (340R1), and in structures flanking the α5 helix (191R1 in the 
β2/β3 loop, and 320R1, 321R1 in the β6 strand).  Prior to receptor activation, all of these sites exhibited 
complex multicomponent spectra consistent with their locations at sites of tertiary contact (Fig. 22).  
Following receptor activation, the spectra of 191R1 and 340R1 reveal a general increase in R1 mobility, 
the spectrum of 320R1 shows a dramatic decrease in mobility, and that for 321R1 shows little change 
(Fig. 21).   
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Collectively, the results for all of the sites demonstrate direct contact interactions between Gα 
and R* and, most importantly, an allosteric change in the Gα subunit involving the α5 helix.  In Figure 
22, the R1 side chains are color-coded according to mobility changes induced by interaction with R*, 
revealing a distinctive pattern that suggests a model for the allosteric change.  For example, there is an 
angular gradient of mobility change along the α5 helix (Fig. 22c), suggesting a rigid-body rotation of the 
α5 helix that would bring 330R1 and 331R1 into strong contact with the β6 strand and 334R1 into weaker 
contact with the same structure, resulting in a decrease in the mobility as observed at each site.  At the 
same time, 340R1 on the opposite side of the helix would experience an increase in mobility as tertiary 
interactions with the β2/β3 loop are weakened, while 333R1 would experience no change as it has no 
tertiary interactions prior to receptor activation and it is too far to make contact with the β6 strand 
following receptor activation. 
However, a simple rotation of the α5 helix cannot readily account for the increase and decrease in 
mobility observed for 191R1 and 320R1, respectively, a result that implies an additional translation of the 
α5 helix away from the β2/β3 loop toward the β6 strand (Fig. 22b).  A translational component of the 
motion could also contribute to the decreased mobility of 342R1, in addition to direct interactions with R* 
(Fig. 22a).  The lack of change for the buried 321R1 indicates that the β6 strand itself does not move 
away from the body of the protein. 
The rigid-body rotation-translation model was tested using double electron-electron resonance 
EPR spectroscopy, a pulsed EPR technique capable of measuring distances between 15 and 80 Å 
(Pannier, et al., 2000), to determine the distance distribution between spin labels at sites 187 and 333 
before and after receptor activation (Fig. 24).  Prior to receptor binding, the major population in the 
distribution is centered at 19 Å, which is consistent with modeling of these side chains into the Gi1 crystal 
structure (Fig. 24a).  The minor population centered on 30 Å can be accounted for by a second rotamer of 
R1 at site 187 since the multi-component continuous wave EPR spectrum of 187R1 supports the presence 
of two R1 rotamers at this site. 
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Figure 23 | Movement of the α5 helix is necessary for GDP release  (a) We introduced spin labels at two sites within an uncoupled base mutant, 
one at the R*-binding surface (349) and the other at the end of the α5 helix (330) (yellow spheres).  (b) This mutation uncouples receptor 
stimulation from receptor binding.  Both of the 5G mutants bind to R*.  (c) When EPR spectra were recorded for these mutants before (black 
trace) and after (red trace) receptor binding, 5G-349 still demonstrated a decrease in side chain mobility.  However, no changes in the EPR 
spectrum were observed for 5G-330 following receptor activation, whereas in the coupled protein, residue 330 becomes less mobile.  This exciting 
result indicates that the movement of the α5 helix couples R* binding to GDP release. 
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Upon receptor activation, the distance distribution is dramatically modified to a broad distribution 
centered at 24 Å.  Interestingly, broadening of the distribution suggests increased dynamics of the region 
upon binding to R* (Fig. 24d).  Importantly, the EPR spectra for 187R1 and 333R1 individually do not 
change upon R* binding (Fig. 21), indicating that the observed  distance change is not due simply to 
rearrangements in R1 conformation, but must be due to movement of the α5 helix relative to 187R1.  This 
distance measurement is entirely consistent with the motion of the α5 helix suggested by the pattern of 
mobility changes for spin-labeled side chains in this region.   
With GTPγS addition, changes in the EPR spectra are observed that reflect the activating 
conformational change in Gα and destabilization of the R*-G protein complex.  These EPR spectra are 
generally similar to spectra recorded for purified, labeled Gαi1(GDP) alone in solution.  
 
Discussion 
 
 Our results provide the first direct evidence of receptor activation-dependent structural changes in 
G proteins.  The striking pattern of mobility changes observed for these sites in the C-terminal region of 
Gα demonstrates that binding to R* induces a structural change in the α5 helix.  Furthermore, we show 
that this movement is coupled to GDP release, suggesting the exciting possibility that this conformational 
change is the trigger for G protein activation. 
Movement of the α5 helix would disrupt the loop connecting it to the β6 strand, which contains 
the TCAT motif conserved throughout the G protein superfamily.  This loop interacts with the guanine 
ring of the bound nucleotide, and mutations in this motif greatly enhance spontaneous GDP release 
(Thomas, et al., 1993; Iiri, et al., 1994; Posner, et al., 1998).  The cysteine-to-alanine mutation in Gαo 
decreases GDP affinity by 10-fold (Thomas, et al., 1993), and this mutation in our cysteine-depleted base 
mutant explains its increased basal nucleotide exchange rate over the native Gαi1 protein (Fig. 20).  
Additionally, the alanine-to-serine mutation in Gαs, A366S, causes pseudohypoparathyroidism and 
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Figure 24 | Distance measurements support the proposed rotation-translation of the α5 helix  (a)  
Molecular modeling of the R1 side chain at positions 187 and 333 suggests an internitroxide distance of 
approximately 19 Å.  (b) Dipolar evolution functions after background subtraction using the Deer 
Analysis 2004 program (Jeschke, et al., 2002; Weese, 1992).  The data were recorded before (black trace) 
and after (red trace) receptor activation.  (c) Dipolar pake spectrum generated from each evolution 
function.  The dotted vertical lines highlight a frequency splitting corresponding to a 19 Å distance.  (d) 
The distance distribution between nitroxide labels increases upon receptor binding.  A broad distribution 
is observed in the receptor-bound state that is centered at 24 Å.  This 5-6 Å increase is consistent with the 
30° rotation predicted from the single site studies.   
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gonadotropin-independent precocious puberty in male patients due to constitutive Gs signaling (Iiri, et al., 
1994).  A homologous mutation in Gαi1 also greatly enhances GDP release (Posner, et al., 1998).  
However, no significant structural differences were observed in the crystal structure of the Gαi1-A326S 
heterotrimer compared to the wild type protein although the GDP-binding site was only partially occupied 
in the crystal (Posner, et al., 1998).  Taken together, these data support our model whereby the receptor-
mediated movement of the α5 helix is sufficient to cause nucleotide release by perturbing the interaction 
between the TCAT motif in the β6/α5 loop and the guanine ring of GDP. 
In addition to providing a direct connection between the Gα C-terminus and the β6/α5 loop, 
mutagenesis and computational studies have suggested that a receptor-induced movement of the α5 helix 
may be transmitted to the GDP-binding pocket via the α1 helix and β2 and β3 strands (Marin, et al., 
2001b; Ceruso, et al., 2004).  The absence of receptor activation-dependent changes in the EPR spectra 
for 187R1 indicates that this is a less likely model than a simple perturbation of the β6/α5 loop.  Several 
other potential routes linking R*-binding sites on Gα to GDP release have also been proposed, mainly 
based on the effects of various mutations on basal and R*-catalyzed nucleotide exchange rates.  These 
include the β6 strand connecting the α4/β6 loop to the β6/α5 loop (Onrust, et al., 1997), the α3 helix 
connecting the α3/β5 loop to Switch III (Grishina & Berlot, 1998; Grishina & Berlot, 2000; Pereira & 
Cerione, 2005), and β strands 1-3 connecting the N-terminus to the phosphate-binding loop and Switches 
I and II (Thomas, et al., 2001).  Reorientation of the GTPase and helical domains has also been suggested 
in order to free the GDP buried between these domains (Warner, et al., 1998; Grishina & Berlot, 1998; 
Warner & Weinstein, 1999; Ceruso, et al., 2004; Majumdar, et al., 2004), however the role of 
interdomain interactions in R*-catalyzed GDP release remains unclear (Marin, et al., 2001a).  Although 
additional studies will be necessary to characterize any potential receptor activation-dependent 
conformational changes in these regions, our data show that an R*-mediated translocation of the α5 helix 
is required for GDP release.   
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In addition to structural changes in Gα, two models have been proposed whereby the receptor 
uses Gβγ as a nucleotide exchange factor to disrupt the nucleotide binding pocket through its interactions 
with Switch II.  In the lever-arm hypothesis, the receptor uses the interactions between the N-terminal 
helix of Gα and Gβγ to pry open the nucleotide binding pocket at the Gβ/Switch II interface (Iiri, et al., 
1998).  An alternative gear-shift model proposes that the receptor uses the N-terminal helix to cause 
close-packing of Gβ to Switch II, allowing the N-terminus of Gγ to engage the helical domain, thereby 
opening the cleft between the helical and GTPase domains to allow GDP release (Cherfils & Chabre, 
2003).  Although sites at the N-terminus of Gα do not demonstrate any receptor activation-dependent 
differences in EPR spectra (Medkova, et al., 2002), sites within Switch I show significant structural 
changes while sites in Switch II report only a minor change at the Gα-Gβ interface (Chapters IV and V).  
Further studies will be necessary to characterize these changes in Gα-Gβ contacts to test the models 
suggested by the lever-arm and gear-shift hypotheses.   
Some knowledge about the nature of conformational changes in the α5 helix also enables 
speculation about the nature of the molecular interaction causing this change.  Site-directed mutagenesis 
of residues on the side of the α5 helix opposite the β6 strand significantly increase the basal nucleotide 
exchange rate of Gα (Marin, et al., 2001b), which is consistent with our own data (Fig. 20).  Indeed, 
several studies have shown that interactions between the α5 helix and the N-terminal region of Gα are 
critical for preserving a low basal nucleotide exchange rate (Denker, et al., 1995; Denker, et al., 1992; 
Natochin, et al., 2000).  This mutagenesis data further supports the role of the conformational change 
described above, and suggests that binding to R* perturbs the stabilizing interactions with α5 helix, 
allowing it to relax into a conformation permissive for GDP release.  One model of the molecular trigger 
suggests that there is a conserved binding site among Gα family members between the α5 helix and the 
adjacent β2/β3 loop for the conserved arginine in the D(E)RY motif of receptors, and that this interaction 
may underlie the mechanism for R*-mediated conformational changes in Gα (Oliveira, et al., 1999).   
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Much work remains to be done, however, to refine our model of the nucleotide-free conformation 
of the G protein, identify the structural cause of the conformational change observed in the α5 helix and 
incorporate these data into improved models of the R*-G protein complex.  Until such time as a high 
resolution crystal structure of the complex is solved, biophysical approaches, like the one described here, 
will be essential to study this crucial step in G protein activation. 
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CHAPTER IV 
 
STRUCTURE AND DYNAMICS OF SWITCH II IN G PROTEIN ACTIVATION 
 
Introduction 
 
Heterotrimeric G proteins mediate signal transduction and amplification in a variety of cell 
signaling pathways (Chapter I).  The affinity of Gα for Gβγ and effector proteins is controlled by the 
identity of the bound nucleotide.  Crystal structures of Gαt(GDP), Gαt(GTPγS) and Gαi1(GDP), 
Gαi1(GTPγS) have been determined (Lambright, et al., 1994; Noel, et al., 1993; Mixon, et al., 1995; 
Coleman, et al., 1994a), and reveal that the nucleotide modulates the structure of three sequences, 
designated Switches I-III, two of these sequences (Switches I and II) are located at the interface of Gα 
with Gβ, effectors, and regulatory proteins, and both make direct contact with the bound nucleotide.  In 
crystals of Gαt, the α2 helix in Switch II is displaced approximately 8 Å to a position with increased 
packing in Gαt(GTPγS) relative to Gαt(GDP); in Gαi1(GDP), Switch II is not resolved due to disorder, 
but within Gαi1(GTP), an irregular helix is formed.  Both results may be interpreted to reflect an increase 
in order of Switch II upon activation in these homologous proteins.  The difference between the Switch II 
structure in Gαt(GDP) and Gαi1(GDP) may be due to crystal lattice contacts at Switch II in the former, 
which are absent in the latter.  If this is the case, Switch II might be expected to be flexible on some time 
scale in the Gα(GDP) states in solution, a view supported by NMR studies of corresponding regions of 
the small G proteins Ras and Cdc42Hs (Loh, et al., 1999; Feltham, et al., 1997; Kraulis, et al., 1994; Ito, 
et al., 1997).  Crystal lattice forces are sufficiently strong to distort flexible structures; indeed, crystal 
structures of Ras from different space groups have different structures within Switch II (Milburn, et al., 
1990).  This raises the possibility that the structures of the Switch regions in the active Gα(GTP) states in 
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solution may differ from those in crystals as well, because they are located at lattice contacts in the 
crystals of Gαt(GTPγS) and Gαi1(GTPγS) (Noel, et al., 1993; Coleman, et al., 1994a).  
The above considerations make it imperative to investigate the status of the Switch regions in 
solution.  In the present work, SDSL is used to investigate the structure and dynamics of Switch II and the 
α4 helix of Gαi1 through G protein activation.  Seven sites were chosen for introduction of R1 in the 
Switch II sequence Gαi1 (205, 206, 209, 211, 213, 214, 217), one within a putative effector binding 
domain in the α4 helix (300), and a control site in the helical domain (106) (Fig. 25) (Rarick, et al., 
1992).  For each of these spin-labeled mutants, EPR spectra were recorded in five states:  (1) Gα(GDP); 
(2) Gα(GDP)βγ; (3) the heterotrimer with dark ROS membranes; (4) the heterotrimer in complex with 
activated rhodopsin, and (5) Gα(GTPγS) formed by addition of GTPγS to the R*-bound complex.  As 
described below, the EPR spectra report salient structural and dynamical features of Switch II in each 
state, providing a basis for comparison with crystal structure where available, and providing the first 
structural data on Switch II in the R*-G protein complex.   
 
Results 
 
Sites 205, 206, 209, 211, 213, 214, and 217 lie in Switch II, but not at conserved sites in the 
signature (DxGGQxxxRxxW) sequence, except W211; site 300 is in the α4 helix.  All spin-labeled 
derivatives of Gαi1 bind to R* and undergo R*-catalyzed nucleotide exchange (Fig. 26).  To follow 
structural changes within Gα at these sites throughout the G protein cycle, a series of EPR spectra were 
collected after sequential sample additions to each R1 labeled Gαi1 mutant.  The results for each state of 
Gα are provided in the sections below.  
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Figure 25 | Location of spin-labeled sites in Switch II  (a) Ribbon model of Gαi1(GDP) (from 1GP2), 
highlighting the sites chosen for SDSL studies in Switch II (205, 206, 209, 211, 213, 214, 217), the α4 
helix (300), and the αB helix (106) (green spheres).  (b) Several of these sites contribute to the Gβ-
binding surface.     
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Gα(GDP) 
The spectra of Gα(GDP) mutants 205R1, 206R1, 209R1, 211R1, 213R1, and 214R1 in Switch II 
and 300R1 in the α4 helix are very similar, each having partially resolved components reflecting 
populations of R1 with different mobility (Fig. 27).  Similar spectra have been previously observed for R1 
in a short helix in T4 lysozyme (Mchaourab, et al., 1996).  The spectra are reasonably well fit to a model 
with two components in slow exchange, one of which corresponds to an R1 population with weakly 
ordered and fast anisotropic motion (S ≈ 0.2, τc = 2-3 ns) and the other with essentially isotropic slow 
motion (τc ≈ 8.5 ns) (Fig. 28).  The weakly ordered population has little or no contact interaction in the 
structure, and thus serves to exclusively monitor internal side chain and backbone motions (Columbus & 
Hubbell, 2004; Columbus & Hubbell, 2002), while the more immobilized population arises from direct 
nitroxide interactions with nearby groups in the protein (Mchaourab, et al., 1996; Hubbell, et al., 2000).  
By contrast, the EPR spectrum for 106R1 is a typical single-component spectrum at a site in a rigid helix 
lacking contact interactions (S = 0.45, τc = 3 ns) (Fig. 28).  The similar anisotropic motion, but low order, 
for the weakly ordered components of 205R1, 206R1, 209R1, 213R1, 214R1, and 300R1 is compatible 
with R1 on a helical structure in which the low order arises from either internal motions of R1 or a 
relatively flexible backbone.  
Site 217R1, in the α2/β4 loop is also fit with a two component model, but the more mobile R1 
population (dominant) is disordered with motion of shorter correlation time (τc = 1.5 ns) than that for the 
other sites in Switch II, consistent with a highly flexible loop structure (Mchaourab, et al., 1996).  The 
more immobilized component is similar to the other sites.   
 
Heterotrimer formation 
The Switch II sequence makes direct contact with the Gα subunit upon heterotrimer formation 
(Fig. 25).  Spin labels in Switch II facing the Gβ interface would thus be expected to become immobilized 
upon heterotrimer formation.  This is indeed the case, as shown by the greatly increased intensity of a  
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Figure 26 | Biochemical characterization of spin-labeled mutants in Switch II  (a) Nucleotide 
exchange assay.  Data represent the mean ± s.e.m. of 4-6 independent experiments.  Site 211R1 is the 
source of the intrinsic fluorescence changes, so it cannot be measured with this assay.  (b) Rhodopsin 
binding assay.  Data represent the mean ± s.e.m. of 3 independent experiments. 
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Figure 27 | EPR spectra of GDP-bound Switch II mutants  These spectra were recorded from purified, 
labeled Gα(GDP) alone in solution.  Arrows highlight the two components that comprise these spectra.   
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Figure 28 | Switch II mutants report two spectral components in Gα(GDP)  Two components were 
required to simulate the experimental EPR lineshape of K209R1 (black and orange traces).  The 
individual component lineshapes were compared to an additional helix surface site spectrum within Gαi1 
(Q106R1).  A simulation of this spectrum reports the backbone dynamics at this site, as it makes no 
tertiary contact interactions (green trace). 
 
 102 
spectral component corresponding to a strongly immobilized state of R1 upon addition of Gβγ at sites 
206R1, 209R1, 211R1, 214R1, and 217R1 (Fig. 29).  No changes are observed for 205R1 and 213R1.  In 
the Gi1 crystal structure, R205 is in a flexible loop and does not interact with Gβ, unlike the other residues 
that contribute directly to the interface.  However, 213R1 is located at the Gβ interface, suggesting that a 
change upon binding should be observed.  Although labeling at this site may perturb heterotrimer 
formation, this mutant does form stable R*-G protein complexes and undergoes R*-catalyzed nucleotide 
exchange.  Modeling of the R1 side chain at this position suggests that the nitroxide can adopt a side 
chain conformation that points into the space between Gα and Gβ, which may account for the absence of 
spectral changes.   
The presence of a more mobile component in the spectra of 206R1 and 217R1 (Fig. 29), located 
in loops preceding and following the α2 helix, respectively, is also compatible with the crystal structure 
of the heterotrimer.  At these sites, some rotamers of the R1 side chain can project away from the 
interface, removing constraints on the motion.  Interestingly, the spectrum of 300R1, distant from the 
binding interface, shows significant immobilization, indicating allosteric changes in Gα upon 
heterotrimer formation.  
Although heterotrimer formation increases the rotational correlation time of Gαi1 by 
approximately two-fold, this does not account for the changes in the EPR spectra.  Increasing the 
viscosity of the sample by a factor of two with ficoll similarly increases the rotational correlation time of 
Gαi1, but has little effect on the EPR spectrum of 214R1 (data not shown).  This demonstrates that the 
immobilized component, the most sensitive to overall rotational diffusion and similar in all cases, is 
insensitive to increases in rotational correlation time.  
To evaluate the level of perturbation caused by introduction of R1 at the subunit interface, Gβγ 
was titrated into solutions containing a fixed concentration of the individual spin-labeled Gαi1 subunits.  
In these experiments, changes in normalized EPR spectral intensity at a particular magnetic field strength 
serve as an indicator of heterotrimer formation.  The fractional change in the intensity of the low-field 
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Figure 29 | Structural changes in Switch II upon heterotrimer formation  Overlay of the EPR spectra 
recorded before (blue traces) and after (pink traces) the addition of an equimolar concentration of Gβγ.  
Arrows indicate the mobile (m) and immobile (i) components of the EPR spectra.   
 
 104 
nitroxide line plotted against the concentration of Gβγ provides a measure of the affinity of heterotrimer 
formation (Fig. 30).  As is evident, the presence of R1 at the interaction interface apparently has 
remarkably little effect on the binding for the mutants examined.    
 
Receptor activation-dependent conformational changes 
Binding of the heterotrimer to R* in the absence of GTP results in the release of GDP from Gα 
resulting in a nucleotide-free R*-G protein complex (Rodbell, et al., 1971b; Emeis, et al., 1982; 
Bornancin, et al., 1989).  Under the conditions of the experiments, each spin-labeled heterotrimer shows 
wild-type levels of binding to R* (40-75% bound; Fig. 26).  The EPR spectra for the heterotrimer show 
little change upon addition of ROS membranes in the dark.  Upon photoactivation, there is a large 
decrease in the mobility of 217R1, which is likely due to its location near the R*-binding surface of Gα 
(Fig. 31).  No other sites in Switch II exhibit receptor activation-dependent conformational changes.  
Interestingly, the spectrum of 300R1, distant from both the Gα-Gβ interface and the receptor contact 
surface, shows a slight decrease in mobility upon binding to R*.   
 
Activated Gα(GTPγS) 
Addition of GTPγS to the R*-G protein complex results in dissociation of activated Gα(GTPγS) 
from Gβγ and the receptor (Bornancin, et al., 1989), with concomitant changes in the corresponding EPR 
spectra (Fig. 32).  For all except 217R1, the EPR spectra of activated Gα are dramatically different from 
those of Gα(GDP), and signal changes in the structure and dynamics of Switch II and the α4 helix that 
are directly coupled to the change in nucleotide.  The qualitative change is most readily recognized in the 
unusual lineshapes of 214R1 and 300R1.  Fitting these spectra reveals a single dynamic mode with high 
ordering about the nitroxide x-axis (S ≈ 0.6),  as compared to the z-axis ordering typical of R1 at most 
helical sites, including the mobile components in Gα(GDP) discussed above.  In addition to the change in 
ordering, correlation times in Gα(GTPγS) have decreased to τc ≈ 0.6 ns compared to τc ≈ 2 ns in     
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Figure 30 | Spin-labeled sites within Gα are sensors of heterotrimer formation  Overlaid spectra 
show an EPR titration experiment following heterotrimer formation with K209R1.  Gβγ was added to the 
spin-labeled mutants (206, 209, 214, 300) and spectral lineshape changes were recorded upon titration.  
The fractional change in intensity of the low-field nitroxide line was plotted versus Gβγ concentration 
(inset).  The data are consistent with a 50 nM dissociation constant (solid line) reported for the cysteine-
depleted Gαi1 mutant (Medkova, et al., 2002).  A Kd of 1 µM is shown (dotted line), illustrating the 
sensitivity of this assay.  
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Figure 31 | Probing the structure of Switch II in the R*-G protein complex  Overlay of the EPR 
spectra recorded before (black traces) and after (red traces) receptor activation and the formation of the 
R*-G protein complex.   
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Gα(GDP).  Although distinction of x- and y- axis anisotropy is ambiguous from fitting of spectra from a 
single frequency, global fits of 214R1 and 300R1 to S-band (3 GHz), X-band (9.5 GHz) and Q band (35 
GHz) spectra confirm x-axis anisotropy (Fig. 33).  Spectra of nearby sites 206R1, 209R1, and 213R1 are 
also reasonably well fit to a single component with x-axis anisotropy, but with reduced ordering (S ≈ 0.2) 
and decreased rates (τc ≈ 1.5).  By contrast, the EPR spectra for 205R1 and 211R1 correspond to a 
decrease in the mobility of these side chains in the activated conformation.  Collectively, these data reveal 
a single highly dynamic, but ordered state of Switch II in the activated subunit.  
 
Discussion 
 
The objective of the present study was to explore salient structural features of Switch II of Gαi1 
along the activation pathway to complement static crystallographic data, add a dimension of dynamic 
information, and to obtain the first direct structural data for this region in the R*-G protein complex.  The 
sections below provide an interpretation of the SDSL data in relation to the crystal structures and current 
models of the empty complex. 
 
Solution structure and dynamics in Gα(GDP) 
In the crystal structure of Gαi1(GDP), the entire Switch II sequence from 204-217 is unresolved, 
presumably due to static disorder (Coleman & Sprang, 1998); in the heterotrimer, residues 206-215 form 
an irregular helix, with 217 in a connecting loop (Fig. 25) (Wall, et al., 1995).  In Gαt(GDP), residues 
corresponding to 206-214 in Gαi1 are irregularly helical, but the structure may be stabilized by contacts 
with symmetry related molecules in the lattice (Lambright, et al., 1994).  In all structures, residues 296-
309 form a regular helix, α4.   
In solution, the EPR spectra of R1 at 205, 206, 209, 211, 213, and 214 are similar to each other 
and similar to spectra of R1 along the solvent exposed surface of helix B in T4 lysozyme.  Thus, the data 
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Figure 32 | Sites in Switch II sense the identity of the bound nucleotide  Overlay of the GDP-bound 
(blue traces) and GTPγS-bound (green traces) Gα spectra.     
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Figure 33 | S- and Q-band spectra of Switch II mutants  Upon nucleotide exchange, a clear increase in 
side chain dynamics is observed at each site.  Q-band EPR spectra were collected using a Bruker, 
ER5106QTW, resonator, while S-band measurements were recorded with a SB-1111 microwave bridge 
(Jagmar, Poland) equipped with a loop gap resonator.  Incident microwave power was set to 10 mW (Q-
band) and 2 mW (S-band).  Field modulation amplitudes were adjusted to give maximal signal with no 
lineshape distortion. 
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are consistent with a helical-like structure for 206-214, which may even extend to 205 based on the EPR 
spectra for this residue.  The two components in such spectra arise either from two rotamers of R1 or two 
conformations of the helix in solution in slow exchange on the EPR time scale (µs – ms).  Given the facts 
that Switch II is helical in some structures, statically disordered in the structure of Gαi1(GDP), and that 
slow conformational exchange (ms) is observed in Switch II in solution structures of small G proteins by 
NMR, the most attractive interpretation of the EPR data is that a helix in Switch II in Gαi1(GDP) is also in 
slow conformational exchange between at least two states in solution. 
The crystal structure of Gi1 provides a basis for speculation on the nature of the putative states.  In 
that structure, 206, 209, 211, 213, and 214 in the α2 helix all face the Gβγ interface, and would lay on the 
solvent-exposed surface of the helix in the isolated Gαi1(GDP) subunit if the structures were similar.  At 
such sites, R1 is has relatively high mobility with a characteristic anisotropic motion modulated by 
backbone motions (Columbus & Hubbell, 2004).  Indeed, one component of each spectrum has such a 
lineshape (Fig. 28) reflecting a comparatively large amplitude backbone fluctuation on the nanosecond 
time scale.  The other component corresponds to an immobilized state that could arise from a partially 
unfolded structure or a rotated state of the helix where R1 can make contacts with other parts of the 
protein.  In this model, the α2 helix would fluctuate between these states.  
Although the spectrum of 300R1 resembles those in Switch II, a similar conclusion cannot be 
extended to the α4 helix based on data from a single site.  Site 217 is located in the α2/β4 loop and the 
dominance of a highly mobile component of the spectrum is consistent with a flexible backbone.  
Collectively, these considerations suggest that Switch II exists as a helix, flexible on the nanosecond time 
scale in exchange on a much slower time scale with another conformation.  
 
Sites in Switch II and the α4 helix sense heterotrimer formation 
Spin-labeled mutants in Switch II of Gα(GDP) form heterotrimers with Gβγ with a Kd similar to 
that for the wild-type subunits (Medkova, et al., 2002), despite the presence of R1 directly at the Gα-Gβ 
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interface (Fig. 25).  This remarkable result is in line with earlier observations that R1 at contact surfaces 
has little effect on arrestin-rhodopsin interactions (Hanson, et al., 2006) or SecA-SecB interactions 
(Crane, et al., 2005).  This result will not likely be general, but as long as highly specific polar 
interactions are not perturbed, the non-polar and flexible nature of the R1 side chain will allow labeling 
with minimum perturbation of the protein-protein interface.  
The strong immobilization of 209R1, 211R1, and 214R1 upon heterotrimer formation is expected 
due to intimate contact of these side chains with the Gβ subunit (Fig. 25).  By contrast, the side chains of 
205R1, 206R1, and 217R1, can adopt conformations that allow the nitroxide to project into cavities in the 
structure.  Accordingly, the EPR spectra of these sites have a relatively increased proportion of a more 
mobile component.  As this mobile component is also observed for residue 213R1, the nitroxide side 
chain at this position must also be oriented away from the subunit interface despite its proximity to 211R1 
and 214R1, both of which show substantial changes.  This possibility is consistent with models of the R1 
side chain at site 213.  Thus, the EPR spectra of sites in Switch II in the heterotrimer in solution reflect 
the crystal structure.    
By contrast, a comparison of the crystal structures of Gαi1(GDP) and the Gi1 heterotrimer reveals 
little difference in the structure of the α4 helix.  Thus, the allosteric change at 300R1, detected as 
decreased mobility of the nitroxide, is an unexpected result of heterotrimer formation, and suggests that 
long range structural changes are propagated though Gα upon heterotrimer formation.  The spectral 
change could be accounted for by a slight reorientation of the α4 helix, a motion that could be masked by 
crystal lattice forces. 
 
Absence of R*-mediated structural changes in Switch II 
Complex formation between the G protein heterotrimer and the activated receptor results in 
dissociation of GDP to form a nucleotide-free complex.  The structural changes in the complex that 
liberate the nucleotide are unknown, but current models for the complex require changes propagated 
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through the heterotrimer, triggered by receptor binding, because the nucleotide binding site is some 30 Å 
from the receptor binding interface.  Detailed mechanisms for the allosteric switch have been proposed.  
In the lever-arm model, both the N- and C-termini of Gα interact with the receptor in such a way as to 
rotate Gβγ away from Gα, pulling Switches I and II with it, thereby opening a door for GDP to escape 
(Iiri, et al., 1998; Rondard, et al., 2001).  Thus, overall packing at the Gα-Gβ interface is decreased.  
Conversely, the gearshift model proposes that a motion occurs in the opposite direction, rotating Gβγ into 
Gα, increasing packing at the interface (Cherfils & Chabre, 2003).  The R1 side chains in Switch II, 
located at this interface, are positioned to sense such changes.  
However, 217R1 is the only site in this region that reports significant R*-dependent 
conformational changes (Fig. 31).  The EPR spectral changes indicate that the mobility of this side chain 
decreases upon binding R*, which is likely due to direct contact interactions with the receptor.  Residue 
217 is adjacent to the extreme C-terminus of Gα, a well established R* contact site.  Additionally, the 
α2/β4 loop has been identified as a specificity determinant in the R*-G protein interaction (Lee, et al., 
1995b).  Although the absence of R*-mediated changes in Switch II does not disprove the lever-arm or 
gear-shift models, it does strongly suggest that significant structural rearrangements are not occurring at 
the Switch II-Gβ interface.  
 
Switch II structure and dynamics in Gα(GDP), Gαβγ, and Gα(GTPγS) 
The EPR spectra of R1 clearly reveal that the Switch II sequence in Gαi1(GDP) is uniquely 
different in both structure and dynamics from that in Gαi1(GTPγS).  To the extent that they can be 
compared, the solution SDSL and crystal structure data for Switch II in the two states provide compatible 
views, but SDSL adds a dimension of dynamic information.  In particular, the absence of electron density 
for Switch II in the crystal structure of Gαi1(GDP) indicates static disorder, but SDSL data are compatible 
with a helical state ordered on the EPR time scale (> 100 ns), but in conformational exchange on a longer 
time scale (> µs).  In the heterotrimer, no specific structural information is available from SDSL, but here 
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the crystal structure is definitive, and the strong immobilization of R1 in Switch II confirms a rigid state.  
In the activated Gαi1(GTPγS), the crystal structure reveals an irregular helix located at a crystal contact 
site with average thermal factors for the structure in which 205, 206, 209, 213, and 217 are solvent-
exposed, 214 is partially buried, and 211R1 is fully buried.  In solution, SDSL data is consistent in detail 
with this structure, but shows Switch II to be in a highly flexible state on the nanosecond time scale.  
Thus, R1 for 206, 209, and 217 exhibits rapid and weakly-ordered anisotropic motion characteristic of the 
side chain at solvent exposed sites in flexible helices (Mchaourab, et al., 1996).  The striking x-axis 
anisotropic motion of 214R1 can be accounted for by its partially buried location.  Modeling 214R1 in the 
Gαi1(GTP) crystal structure reveals that the entire side chain up to the nitroxide is highly constrained by 
the steric interactions, allowing free rotation only about the terminal bond.  This motion is approximately 
along the molecular x-axis of the nitroxide, and rotational diffusion about this bond has been previously 
shown to be rapid (Liang, et al., 2004).  The constraints imposed by the structure, together with rapid 
motions of the backbone indicated by the other sites, account for the unusual lineshape, as revealed by the 
spectral simulations.  
 
Summary 
This study illustrates the capability of SDSL to map structural and dynamical changes stepwise 
along the entire activation pathway of a Gα subunit, and provides the first direct structural and dynamical 
data on changes in Switch II along that pathway.  From the standpoint of SDSL technology, it is 
interesting that the presence of the R1 side chain at a direct subunit contact interface has little effect on 
the interaction.  Thus, SDSL will find use in mapping protein-protein interaction sites and their 
modulation related to function.  Regarding this point, a most interesting result reported here is the 
identification of allosteric changes propagated from the Gα-Gβ interface to the α4 helix.  For Gα, 
catalysis of nucleotide exchange from GDP to GTP by the receptor releases Gα(GTP) into solution and 
transforms Switch II from the rigid, partially helical structure observed in crystals to a unique structure 
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entirely consistent with the crystal conformation (spatially ordered), but with a highly flexible backbone.  
This feature is not apparent from the crystal structure.  This is in striking contrast to the conformational 
exchange in Switch II inferred from the dynamics of R1 in the isolated Gαi1(GDP) subunit (spatially 
disordered).  The flexible backbone in Switch II of the activated subunit is consistent with the emerging 
view that flexible sequences are involved in protein-protein interaction.  
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CHAPTER V 
 
DYNAMICS OF SWITCH I IN G PROTEIN ACTIVATION 
 
Introduction 
 
 In addition to Switch II, which forms an important effector-binding site on Gα (Chen, et al., 
2005b; Tesmer, et al., 1997b; Tesmer, et al., 2005; Slep, et al., 2001), Switch I plays a more critical role 
in binding RGS proteins (Slep, et al., 2001; Tesmer, et al., 1997a).  Switch I is composed of a loop 
connecting the αF helix to the β2 strand (Fig. 34).  In crystals of Gαt, GTP binding draws Switch I toward 
to the nucleotide as it forms stabilizing interactions with Mg2+ and the γ-phosphate (Lambright, et al., 
1994); a similar structural transition is observed in Gαi1 (Mixon, et al., 1995).  These results suggest that 
G protein activation orders Switch I through interactions with GTP.  Compared to Gαt(GDP), Switch I in 
Gαi1(GDP) is in a more compact conformation, closer to the nucleotide-binding pocket, which is likely 
due to quaternary contacts with the N-terminal microdomain of an adjacent molecule in the crystal 
(Mixon, et al., 1995).  Switch I is also located at sites of crystal contact in the GTPγS-bound structures of 
these proteins (Noel, et al., 1993; Coleman, et al., 1994a), suggesting the possibility that the conformation 
and dynamics of this region is different than would be predicted based on the crystal structures. 
 Due to the crucial role this flexible region plays in the structural switch leading to G protein 
activation, it is important to investigate the native structure and dynamics of Switch I in solution.  Toward 
this end, conformational changes in the region were directly monitored with SDSL through each 
transition leading to G protein activation.  For each spin-labeled mutant, EPR spectra were recorded for 
each of five conformations:  Gα(GDP), Gα(GDP)βγ, the heterotrimer in the presence of dark ROS 
membranes, R*·Gα(O)βγ, and Gα(GTPγS).  These spectra are characteristic of the local secondary and 
tertiary structure of the spin-labeled region (Mchaourab, et al., 1996; Langen, et al., 2000).
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Figure 34 | Location of spin-labeled sites in the Switch I region  (a) Ribbon model of Gαi1(GDP) 
(from 1GP2), highlighting the sites chosen for SDSL studies in the αF helix (171), Switch I (179, 180, 
182, 184, 186, 187), and the α1 helix (50) (green side chains).  (b) Several of these sites contribute to the 
Gβ-binding surface.     
 117 
In this work, the EPR spectra presented describe the native structure and dynamics of the Switch I region 
at each point in G protein activation, enable comparison with the crystal structures when available, and 
provide the first structural insight into the conformation of Switch I in the R*-bound, nucleotide-free 
conformation of Gα.  
 
Results 
 
Characterization of spin-labeled mutants 
 Several sites were chosen for the introduction of the nitroxide side chain, R1, into the Switch I 
sequence (179, 180, 182, 184, 186, 187), one site in a contiguous sequence of the helical domain on the 
αF helix (171), and one site on the adjacent α1 helix (50) (Fig. 34).  Each of these sites is on the surface 
of Gα, although 50 and 187 are slightly more buried.  Importantly, none of the side chains mutated in the 
Switch I loop contribute directly to nucleotide binding.  All of the spin-labeled mutants demonstrate R*-
catalyzed increases in GTPγS binding, except for 184R1, and all had the ability to form stable R*-G 
protein complexes in the absence of nucleotide (Fig. 35).  Three of the spin-labeled mutants (171, 182, 
184) demonstrated substantially faster rates of basal nucleotide exchange compared to the cysteine-
depleted Gαi1 base mutant, while the basal exchange rate for 187R1 was slightly slower.  Site 184R1 was 
the only mutant that did not have a further increase in the GTPγS binding rate in the presence of R*.  
However, this mutant is clearly able to bind to Gβγ and R* in a GTPγS-dependent manner, as shown both 
by the rhodopsin binding assay and EPR measurements.  Following biochemical characterization, a series 
of EPR spectra were recorded for these mutants at each step in the G protein cycle from Gα(GDP) to 
Gα(GTPγS).   
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Figure 35 | Biochemical characterization of spin-labeled mutants near Switch I  (a) Nucleotide 
exchange assay.  Data represent the mean ± s.e.m. of 5-6 independent experiments.  (b) Rhodopsin 
binding assay.  Data represent the mean ± s.e.m. of 3 independent experiments. 
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Gα(GDP) 
 The EPR spectra for Gα(GDP) mutants 179R1, 180R1, 182R1, 184R1, and 186R1 in Switch I are 
very similar, each reflecting a high degree of side chain mobility where the nitroxide has little or no 
contact interaction in the structure (Fig. 36, blue traces) (Columbus & Hubbell, 2002; Columbus & 
Hubbell, 2004).  As expected, the dynamics of this region increase near the center of the Switch I loop.  
This is consistent with the location of these side chains in the Gαi1(GDP) crystal structure (Mixon, et al., 
1995; Coleman & Sprang, 1998).  Additionally, the spectra for 179R1, 180R1 and 182R1 indicate a 
small, less mobile population where the nitroxide makes direct contact with nearby groups in the protein. 
 The remaining sites, 50R1, 171R1, and 187R1, exhibit complex, multi-component spectra 
suggesting that the nitroxide makes tertiary contacts with adjacent chemical groups in the protein (Fig. 36, 
blue traces) (Langen, et al., 2000; Mchaourab, et al., 1996).  While the mobile component of the 
spectrum for 171R1 is predominant, the spectra for sites 50R1 and 187R1 reflect much lower nitroxide 
mobility.  Again, this is consistent with the location of these sites in the structure, where 187R1 is on the 
internal face of the β2 strand, which overlays the α1 helix where residue 50 is located, while 171R1 is the 
most surface-exposed of these three residues, but still forms interactions across the interdomain cleft. 
 
Heterotrimer formation 
 Switch I contributes to the Gβ-binding surface on Gα, and several interesting changes are 
observed in the EPR spectra for these residues upon heterotrimer formation.  Sites 182R1, 184R1, and 
186R1 are located in the Gα-Gβ interface, and each reports a decrease in side chain mobility with Gβγ 
binding (Fig. 36, pink traces).  This is most clearly observed at residue 184R1, which reports a new 
spectral component corresponding to a strongly immobilized R1 conformation.  The spectral changes at 
182R1 and 186R1 are more subtle, where the spectra are still dominated by the mobile component.  These 
two sites are at the edges of the Gβ interface with Switch I, and some rotamers of the R1 side chain can 
escape the steric constraints associated with complex formation.   
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Figure 36 | Structural changes in Switch I upon heterotrimer formation  Overlay of the EPR spectra 
recorded before (blue traces) and after (pink traces) the addition of an equimolar concentration of Gβγ.   
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 Residues 179R1 and 180R1 are further from the Gβ-binding site, and while 180R1 reports a 
slight decrease in mobility, no changes are observed for 179R1 (Fig. 36, pink traces).  By contrast, each 
of the three remaining sites, 50R1, 171R1, and 187R1 all demonstrate a striking increase in the intensity 
of the immobile component following Gβγ binding (Fig. 36, pink traces).  Inspection of the Gi1 
heterotrimer crystal structure suggests that binding to Gβγ moves the β2 strand with residue 187R1 
approximately 1 Å closer to the α1 helix and residue 50R1, which may account for the decrease in the 
mobility observed at these sites.  However, there are no obvious differences in the crystal structures 
around residue 171R1. 
 
Receptor activation-dependent conformational changes 
 Upon the addition of ROS membranes in the dark, spectral changes are observed for residues 
50R1, 180R1, 182R1, and 184R1, which may be due to heterotrimer association with the membrane or 
some interaction with inactive rhodopsin (Fig. 37, black traces).  While there is a small increase in the 
mobility of 50R1 and small decreases in that of 180R1 and 182R1, there is a significant increase in the 
mobility of 184R1.  Although the dark spectra for 50R1, 180R1, and 182R1 represent an intermediate 
shift in the dynamics between the free heterotrimeric conformation and the R*-bound, nucleotide-free 
conformation, the difference in the mobility of 184R1 is the opposite of that observed upon receptor 
activation, suggesting that these changes are not simply due to a small amount of activated rhodopsin in 
the membrane preparations.  No changes following the addition of dark ROS membranes were observed 
at the other sites. 
 Photoactivation of rhodopsin results in G protein binding and GDP release.  This nucleotide-free 
conformation of the G protein is stable in the absence of nucleotides, and each of the mutants shows wild-
type levels of binding under the conditions of these experiments (Fig. 35b).  A very interesting pattern of 
spectral changes emerges upon formation of the R*-G protein complex (Fig. 37, red traces).  Beginning 
from the β2 strand of Switch I, a slight decrease in the mobility of 187R1 is observed, while 184R1 and 
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Figure 37 | Receptor activation-dependent conformational changes in Switch I  Overlay of the EPR 
spectra recorded before (black traces) and after (red traces) receptor activation and the formation of the 
R*-G protein complex.   
 
 
 123 
186R1 at the Gβ interface become immobilized.  There are no differences in the EPR spectra for 182R1.  
These data suggest some structural rearrangement of the Gα-Gβ interface upon binding to R*. 
At the empty nucleotide-binding pocket, there is a decrease in the mobility of 179R1, and a 
substantial decrease in the mobility of 180R1, which is immobilized by new tertiary contact interactions 
in the nucleotide-free conformation of Gα.  Interestingly, residue 171R1 at the interdomain hinge also 
becomes immobilized upon binding R*.   
 
Activated Gα(GTPγS) 
 Addition of GTPγS to the R*-bound, nucleotide-free G protein causes a conformational change 
leading to dissociation of the activated Gα(GTPγS) subunit from Gβγ and the receptor.  As a result of 
these conformational changes, the EPR spectra for all sites, except 50R1, indicate a reversal of the 
immobilization observed upon formation of the R*-bound complex (Fig. 38, green traces).  The mobility 
of 50R1 does not change with the addition of GTPγS. 
A comparison of the GDP-bound and GTPγS-bound conformations of Gα illustrates the 
dependence of the Switch I conformation on the identity of the bound nucleotide (Fig. 38).  The EPR 
spectra for three sites, 171R1, 182R1 and 187R1, are similar in both conformations.  However, the 
remaining five sites reflect conformational differences between these two states.  The dynamics of sites 
184R1 and 186R1 decrease and increase, respectively, in the GTPγS-bound conformation relative to the 
GDP-bound subunit.  Residue 180R1 is immobilized while the mobility of 179R1 increases in the 
activated conformation.  Similarly, the mobility of 50R1 is increased relative to the GDP-bound 
conformation. 
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Figure 38 | Comparison of Switch I dynamics in GTPγS- and GDP-bound Gα  Overlay of the GDP-
bound (blue traces) and GTPγS-bound (green traces) Gα spectra.     
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Discussion 
 
Crystallographic studies have identified conformational changes in the Switch I region as an 
important feature of the activating conformational change in Gα subunits.  The goals of this study were to 
explore the dynamics of Switch I in solution and to obtain structural information about the R*-bound, 
nucleotide-free conformation of the G protein.     
 
Switch I structure and dynamics in Gα(GDP), Gαβγ, and Gα(GTPγS) 
 Although located in or near the Switch I sequence, all of the sites examined in this study have 
significantly different local environments based on the G protein crystal structures.  Three sites, 182, 184, 
and 186 face the solvent and form direct interactions with Gβ.  As expected, the mobility of these residues 
decreases upon heterotrimer formation, however, the spectrum for 184R1 is the only one that shows a 
strongly immobilized component upon Gβγ binding.  Modeling the R1 side chain at these sites indicates 
that 182R1 and 186R1 can adopt conformations that move the nitroxide into gaps between Gα and Gβ, 
while 184R1 remains buried at the interface.  As the subunits dissociate following GTPγS binding, the 
spectrum of 182R1 reflects a high degree of side chain mobility, similar to the spectrum recorded in the 
Gα(GDP) conformation.  By contrast, 184R1 and 186R1 are less mobile in the Gα(GTPγS) conformation.  
This observation is consistent with the interpretation of the changes seen in Switch I in the G protein 
crystal structures, where activation induces close-packing of the Switch I loop onto the β3 strand.   
 Residues 179R1 and 180R1 are on the flexible Switch I loop much closer to the nucleotide-
binding pocket.  In the GDP-bound conformation, both residues exhibit a very high degree of side chain 
mobility that is relatively unaffected by heterotrimer formation.  There is a slight decrease in the mobility 
of residue 180R1 and no detectable change at 179R1.  The local environment of these residues does not 
change much as a result of Gβγ binding, in line with crystallographic observation.  Upon G protein 
activation, 179R1 becomes more mobile while 180R1 becomes less mobile.  Based on the orientation of 
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the 180R1 side chain, the decrease in mobility is likely due to direct contact interactions with the γ-
phosphate.  The 179R1 side chain points toward the helical domain, and upon GTPγS binding, Switch I 
translates away from the helical domain, toward the nucleotide.  This would account for the increase in 
dynamics at 179R1 compared to the Gα(GDP) conformation. 
 At the other end of the Switch I loop, sites 50R1 and 186R1 report significantly less mobile EPR 
spectra due to their more buried location in the protein.  Heterotrimer formation significantly decreases 
the mobility of these sites.  Since the mobility at both sites decreases, it seems likely that the β2 strand is 
moving closer to the α1 helix, which is supported by the crystal structures of the G protein heterotrimers.  
Although GTPγS binding induces a side chain conformation at 187R1 that is similar to the Gα(GDP) 
structure, the spectra of 50R1 indicates a more mobile side chain conformation.  Modeling suggests that 
50R1 may make some contact with the Switch I loop in the GDP-bound state, but the GTP-induced 
conformational change moves Switch I away from 50R1, possibly accounting for the observed increase in 
mobility.   
 Residue 171R1 is located near the interdomain hinge on the αF helix.  A model of R1 at this 
position suggests that the nitroxide makes interactions across the interdomain cleft that account for the 
immobile component of the spectra.  The intensity of the immobile component increases when Gβγ binds, 
which may be due to structural changes in Linker 1, the α1 helix, or even the α5 helix, although a precise 
structural explanation is not obvious from the crystal structures.  GTPγS binding reverses the changes 
observed with heterotrimer formation.  
 
Receptor activation-dependent conformational changes near Switch I 
 Excitingly, nearly every site examined in this region demonstrated receptor activation-dependent 
conformational changes, and this study is the first to implicate Switch I in the mechanism of GDP release.  
Three mutants, 171R1, 182R1, and 184R1, had much faster rates of basal nucleotide exchange than the 
base mutant did.  This result is particularly surprising since mutations of 179R1 and 180R1, two residues 
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much closer to the nucleotide, had no effect on the exchange rate.  Although no structural explanation is 
obvious for the effects of 182R1 and 184R1, as these residues point away from the binding pocket into 
solution, the R1 side chain at 171 is long enough to perturb the β6/α5 loop, which can have a significant 
impact on nucleotide exchange (Thomas, et al., 1993; Iiri, et al., 1994; Posner, et al., 1998).   
 Comparing the dark and light EPR spectra for the Gβ-binding residues, 182R1, 184R1 and 
186R1, suggests some structural rearrangement of the Gα-Gβ interface.  No differences are seen at 
182R1, while there is a decrease in the mobility at 184R1, with a greater decrease in mobility at 186R1.  
The location of 186R1 in the structure suggests that the new contact interactions formed are with Gβ, 
indicating a reorientation of the subunits compared to the heterotrimeric conformation.  Two models have 
previously suggested that the activated receptor uses Gβγ to open the nucleotide-binding pocket for GDP 
release.  In the lever-arm model, R* rotates Gβγ away from Gα, pulling Switches I and II along with it, 
thereby causing GDP release (Iiri, et al., 1998; Rondard, et al., 2001).  The gear-shift model proposes a 
rotation in the opposite direction that causes close-packing of Switches I and II with the core of Gα 
(Cherfils & Chabre, 2003).  In light of the lever-arm hypothesis, the observation that the mobility of 
residue 50R1 increases upon receptor activation is very interesting.  The spectra suggest that the 
nucleotide-free and GTPγS-bound conformations of the 50R1 side chain are similar, and the GTPγS 
crystal structure shows that Switch I has translated away from the α1 helix.  Although the spectral 
changes at these four sites do not uniquely describe the motion, they generally do support a role for 
intersubunit structural rearrangements in the formation of the R*-bound, nucleotide-free G protein 
complex. 
 In addition to conformational changes at the Gα-Gβ interface, GDP release causes a decrease in 
the mobility of 179R1 and 180R1 near the nucleotide-binding pocket.  Indeed, residue 180R1 establishes 
new contact interactions in the absence of nucleotide.  Based on the orientation of the R1 side chain, the 
most likely interaction is with the α1 helix across the binding pocket.  If Switch I closes onto the empty 
pocket, then perhaps this is evidence that the nucleotide is released through the opposite side of the 
 128 
protein.  The decrease in the mobility of 179R1 is likely secondary to immobilization of the backbone due 
to the new contact interactions formed by K180.   
 Site 171R1 also demonstrates receptor activation-dependent conformational changes.  The EPR 
spectra for this site report a decrease in mobility upon formation of the empty complex.  Based on the 
location of this residue at the interdomain hinge, one exciting possibility is that 171R1 is reporting an 
interdomain reorientation.  The location of GDP buried deeply between the GTPase and helical domains 
seems to demand some sort of opening in the interdomain cleft to allow GDP release.  If there was an 
opening in the cleft, the mobility of residue 171R1 at the hinge would be predicted to decrease.  
Alternatively, this side chain may be sensing conformational changes in the α5 helix (Chapter III) or a 
more localized structural change in the αF helix.  
 
Summary 
 This study demonstrates the utility of combining low resolution dynamic information provided by 
SDSL with high resolution crystal structures to explore protein function in solution.  Unlike the Switch II 
region (Chapter IV), the structure and dynamics of Switch I agree well with each of the corresponding 
crystal structures.  Importantly, this approach has provided the first structural information for Switch I in 
the receptor-G protein complex, revealing convincing evidence of structural changes at the Gα-Gβ 
interface as well as the nucleotide-binding pocket, and interdomain hinge.  Additional studies will be 
necessary to characterize these conformational changes further, using additional single-site mutants and 
interspin distance measurements.  Future studies using this series of spin-labeled mutants will explore 
how the dynamics of this region influence GTP hydrolysis and interaction with RGS proteins to provide 
greater insight into the mechanisms of G protein inactivation.     
 129 
CHAPTER VI 
 
ADDITIONAL SDSL STUDIES OF G PROTEIN STRUCTURAL CHANGES 
 
Introduction 
 
 Receptor activation-dependent conformational changes in the α5 helix play a prominent role in 
the mechanism of receptor-catalyzed GDP release (Chapter III).  In addition to exploring this region for 
changes associated with the formation of the R*-bound, nucleotide-free complex, the dynamics of the 
other G protein conformations were also recorded.  This chapter provides a more quantitative analysis of 
the EPR spectra at each point in the activation pathway, and presents data for sites that have not been 
discussed previously.   
 
Results and Discussion 
 
Location and characterization of spin-labeled mutants 
 The structure and dynamics of several regions in Gαi1 have been explored with SDSL, including 
the α5 helix (330, 331, 333, 334, 340, 342), the C-terminal tail (344, 345, 349, 351), the β6 strand (318, 
320, 321), the β2/β3 loop (191, 192, 194), and miscellaneous sites in α-helices 1 (56), 4 (305), B (106), 
and G (273) (Fig. 39).  Each of these spin-labeled mutants undergoes R*-catalyzed nucleotide exchange 
and forms stable R*-G protein complexes with rhodopsin in ROS membranes (Fig. 40 for data not 
reported elsewhere).  Similar to other residues located between the α5 helix and β strands 2 and 3, 192R1 
has a much faster basal exchange rate than the base mutant does.  Biochemical characterization of 305R1 
has not yet been completed.  For each spin-labeled mutant, EPR spectra were recorded for each of five 
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Figure 39 | Location of spin-labeled mutants  Ribbon diagram of the Gαi1 subunit from the structure of 
the Gi1 heterotrimer (1GP2).  The N-terminus is truncated, and the extreme C-terminus was modeled as a 
flexible loop.  Sites chosen for spin-labeling are identified as spheres on the α-carbons and color-coded 
according to their location in the structure.   
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Figure 40 | Biochemical characterization of spin-labeled mutants  (a) Nucleotide exchange assay.  
Data represent the mean ± s.e.m. of 4-6 independent experiments.  (b) Rhodopsin binding assay.  Data 
represent the mean ± s.e.m. of 3 independent experiments. 
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conformations:  Gα(GDP), Gα(GDP)βγ, the heterotrimer in the presence of dark ROS membranes, 
R*·Gα(O)βγ, and Gα(GTPγS).    
 
Comparison of Gα(GDP) and Gα(GDP)βγ 
The EPR spectra of R1 residues at sites 106, 331, 333, 334, 344, and 345 in Gα(GDP) reveal an 
anisotropic motion characteristic of R1 at the solvent-exposed surface of an α-helix (Fig. 41, blue traces), 
where the nitroxide has no interactions with other residues or main chain atoms (Columbus, et al., 2001).  
Models of R1 at these sites based on the crystal structure are consistent with this result.  The EPR spectra 
of 349R1 and 351R1 are characteristic of dynamically disordered sequences (Columbus & Hubbell, 
2004), and these residues are in the statically disordered C-terminal sequence not resolved in the crystal 
structure.  For non-interacting helix surface sites, site-dependent variations of the correlation time and 
order parameter are due to backbone motions (Columbus & Hubbell, 2004).  Using sites 331, 333, 344, 
345, 349, and 351 as monitors of backbone motion, a clear gradient in fast backbone dynamics (measured 
by τc-1) is resolved along α5 helix into the C-terminal sequence (Fig. 42b).  This result is in agreement 
with the crystallographic B-factors in the structure, which also reveal a gradient (Fig. 42c).  Residue 
106R1 also has a spectral lineshape reflecting highly ordered anisotropic motion, in agreement with the 
helix surface location of this site in the crystal structure.  
The EPR spectrum of 318R1 reflects a surprisingly high mobility, again compatible with the 
crystallographic data, which show residues in the α4/β6 loop to have high B-factors (Fig. 42c).  The EPR 
spectra of R1 at other sites in Gα(GDP) are multicomponent, suggesting tertiary contact interactions of 
the nitroxide (Mchaourab, et al., 1996), generally consistent with expectations from the crystal structure.  
When Gβγ is added to Gα(GDP) to form the heterotrimer, significant spectral changes are 
detected for 191R1 and 194R1 in the β2/β3 loop, 320R1 in the β6 strand, and 340R1 in the α5 helix (Fig. 
41, pink traces).  In each case, except 194R1, the change is a reduction in spectral intensity in a region 
corresponding to more mobile components (Fig. 41).  These residues, except for 320R1, are located in 
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Figure 41 | Conformational changes upon heterotrimer formation  Spectra for each of the spin-
labeled mutants before (blue traces) and after (pink traces) addition of an equimolar amount of Gβγ.  
The spectral intensity for sites 349R1 and 351R1 has been reduced by half as compared to the intensity of 
the other spectra.   
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Figure 42 | Gradient of backbone mobility within the α5 helix  (a) MOMD simulations (dashed lines) 
of the experimental spectra (solid lines) corresponding to labeled sites on the surface of the α5 helix when 
bound to Gβγ.  The spectra are colored by B-factor values observed at each site in the crystal structure.  
(b) The rotational correlation time (τc) was determined from spectral simulation, and τc-1 was plotted 
against sequence position.  For multi-component spectra, the fastest τc was used.  A linear gradient is 
observed, in agreement with the crystallographic B-factors.  (c) Ribbon diagram of the Gαi1 subunit from 
the structure of the Gi1 heterotrimer (1GP2).  The backbone is colored according to crystallographic B-
factor, and spheres within the α5 helix represent sites where R1 was introduced to measure backbone 
dynamics.  Residues beyond 348 where not observed in the structure and have been modeled in as a 
flexible loop.   
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structures that face the binding surface of the Gβ subunit, and the spectral changes are likely due to 
changes in internal structure; components of such high mobility would not be affected by the reduction in 
the rotational diffusion of Gα subunit due to heterotrimer formation.  The origin of such changes is not 
obvious in a comparison of the crystal structures of Gαi1(GDP) (Mixon, et al., 1995) and Gi1 (Wall, et al., 
1995), which are essentially identical at these sites, but may be due to damping of backbone motions.   
Although residue 194R1 is adjacent to sites that become less mobile in the heterotrimer, it reports an 
increase in the intensity of the mobile component of the spectrum.  A comparison of the crystal structures 
suggests that this residue may be uniquely positioned to monitor the structural change in the αN helix as 
it stretches out to bind Gβ, accounting for the increase in mobility at this site.  Addition of the 
heterotrimer to dark ROS membranes produces essentially no change in the EPR spectra at any site.  
 
Structural changes upon formation of the R*-G protein complex 
 Upon photoactivation of rhodopsin to form R*, the heterotrimer undergoes dramatic changes 
throughout the nucleotide binding domain (Figs. 21, 43a).  Only 20-70% of the labeled protein binds to 
the activated receptor (Figs. 20, 40), so the spectral changes shown represent the lower limit of the 
mobility changes within the actual complex.  As shown in Chapter III, R1 side chains near the α5 helix 
support a rotation and translation of this helix upon binding to R*.  The spectral changes observed for 
56R1 in the α1 helix and 192R1 in the β2/β3 loop may also support this movement, although the 
interpretation of these differences is less clear.  Residue 56R1 undergoes a striking decrease in side chain 
mobility upon binding to R*.  This is a surprising result, as the predicted result based on our model is that 
the mobility of this residue would increase as the α5 helix moved away from the α1 helix.  One 
possibility that may account for this change is that the R1 side chain at this position is repacking into a 
pocket formed following the rotation-translation of the α5 helix, thereby accounting for the decreased 
mobility observed.  Similarly, new contacts may be formed upon rotation of the helix that immobilize 
56R1.  The spectral change at 192R1 is more complicated in that the order or anisotropy of the side chain 
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Figure 43 | Receptor activation-dependent conformational changes  (a) Spectra for each of the spin-
labeled mutants in solution with Gβγ and rhodopsin were recorded before (black traces) and after (red 
traces) photoactivation of the receptor.  (b) Spectra from the extreme C-terminal mutants represent a 
mixture of bound and unbound G protein components.  To extract the individual spectral components, 
MOMD simulations were used.  The bound (solid lines) and unbound (dashed lines) lineshape 
components are shown for each site. 
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is different, making a definitive interpretation regarding any changes in mobility difficult.  Based on the 
decreases in side chain mobility observed at adjacent receptor contact sites (Chapter III), residue 192R1 
may be at the edge of this interface.   
 Nitroxides at residues 344, 345, 349, and 351 in the C-terminal tail of Gα show the appearance of 
a strongly immobilized state in the presence of R*.  Only about 30% of the labeled protein is bound to R* 
for 345, 349 and 351 (Figs. 20, 40).  In the spectrum of 351R1, the relative intensity of the immobilized 
component is quite low, partly due to the presence of the very narrow lineshape corresponding to the 
unbound state (60%) which dominates the first-derivative display.  In each case, “spectral titration” by 
subtraction of the unbound component yields the EPR spectrum of the bound state (Fig. 43b).  The 
titration suggests that about 30% of the protein is bound to the receptor to give the immobilized 
conformation, which is consistent with the result from the rhodopsin binding assay.  Except in the case of 
349R1, the spectrum of the bound component is essentially a powder pattern, characteristic of a 
completely immobilized state.  A number of studies have shown that a synthetic undecapeptide 
corresponding to the C-terminal segment of Gα binds to R*, implying that this sequence is involved in 
direct receptor-G protein interaction (Dratz, et al., 1993; Kisselev, et al., 1998; Koenig, et al., 2002; Janz 
& Farrens, 2004).  The present study is the first direct demonstration that this sequence in the intact G 
protein is involved in R* binding, and demonstrates the utility of the SDSL method for identifying 
protein-protein interaction sites.  
 Changes do not occur everywhere in the structure; in particular residues 106R1 and 305R1, which 
are located at some distance from the nucleotide-binding pocket.   
 
Structural changes upon activation with GTPγS 
 When GTP or GTPγS binds to the empty nucleotide-binding site of the complex, the Gα subunit 
is switched to a new, active, conformation.  In general, the spectra return to a state more closely 
resembling the Gα(GDP) form (Fig. 44).  However, in the case of 191R1, 330R1, 331R1, and 344R1, the 
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nitroxide is significantly more immobilized in Gα(GTPγS) compared to Gα(GDP).  This suggests that the 
disposition of the helix is different in the two forms, although this is not apparent from a comparison of 
the crystal structures of these two conformers.  Additionally, sites 56R1 and 305R1 are much less mobile 
in the activated conformation.  While the difference at 56R1 may be associated with differences observed 
in the α5 helix, more sites will be required to define the structural rearrangement at the α4 helix.  As 
expected, the strongly immobilized components of 345R1, 349R1 and 351R1 disappear as the G protein 
dissociates from the receptor.   
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Figure 44 | Comparison between the GTPγS- and GDP-bound conformations  Spectra for each of the 
spin-labeled mutants in the GDP-bound (blue traces) and GTPγS-bound (green traces) conformations 
highlight sites that are sensitive to the identity of the bound nucleotide.  The spectral intensity for sites 
349R1 and 351R1 has been reduced by half compared to the intensity of the other spectra.   
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CHAPTER VII 
 
COMPLEMENTARY APPROACHES TO STUDY G PROTEIN STRUCTURE 
 
 Each of the preceding four chapters has described results from site-directed spin-labeling studies 
of the G protein α subunit, which have revealed exciting new insights into the mechanism of receptor-
catalyzed nucleotide exchange and provided important information on the dynamics of each 
conformational state in G protein activation.  To complement the conclusions from SDSL, several 
alternative approaches were undertaken with varying degrees of success, including site-directed 
mutagenesis, cross-linking experiments, x-ray crystallography, and computational approaches.  This 
chapter will serve to discuss these as works-in-progress. 
 
Mutagenesis of Evolutionarily Conserved Residues in the α5 Helix 
 
Introduction 
 Activated receptors catalyze GDP release from Gα by inducing a rotation and translation in the 
α5 helix (Chapter III).  Although we have developed a reasonably good model of this conformational 
change, less is known about the specific point-to-point contacts between the receptor and G protein that 
cause this movement.  One hypothesis that is consistent with our model is based on evolutionary sequence 
analysis of receptors and G proteins, which identifies groups of amino acids that are either conserved or 
mutated together using a large multiple sequence alignment.  This analysis identified set of conserved 
residues that cluster around a conserved negative charge in the α5 helix (Fig. 45) (Oliveira, et al., 1999).  
The authors propose that these residues form a binding site for the conserved, positively charged arginine 
of the D(E)RY motif in receptors.  Upon G protein binding, this arginine would disrupt interactions with 
the α5 helix, leading to GDP release.  In support of this hypothesis, several mutations in this region have 
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been shown to increase the spontaneous nucleotide exchange rate of Gα (Denker, et al., 1992; Marin, et 
al., 2001b; Woon, et al., 1989).  
In Gαi1, the conserved residues form a salt bridge between K192 in the β2/β3 loop and D341 in 
the α5 helix (Fig. 45a), which may serve as an ionic buckle to maintain the α5 helix in the proper 
orientation for high-affinity GDP binding.  When this restraint is removed, the α5 helix could rotate, 
thereby altering the geometry of the nucleotide binding pocket and reducing its affinity for GDP.  To 
investigate this hypothesis, several mutants have been made where charges on the salt bridge were 
reversed, paired or eliminated and the basal nucleotide exchange rates were measured.   
 
Results and Discussion 
 Several of the mutations had no effect on the basal nucleotide exchange rate of Gαi1 (Fig. 46a).  
Compared to the wild-type sequence (KD), the KA and AA mutations have the same affinity for GDP.  
Since alanine mutations effectively eliminate the side chains beyond the β-carbon, these two mutants 
suggest the presence of additional interactions that stabilize the α5 helix.  Although the AD mutant would 
be important to examine for completeness, this mutation would likely not be predicted to affect the 
exchange rate.  Similar to the KA mutant, the RA mutant had no effect on the exchange rate.  
Surprisingly, the RR mutant also had no effect on exchange.  The close proximity of two positive charges 
would be expected to force the α5 helix and β2/β3 loop apart, thereby increasing GDP release.  This 
result suggests that the two arginine residues can adopt a side chain conformation that places the charges 
far apart from each other (Fig. 46b). 
 Other single mutations at site D341 had more significant effects on GTPγS-binding than the 
D341A (KA) mutant (Fig. 46c).  Interestingly, the D341N (KN) mutation increased the basal exchange 
rate.  Since asparagine is structurally similar to aspartate, but without the negative charge, this mutant 
seems to indicate that there is a charge interaction between K192 and D341 in the wild-type protein.  A 
similar effect on the exchange rate was also observed in the D341K (KK) mutant.  Although two positive 
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Figure 45 | Alignments of evolutionarily conserved residues in Gα subunits  (a) Ribbon models of 
representatives of the four Gα subfamilies highlighting amino acids conserved or mutated as a group 
surrounding the highly conserved aspartate residue (D341 in Gαi1) on the α5 helix.  Interestingly, each of 
the Gα family members has devised different ways to balance the charges present in this region.  (b) 
Sequence alignments of all human Gα subunit genes from the β2 strand to the β3 strand (left) and the α5 
helix to the C-terminus (right) highlighting the similarities and differences in this region. 
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charges might have had a more profound effect, rotamer analysis indicates that all of the favored side 
chain conformations for these residues would direct the positively charged amino group on K341 away 
from the α5 helix and the β2/β3 loop.  Interestingly, the D341E (KE) mutant had a reduced exchange 
rate, which may be due to an increased ability of K192 to interact with an α5 helix containing a long, 
negatively charged side chain at site 341.  Similar reasoning may apply to the reduced exchange rate 
observed for the RD mutant.  The larger arginine side chain might make a better salt bridge with D341, as 
well as additional interactions with the gaunidino group to stabilize these two structural elements.  This 
group of mutations indicates that a charge interaction between the α5 helix and the β2/β3 loop may play 
some role in stabilizing the GDP-binding pocket. 
 One approach to prove the importance of a charge interaction is to reverse the charges on the two 
structural elements to recapitulate the salt bridge in reverse (Fig. 46d).  When the wild-type residues were 
swapped (DK), an increase in the basal exchange rate was observed similar to the increase with the KN 
and KK mutants, which supports the hypothesis that a lysine mutation at residue 341 has a minor impact 
on the structure of this region, but it does not have the appropriate geometry to recapitulate the interaction 
with the β2/β3 loop.  Although a flexible arginine residue at site 341 might be expected to interact with an 
aspartate at site 192, the DR mutation actually had a much faster exchange rate than the wild-type (KD) 
and even the DK mutation.  The structural basis for this effect is unclear, although one possibility is that 
there is, indeed, some interaction between D192 and K341 in the DK mutant.  This is supported by the 
observation that the EK and ER mutants have approximately the same exchange rate as the DK mutant 
(i.e. the ER exchange rate is not significantly faster than the EK exchange rate, unlike the situation 
observed for the DR and DK mutants), which may indicate that the increased tether on the negative 
charge at E192 is more capable of forming a productive salt bridge with a positively charged amino acid 
at 341 than is the shorter side chain, D192.  Further reinforcing this model is the fact that the QR 
exchange rate, which eliminates the negative charge at site 192, has a much faster exchange rate than the 
ER mutant.  Several additional mutants would help to clarify these results, including DA, QK, NK, and 
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NR.  For example, the QK, NK, and NR mutants would help dissect the role of a charge interaction with 
K341 and R341, and the DA mutation would test for the effects due to an arginine at position 341. 
 The interpretation of the final group of double mutants is the most clear.  When two negatively 
charged residues are placed at positions 192 and 341 (DD, EE, and ED), substantial increases in 
nucleotide exchange are observed (Fig. 46e).  Interestingly, these three mutations exhibit a range of 
effects, with ED having the fastest rate, EE the slowest, and DD intermediate between the two.  Modeling 
suggests that the DD and ED mutants are the most conformationally constrained, and the additional length 
of the glutamate residue brings these two negatively charged residues into closer proximity than in the 
DD mutant (Fig. 46f).  The EE mutant is most capable of moving these charges away from each other, 
although its rate is still faster than the EK and ER mutants.  Since position 341 is less enclosed, the DE 
mutation should have an exchange rate intermediate between the DD and EE mutants.   
 In the context of the model for receptor-catalyzed nucleotide exchange described in Chapter III, 
the rapid exchange rates of the DD and ED mutations are even more exciting.  These mutations support 
our model for the R*-mediated movements of the α5 helix, where the helix rotates and translates away 
from the β2/β3 loop toward the β6 strand.  Indeed, the R*-catalyzed nucleotide exchange rate for the 
wild-type Gαi1 is 0.0017 s-1, which is only slightly faster than the basal exchange rate for the DD mutant, 
0.0015 s-1 (Fig. 46e). 
 In summary, this particular salt bridge does not appear to be critical for maintaining the protein’s 
affinity for GDP as indicated by the alanine substitutions, however, charge interactions play some role in 
defining the structure of the region, and perturbations in this region can have a substantial impact on GDP 
release.  Besides the additional mutations described above, the effects of these mutations on the R*-
catalyzed nucleotide exchange rate may shed more light on the mechanism of receptor-G protein 
coupling.  Furthermore, although this particular salt bridge is unique to the Gαi family, the structures and 
the sequences of the other Gα family members may provide useful insight to guide future mutagenesis in 
this region (Fig. 45). 
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Figure 46 | Basal exchange rates of salt bridge mutants  (a) Several mutations had little effect on the 
basal exchange rate, suggesting that this connection is not critical for the stability of the region.  (b)  
Surprisingly, the RR mutation did not have a fast exchange rate, but this could be due to the flexibility of 
these side chains allowing the positive charges to move away from each other.  (c) Single mutations at 
D341 resulted in relatively mild changes in GTPγS binding, particularly compared to DR and QR (d) and 
the double-negative mutants (e).  The DD and ED mutants have basal exchange rates similar to or greater 
than the R*-catalyzed rate for the wild-type (KD) protein (red bar).  (f) Modeling the ED mutant with the 
most common rotamer of glutamate clearly demonstrates the electrostatic repulsion between the α5 helix 
and β2/β3 loop.  Positively charged amino acids are labeled in blue, negatively charged amino acids are 
labeled in red, and uncharged amino acids are labeled in black.  Data are the mean ± s.e.m. of 6 
independent experiments.  (See Appendix C to compare the exchange rates for all of the mutants.) 
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Double Cysteine Mutagenesis in Gαi1 
 
Preliminary cross-linking experiments 
After SDSL studies identified a major conformational change in the α5 helix associated with 
GPCR activation, cross-linking studies were designed to either prevent the conformational change or to 
lock the helix in the receptor-bound conformation.  Toward this end, six double cysteine mutations have 
been introduced into Gαi1 in order to restrict the movement of the α5 helix with disulfide cross-links.  
The double cysteine mutants 56-333, 192-340, 192-341, and 194-344 were introduced to prevent the 
rotation-translation of the α5 helix, while 320-342 and 324-335 were intended to freeze the post-
movement, R*-bound conformation of the α5 helix (Fig. 47).   
When the Gαi1(GDP) crystal structure (Mixon, et al., 1995) was analyzed with Disulfide by 
Design (Dombkowski, 2003), no good opportunities for disulfide bond formation between the α5 helix 
and adjacent structures were identified.  In order to encourage disulfide bond formation, these proteins 
were treated with the oxidizing agent copper phenanthroline.  Treatment of 50 µM of wild-type Gαi1, 56-
333, and 192-341 with 50 µM CuPh (6.25 µL each of 12 mM 1,10-phenanthroline in 2% glycerol and 4 
mM CuSO4) for 1 h at room temperature precipitated much of the protein.  The oxidized samples were 
subsequently washed with buffer B containing 10% glycerol and 50 µM GDP and the precipitant was 
separated by centrifugation.  The protein concentration and activity for all three were reduced compared 
to a control aliquot containing 1 mM DTT.  Disulfide bond formation was assessed by SDS-PAGE (Fig. 
48).  Proteins that have formed disulfide bonds will have a lower apparent molecular weight and high 
molecular weight aggregates will be apparent.  When compared to untreated Gαi1, the bands for both 56-
333 and 192-341 were smeared toward faster-running species, consistent with the possibility that these 
proteins form disulfide bonds without oxidant treatment.  This smearing was eliminated in the DTT-
treated samples, and potentiated in the CuPh-treated samples.  Similarly, the addition of reducing loading 
buffer reduced the amount of smearing in the CuPh-treated samples.   
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Figure 47 | Locations of double cysteine mutations in Gαi1  Six pairs of cysteine mutants were 
constructed in Gαi1, 56-333, 191-340, 191-341, 194-344, 320-342, and 324-335.  These mutations were 
designed to allow disulfide bond formation to restrict the movement of the α5 helix in the GDP-bound 
(blue, cyan, and green side chains) or nucleotide-free (pink and yellow side chains) conformation based 
on the model developed from SDSL studies of receptor-catalyzed GDP release.   
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Overall, this study indicates that increased disulfide bonds are forming in the 56-333 and 192-341 
mutants, even without CuPh treatment.  Since spontaneous disulfide bond formation is not predicted from 
the crystal structure, this may suggest that the α5 helix is an inherently flexible and dynamic element of 
the protein, supporting our model of G protein activation.  However, once the protein is denatured in 
SDS, any pair of cysteines may form a disulfide bond.  This experiment needs to be repeated using a 
thiol-reactive reagent prior to denaturation, which will protect all of the free thiol groups and more clearly 
demonstrate whether a disulfide bond is formed between the two mutant cysteine residues.  Furthermore, 
the oxidizing conditions using CuPh need to be optimized to prevent aggregation and precipitation.  This 
chemical is a catalytic oxygen generator, and a much smaller concentration at a much lower temperature 
would still be effective.  Glutathione may also be useful as a milder oxidizing agent. 
As an alternative to disulfide bond formation, homo bi-functional sulfhydryl-reactive reagents 
may be used to cross-link two cysteine residues.  The length of the linkers ranges from 8 Å with bis-
maleimidoethane to greater than 15 Å for other compounds.  Since the distance between the cysteines in 
the double mutants was approximately 8 Å, these proteins were treated with BMOE.  Wild-type Gαi1, 56-
333, 192-341, 320-342, and 324-335 (25 µM in degassed buffer B, pH 6.0, containing 10 mM EDTA and 
75 µM GDP) were treated with a 10 molar excess of BMOE for 1 h at room temperature.  Degassing and 
EDTA were employed to reduce the extensive oxidation caused by the initial labeling reaction.  The 
reaction was stopped with 10 molar excess over BMOE of βME.  No obvious cross-linking was observed 
when the samples were analyzed by SDS-PAGE.  However, treatment with the cross-linking reagent 
increased the basal rates of GTPγS binding for all of the treated mutants (Fig. 49).  Since this effect was 
observed for each mutant, the effect may be either a non-specific consequence of protein oxidation or a 
result of labeling one of the other ten cysteines in the protein.  Treatment with BMOE did not have the 
predicted effects on the catalyzed exchange rates, and the untreated exchange rates have not yet been 
measured for comparison. 
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Figure 48 | SDS-PAGE analysis of CuPh-treated double cysteine mutants  Samples of wild-type Gαi1, 
56-333, and 192-341 treated under oxidizing or reducing conditions were analyzed by SDS-PAGE.  Lane 
1 contains purified protein.  Lane 2 contains purified protein treated with 1 mM DTT.  Lane 3 contains 
CuPh-treated protein.  Lane 4 contains CuPh-treated protein with loading buffer containing βME.  The 
loading buffer used in Lanes 1-3 did not contain βME.  This gel indicates that additional disulfide bonds 
are formed in the 56-333 and 192-341 mutants. 
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Although the consequences of BMOE modification are unclear from this preliminary experiment, 
this may prove to be a very useful technique to study conformational changes in G proteins.  Some work 
remains to be completed to optimize the cross-linking conditions to prevent protein oxidation.  
Additionally, these double cysteine mutants should be introduced into our cysteine depleted base mutant, 
so that each pair of cysteines could be specifically labeled, thereby avoiding modification of the receptor-
binding C-terminus and intermolecular cross-link formation.  This would also allow a smaller excess of 
cross-linking reagent to be used.  Once the appropriate system is in place, reagents of different linker 
lengths may be employed to more closely examine the conformational dynamics of this, or any, region of 
Gα. 
 
Crystallographic study of a fast exchanging mutant Gαi1 
A serendipitous consequence of the double cysteine mutagenesis in Gαi1 was the discovery of a 
fast-exchanging mutant, 56-333.  This mutant has a 34-fold faster basal GTPγS-binding rate than the 
wild-type protein, which is 6.8-fold faster than even the R*-catalyzed rate of Gαi1! (Fig. 50).  Since this 
mutant has such a low affinity for GDP, it may structurally resemble the receptor-bound, nucleotide-free 
conformation of Gα.  Moreover, a structure might provide insight into the mechanism of R*-catalyzed 
GDP release if the structural basis of the fast exchange rate could be identified.  Although the structure of 
another fast exchanging mutant, A326S in Gαi1, has been solved, it did not reveal any clues as to the 
mechanism of GDP release (Posner, et al., 1998).  Thus, in collaboration with Tina Iverson, Ph.D. and 
Michael Funk, crystallization trials of the 56-333 mutant were begun.     
In addition to the purification steps described in Chapter II, the 56-333 eluent from anion 
exchange chromatography was further purified with gel filtration chromatography on a HiPrep™ 16/60 
Sephacryl™ S-200 HR column (Amersham Biosciences, Piscataway, NJ) in buffer B containing 20 µM 
GDP and 10 mM βME.  The purified protein was then buffer-exchanged into a low salt, AlF4−-containing 
buffer (20 mM HEPES, pH 8.0, 1 mM EDTA, 2 mM DTT, 10 mM MgCl2, 5 µM GDP, 16 µM AlCl3, and 
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Figure 49 | Basal exchange rates of BMOE-treated double cysteine mutants  BMOE treatment non-
specifically increased the basal exchange rates of the double cysteine mutants examined. 
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40 µM NaF) prior to crystallization, which was performed using the hanging drop method.  Protein drops 
(2-3 µL at 250-375 µM) were added to an equal volume of well solution containing 100 mM Bis-Tris, pH 
5.5, 16% PEG 3350, 240 mM Li(CH3COO), and 10 mM SrCl2 or 100 mM guanidine-HCl and allowed to 
equilibrate for 4-5 days at 18 °C, although small bipyramidal crystals formed overnight (Fig. 51a).  
Crystals used for data collection were generally 50 µm × 50 µm × 25 µm or smaller and belonged to the 
spacegroup P43212.  Cryoprotection was performed by briefly equilibrating in well solution containing 
increasing concentrations of ethylene glycol, with a final concentration of 25%.  Crystals were collected 
and flash cooled by plunging in liquid nitrogen.   
In total, five data sets were collected from four crystals with a maximum resolution of 3.2 Å (Fig. 
51b).  All data were collected at the IMCA-CAT beamline at the Advanced Photon Source (Argonne 
National Laboratory, Chicago, IL).  A wavelength of 1.0000 Å was used for screening and native 
collections on each of the four crystals, and an additional data set from a crystal diffracting to 3.5 Å was 
collected at 1.7712 Å for the purpose of single wavelength anomalous diffraction phasing from sulfur 
atoms.  Native and sulfur data were indexed, integrated, and scaled using the programs DENZO and 
Scalepack (Otwinowski & Minor, 1997).  Statistics for data collection and processing are provided in 
Table 3. 
An initial molecular replacement solution was calculated from the data at 3.2 Å resolution using 
coordinates from the Gαi1(GDP·AlF4−) crystal structure (1GFI) (Coleman, et al., 1994a) in order to obtain 
the approximate location of the 17 endogenous sulfur atoms.  These coordinates were read into SHARP 
(de La Fortelle & Bricogne, 1997) for determination of the sulfur anomalous intensities from which 
phases were calculated.  Refinement of these initial phases was performed at 3.5 Å using MLPHARE and 
DM for solvent flattening (1994).  At this resolution, sulfur phases alone proved insufficient to 
successfully interpret the data; phase combination with SIGMAA (Bailey, 1994) using coordinates from 
1GFI as the starting model produced density maps ready for refinement.  These coordinates were again 
used as a starting model for refinement and model building, which was carried out in the program O 
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Figure 50 | Basal nucleotide exchange rate of the double cysteine mutant 56-333  (a) The 56-333 
mutant (●) demonstrated a rapid increase in intrinsic fluorescence upon the addition of GTPγS, 
particularly as compared to the basal (●) and catalyzed (●) exchange rates of the wild-type protein.  (b) 
Comparison of the exchange rates determined by nonlinear regression analysis of the curves in (a).   
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(Jones, et al., 1991).  Subsequent computational refinement was carried out in CNS (Brunger, et al., 
1998) and the CCP4 program REFMAC (Fig. 51c) (Bailey, 1994).  Refinement statistics for the as yet 
uncompleted model are listed in Table 3.    
In addition to refining the structure, several important biochemical studies must be completed to 
fully characterize this mutant.  Although this mutant has a very fast exchange rate, the affinity of this 
protein for GDP and GTPγS must be measured directly with radionucleotide binding assays to determine 
how the mutation impacts the binding of these nucleotides.  The effects of Gβγ on GDP dissociation and 
the stability of Gα will also be important to examine, as Gβγ inhibits GDP release and stabilizes the wild-
type protein against irreversible inactivation at 37 °C.  While Gβγ was able to stabilize the A326S mutant, 
it was unable to slow the release of GDP (Posner, et al., 1998).  Additionally, the interaction between this 
mutant and the receptor needs to be assessed in terms of catalyzed GTPγS binding and stabilization of a 
receptor-G protein complex in the absence of nucleotides.  This mutation could also affect the GTPase 
activity and the ability of Gα to interact with RGS proteins.  Each of these will be tested with GTP 
hydrolysis assays. 
In light of the results described above, this double cysteine mutation may also be particularly 
sensitive to the redox potential of its environment, and the effects of oxidizing and reducing agents on its 
biochemical properties will be important to test.  Similarly, single mutants or alanine mutants at these 
positions will help dissect the role of a putative disulfide bond in determining the phenotype of this 
mutant.  Certainly the refined structure may suggest additional experiments, and crystallization screens 
for the GDP- and GTPγS-bound conformations of the 56-333 mutant are currently underway.    
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Figure 51 | Crystallographic data from the 56-333(GDP·AlF4−) double cysteine mutant  (a) 56-333 
crystals formed in well solution containing 100 mM Bis-Tris, pH 5.5, 16% PEG 3350, 240 mM 
Li(CH3COO), and 10 mM SrCl2.  (b) Diffraction pattern of the double mutant crystals to 2.9 Å collected 
with the IMCA-CAT beamline at APS at 1.0000 Å.  (c) The Fo-Fc electron density map (blue mesh) was 
calculated using model structure factors and phases from a partially refined Gαi1 structure (1GFI) (green).  
Preliminary refinement shows density that indicates a possible disulfide bond between 56C in the α1 
helix and 333C in the α5 helix.      
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Table 3 | Data collection and refinement statistics for 56-333(GDP·AlF4−) crystals 
 
 
 
Crystallographic Statistics 
 S Anomalous Native 
Wavelength (Å) 1.7712 1.0000 
Maximum res.  3.50 3.20 
Completeness 100% (100%) 99.3% (100%) 
Reflections (Unique) 65,909 (5,060) 34,009 (6,498) 
Redundancy 13.0 5.2 
I/σ 62.9 (18.2) 30.14 (5.56) 
Rsym 0.090 0.054 
 
 
Sulfur Phasing Statistics 
No. of sites 17 
Rcullis 0.937 
Phasing power for bins:  
35-13.52 1.209 
7.19 0.992 
5.14 1.121 
4.40 0.812 
3.91 0.548 
3.66 0.229 
3.45 0.289 
35-3.45 Å 0.495 
Figure of merit 0.323 
 
 
Refinement Statistics 
Res. 35-3.5 Å 
Rwork 0.3418 
Rfree 0.3831 
RMS length deviation 0.0094 Å 
RMS angle deviation 1.8186° 
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In Meso Crystallization Trials of Rhodopsin Complexes 
 
Introduction 
Despite extensive effort on the part of a number of investigators, no high resolution structures are 
currently available for an activated GPCR, let alone the R*-G protein complex.  Indeed, the nucleotide-
free conformation of Gα remains the only major G protein conformation for which atomic scale 
resolution remains unavailable.  Membrane proteins are notoriously difficult to crystallize, and the 
crystallization of a membrane-bound protein-protein complex adds another layer of complexity.  The 
cubic lipidic phase offers promise as a new technique for the crystallization of membrane proteins 
(Caffrey, 2003).  In this method, detergent-solubilized protein is dispersed with lipid, typically monoolein, 
resulting in self-assembly of the cubic phase.  A precipitant is added to trigger crystal nucleation and 
growth.  Structures have been solved for multiple seven transmembrane-spanning proteins using this 
technique, including bacteriorhodopsin (1.55 Å) (Luecke, et al., 1999), sensory rhodopsin II (2.1 Å) with 
(Edman, et al., 1999) and without (1.93 Å) (Gordeliy, et al., 2002) its transducer domain, and 
halorhodopsin (1.8 Å) (Kolbe, et al., 2000).  Using this approach, we screened for rhodopsin complexes 
with transducin and a high-affinity C-terminal peptide (Aris, et al., 2001) in collaboration with Martin 
Caffrey, Ph.D. and Vadim Cherezov, Ph.D. in the Department of Chemistry at Ohio State University. 
 
Materials 
Urea-washed bovine ROS membranes (100 µM rhodopsin) and bovine transducin (70 µM in 20 
mM Tris, pH 8.0, 10 mM MgSO4, 10 µM GDP, 200 mM NaCl, 5mM βME, and 10% glycerol) were 
prepared as described in Chapter II.  The high-affinity C-terminal peptide, Ac-MLRNLRDCGMF (1,397 
g/mol; EC50 for Meta II stabilization = 9.9 µM) was synthesized as previously described (Aris, et al., 
2001).  n-Heptyl-β-D-thioglucopyranoside (294.4 g/mol) was received from Anatrace, Inc. (Maumee, 
OH).  All-trans-retinal (284.4 g/mol) was from Sigma-Aldrich, Inc. (St. Louis, MO).  9.9 MAG (356.5 
 162 
g/mol) was obtained from Nu-Chek Prep, Inc. (Elysian, MN) and 7.7 MAG (300.5 g/mol) was 
synthesized by the David Hart, Ph.D. laboratory at OSU.  The crystallization screens used were:  Crystal 
Screen™ HT, Index™ HT, SaltRx™ HT, and MembFac™ screens from Hampton Research Corp. (Aliso 
Viejo, CA); JBScreen Membrane from Jena Bioscience GmbH (Jena, Germany); and MemStart™ from 
Molecular Dimensions, Inc. (Apopka, FL). 
 
Rhodopsin solubilization 
Rhodopsin was solubilized from ROS following Okada's selective extraction procedure (Okada, 
et al., 2004).  Briefly, 250 µL of ROS were centrifuged at 12,000 rpm at 15 °C for 15 min.  The 
supernatant (~150 µL) was removed.  The pellet was mixed with 41.5 µL of buffer containing 84 mM 
MES, pH 6.5, 7.95% HTG, and 386 mM Zn(CH3COO)2 for 1 min and centrifuged at 6,400 rpm at 15 °C 
for 1 min.  There was not a clear separation of pellet and supernatant, and the detergent concentration was 
adjusted by the addition of 1 µL of 15% HTG.  The sample was mixed for 1 min and left at 20 °C in the 
dark for 3 h.  After incubation, the tube was centrifuged at 12,000 rpm at 15 °C for 5 min, and the 
resulting supernatant containing solubilized rhodopsin was collected.  The rhodopsin concentration was 
determined to be 200 µM.  All subsequent manipulations of solubilized rhodopsin were performed at 
room temperature in dim red light.  Solubilized rhodopsin was stored on ice in the dark for three days 
prior to use in crystallization trials.  Immediately before use, the rhodopsin solution was centrifuged at 
12,000 rpm for 5 min to remove insoluble aggregates. 
 
Addition of all-trans-retinal to MAG 
 All-trans-retinal was added to 7.7 MAG and 9.9 MAG lipids at a concentration of 1 mol% to 
increase the stability of rhodopsin complexes in the lipidic cubic phase.  To this end, all-trans-retinal 
powder and lipid were combined in a small centrifuge tube.  The tube containing 9.9 MAG was heated to 
40 °C to melt the lipid, while the tube containing 7.7 MAG was manipulated at room temperature as the 
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lipid is liquid at this temperature.  Both tubes were vigorously mixed until the lipid appeared transparent 
and uniform in color.  All subsequent manipulations with all-trans-retinal were performed under dim light 
and the centrifuge tubes were covered in aluminum foil during mixing. 
 
Crystallization screens 
Solubilized rhodopsin (200 µM) was mixed with either transducin (70 µM) or peptide (7.15 mM) 
in 1:1 mol ratio and gently mixed.  The rhodopsin/transducin solution became cloudy while the 
rhodopsin/peptide solution remained clear.  Both solutions were mixed with either 7.7 MAG/all-trans-
retinal (at 50% w/w lipid) or 9.9 MAG/all-trans-retinal (at 60% w/w lipid) using a lipid mixing device.  
Three types of samples were made, (1) rhodopsin/Gt in 9.9 MAG/all-trans-retinal, (2) rhodopsin/Gt in 7.7 
MAG/all-trans-retinal, and (3) rhodopsin/peptide in 9.9 MAG/all-trans-retinal.  Each solution formed 
transparent cubic phase upon mixing.  Approximately 60-70 mg of each protein/lipid mixture was 
prepared.  To activate rhodopsin, the syringe containing the lipid/protein cubic phase was illuminated by a 
150 W white spectrum lamp for 2 min.  After activation, the lipid/protein cubic phase was used directly in 
crystallization.  Crystallization set-up was performed by the in meso robot using 50 nL cubic phase and 1 
µL precipitant solution per drop.  The commercial screen kits described above were applied to each 
protein/lipid combination in duplicate.  In the case of rhodopsin/peptide in 9.9 MAG/all-trans-retinal only 
Crystal Screen™ HT and Index™ HT screens were duplicated due to a shortage of lipid/protein 
dispersion.  Dim red light was used while the trays were prepared.  Immediately after set-up, the plates 
were covered in aluminum foil and stored at 20 °C.  In total, 32 plates, each containing 96 conditions, 
were made.  Screening was performed manually four times during a period of 35 days using a 
microscope, and the results were recorded into spreadsheets using a 10-point scoring scheme.  
Photographs were taken with a Nikon CoolPix 995 digital camera attached to the microscope.  
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Results 
Many screens containing phosphates (regardless of protein/lipid mixture) produced small 
crystallites (Fig. 52a) or needle clusters (Fig. 52b).  Crystallites were colorless, either non-birefringent or 
had low birefringency, and formed predominantly in the lipidic cubic phase.  However, in some cases, 
they were found in the bathing solution outside the cubic phase droplet.  These crystallites are most likely 
formed by insoluble Zn3(PO4)2 (Zinc was used to extract rhodopsin from ROS membranes and would be 
present in the rhodopsin solution).  These crystallites were the only type of hits observed with 
rhodopsin/Gt in 9.9 MAG/all-trans-retinal. 
More hits were identified with 7.7 MAG/all-trans-retinal trials.  The most interesting was the 
formation of rod or plate-like crystals in the lipidic cubic phase in the presence of imidazole (10% w/v 
PEG-8000, 0.1 M imidazole, pH 8.0 with rhodopsin/Gt and 10% v/v 2-propanol, 0.1 M imidazole, pH 8.0 
with rhodopsin/peptide) (Fig. 52c).  These crystals were highly birefringent and most likely colorless, 
although it is hard to judge the color of crystals in the cubic phase due to the bright yellow-green 
background from the all-trans-retinal.  Although it is possible that these crystals are due to the 
combination of zinc and imidazole (see Fernandez-Patron, et al., 1995), no crystals were observed in 
these or similar solutions with rhodopsin/Gt in 9.9 MAG/all-trans-retinal. 
The next group of hits is associated with high molecular weight PEGs.  Crystals here typically 
look like bunches of fine, colorless plates (Fig. 52d).  These were more frequently observed with the 
rhodopsin/peptide in 9.9 MAG/all-trans-retinal system.  The last group of hits that formed in the lipidic 
cubic phase was observed in the presence of Li2SO4.  These colorless and birefringent crystals were either 
plates or needles and were found both in the cubic phase and in the precipitant solution. 
 
Discussion 
Many crystalline hits were identified in this trial, however, many of them are likely zinc salts and 
all of them are colorless.  Therefore, it is unlikely that any of them represent crystals of rhodopsin 
complexes.  Although it is possible that some of the hits are crystals of Gt, peptide, or bleached rhodopsin, 
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Figure 52 | Hits from an in meso crystallization trial  (a) Rhodopsin/Gt in 7.7 MAG/all-trans-retinal + 
100 mM NaH2PO4, pH 6.8, 15% PEG 2000, and 500 mM NaCl.  (b) Rhodopsin/Gt in 9.9 MAG/all-trans-
retinal + 100 mM Tris/HCl, pH 8.50, 100 mM NH4HPO4, and 12% w/v PEG 6000.  (c) 
Rhodopsin/peptide in 9.9 MAG/all-trans-retinal + 100 mM imidazole, pH 7.8 and 10% v/v 2-propanol.  
Photograph was taken using polarized light.  (d) Rhodopsin/peptide in 9.9 MAG/all-trans-retinal + 100 
mM Tris, pH 6.9 and 20% w/v PEG 1000. 
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protein-free controls need to be done to test this possibility.  The approach to this first screening attempt 
was to mix the proteins and hope for the best.  Much more work remains to be done in order to 
characterize the rhodopsin-transducin complex in the lipidic cubic phase.  A previous report demonstrated 
rhodopsin-dependent Gt activation in meso (Navarro, et al., 2002), and fluorescence and UV-visible 
spectrophotometry may be used to study the stability of this complexes and identify the optimal ratios of 
the proteins.  A similar approach may be used with the rhodopsin-peptide complex.  Additionally, a 
higher affinity peptide sequence may be more suitable to use in these experiments.  In addition to the 
proteins used in the study, the cubic lipidic phase may be modified with different lipids, detergents and 
additives.  Recent work has identified a lipid that forms the cubic phase at low temperatures (Misquitta, et 
al., 2004), which may be more suitable for these trials.  Based on the optimized experimental conditions, 
new crystallization screens may be more successful in forming crystals of rhodopsin complexes.   
 
BEST Analysis of G Protein Structures 
 
Introduction 
Structural and kinetic studies have provided extensive information about the molecular 
mechanisms of G protein function, however, much less is known about how changes in protein dynamics 
regulate the interactions between G proteins, nucleotides, and binding proteins.  One experimental 
strategy to study the conformational flexibility of proteins is monitoring amide backbone 
hydrogen/deuterium exchange using NMR or mass spectrometry.  Since the rate of exchange is 
proportional to the solvent-accessibility of the backbone amide, this technique can provide a wealth of 
information about protein structure and dynamics as well as changes due to ligand binding, covalent 
modification, and protein-protein interactions (reviewed in Hoofnagle, et al., 2003).  In 1996, Hilser and 
Freire developed a statistical thermodynamic formalism that could describe the hydrogen exchange 
behavior that is observed in proteins under native conditions reasonably well (Hilser & Freire, 1996).  
Since the current version of this algorithm, Biology using Ensemble-based Structural Thermodynamics, 
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or BEST, is freely accessible online (Vertrees, et al., 2005), several of the numerous G protein crystal 
structures were subjected to this analysis in the hopes that this approach would provide some insight into 
the variations in G protein dynamics throughout the G protein cycle.   
 
Theory 
 The unique approach adopted by the BEST algorithm is that, rather than treating a protein as a 
static structure, the algorithm generates an ensemble of conformational states.  The protein ensemble is 
generated through the combinatorial unfolding of a set of predefined folding units, the boundaries of 
which are incrementally shifted to provide an exhaustive enumeration of that protein’s partially folded 
states (Fig. 53) (Hilser & Freire, 1996).  The Gibbs energy for each partially folded state is calculated 
based on changes in heat capacity, enthalpy, solvation entropy, and conformational entropy compared to 
the fully folded structure.  These differences are determined based on the change in the solvent-accessible 
surface area of a region in the native conformation (based on the high-resolution structure) and the region 
in the unfolded state of the protein, except for the change in conformational entropy, which has been 
determined empirically for each amino acid.  The Boltzmann weight of each partially folded state is 
determined from the calculated Gibbs energy, which provides the probability of each state in the 
ensemble.  A more stable state will have a smaller Gibbs energy and a higher energetic contribution to the 
ensemble.  Therefore, the more stable states will have a higher probability of being in the ensemble.  
From these probabilities, a residue-specific stability constant may be calculated that indicates the relative 
probability that a residue is folded versus unfolded in the states in the ensemble (i.e. a high stability 
constant indicates a higher folded probability) (Hilser & Freire, 1996).  These residue-specific stability 
constants correlate to experimentally determined hydrogen exchange protection factors (Hilser & Freire, 
1996; Hilser & Freire, 1997).  Of course, residues with a higher probability of being folded are likely the 
more stable residues in the protein. 
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Figure 53 | Enumeration of the protein ensemble  (a) The linear sequence of the protein is partitioned 
into folding units.  (b) The folding units are applied to the three dimensional structure and all possible 
combinations of 'unfolded' and 'folded' states of each folding unit are created to define the ensemble.  (c) 
The boundaries of the folding units are shifted to completely enumerate the possible folding states.  Each 
unit must have a minimum of three amino acids; otherwise the ends are included with the adjacent unit. 
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Results 
 The residue-specific stability constants for the Gα subunit in several G protein crystal structures 
were calculated using the web-based portal for the BEST algorithm (Vertrees, et al., 2005).  
Unfortunately, an exhaustive enumeration of the ensemble is computationally impossible for a protein as 
large as Gα.  A 350-residue protein divided into 8-residue folding units equals 1.4 × 1014 partially folded 
states (Fig. 53).  To account for this, a Monte Carlo simulation was employed to generate 150,000 
partially folded states per partition, for a total of 1.2 × 106 states in the ensemble.  Using this method, the 
residue-specific stability constant for several different conformations of Gα were determined.     
 The first group of structures explored were Gαi1(GDP), Gαi1(GDP)βγ, and Gαi1(GTPγS) (Fig. 
54).  In order to decrease the number of folding units in the heterotrimer, the atoms in PDB file for Gβγ 
were treated as heteroatoms, similar to GDP, so they would not be considered in the partitioning scheme, 
but they would still impact the solvent-accessible surface area of the atoms in Gα.  Generally, the 
heterotrimer had higher stability overall, followed by the GDP-bound conformation, and the pattern of 
changes in the stability constant is similar for each structure.  The least stable regions are found at the N- 
and C-termini and the helical domain.  In the absence of Gβγ, there is less stability observed in the β2 and 
β3 strands as well.  As expected, the most stable residues are located at the core of the protein near the 
nucleotide-binding pocket.  Interestingly, Gβγ binding has a global stabilizing effect on the structure, 
which is consistent with the results from SDSL experiments that show a decrease in side chain mobility at 
residue 300 in the α4 helix upon heterotrimer formation (Chapter IV).   
A similar comparison was made between the three conformations of Gαt (Fig. 55).  Unlike the 
Gαi1 structures, there were no global differences in the stability of one conformation versus another, 
although the most stable regions of the protein were more so in the presence of Gβγ.  Surprisingly, one of 
the least stable regions of the Gt heterotrimer is Switch II (residues 199-219) according to this analysis. 
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Figure 54 | Residue-specific stability constants for Gαi1 structures  (a) The log of the residue-specific 
stability constants are plotted as a function of primary sequence.  (b) The stability constants have been 
mapped onto the appropriate Gαi1 structure, where red indicates low stability and blue indicates high 
stability.     
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A similar pattern of stability constants was also recorded for the Gαt(GDP·AlF4−) structure alone and in 
complex with RGS9 and RGS9 with PDEγ.  The transition-state conformation generally had lower 
stability than the GTPγS-bound conformation, but the stability values were similar to the activation 
conformation in the presence of RGS9.  However, PDEγ binding reversed these effects.   
 In addition to comparing different crystal structures, the stability constants in the presence or 
absence of nucleotide or Gβγ can also be calculated.  These determinations were performed on the Gi1 
heterotrimer with the C-terminal tail of Gαt attached.  Although some differences were observed between 
the four states, Gα(O), Gα(GDP), Gα(O)βγ, and Gα(GDP)βγ, the overall pattern was nearly identical.   
 
Discussion 
 Clearly this is a less intensive approach to gaining insights into protein stability than measuring 
hydrogen exchange rates experimentally.  However, there are some questions that remain about the 
interpretation of these results.  One concern is that stability constants cannot be compared between two 
different crystal structures, as described above.  The effects of the resolution, thermal factors, and other 
features of a crystal structure on the stability constants returned from this analysis are unclear, and may 
confound direct comparisons between different structures.  Perhaps this concern can be alleviated by 
normalizing each pattern to the most and least stable structural regions in any given model prior to 
comparing the differences.  Along similar lines, it is unclear how large a difference in the stability 
constant is significant.  Within one structure it is very easy to see the relative differences in stability; 
however, this issue complicates the direct comparison of several structures.  Finally, since all of the 
ensembles were generated using a Monte Carlo sampling protocol, although the same number of states 
was calculated for each conformation, multiple ensembles may have to be generated to obtain an accurate 
pattern of stability constants for comparison between structures.  Indeed, these ensembles contain 1 × 10-6 
% of the possible states in an exhaustively enumerated ensemble for Gα.  Several iterations of ensemble
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Figure 55 | Residue-specific stability constants for Gαt structures  (a) The log of the residue-specific 
stability constants are plotted as a function of primary sequence.  (b) The stability constants have been 
mapped onto the appropriate Gαi1 structure, where red indicates low stability and blue indicates high 
stability.  In the 1GOT structure, yellow sites are selenomethionine heteroatoms that were not considered 
in the analysis.     
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generation will need to be run for each conformation to accurately assess the fidelity of the Monte Carlo 
protocol.    
Perhaps a more interesting use of the BEST algorithm is to explore the effects of ligand or protein 
binding on the stability of the protein.  Connectivity between residues can be identified by exploring the 
ensemble to see if the folded status of a given residue impacts the folded status of another residue (Pan, et 
al., 2000).  This analysis can be extended to look at how the folded probability of any given residue 
correlates to the probability of a group of residues, like a ligand-binding site, being folded (Pan, et al., 
2000).  Unfortunately, the ensembles themselves are not available from the web site, so it is impossible to 
examine each state in the ensemble to compare the folded status of two residues in this manner.  
However, this information may provide some important insight into the intramolecular connections 
between the nucleotide-binding pocket and protein-interaction surfaces on Gα.  Until that data is 
assembled, this technique provides another simple method to explore changes in G protein dynamics, and, 
in its current form, may be most useful as a tool to guide future SDSL studies of the protein. 
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CHAPTER VIII 
 
FUTURE DIRECTIONS 
 
Assembling the Receptor-G Protein Complex 
  
Perhaps the most important unanswered question regarding G protein function is how these 
proteins are activated by heptahelical receptors.  Although there is experimental evidence supporting a 
variety of conformational changes that may lead to GDP release, these models are based primarily on the 
indirect evidence that mutagenesis can provide.  Direct structural observation of R*-mediated 
conformational changes in G proteins is needed to identify how receptors are actually causing GDP 
release.  Unfortunately, crystallographic approaches are hampered by the size and membrane-bound 
location of the receptor-G protein complex.  Until such time as these technical challenges are solved, 
biophysical approaches, like SDSL, will be invaluable to test specific hypotheses and explore the 
nucleotide-free conformation of the G protein.  From the work described here, the most important next 
steps are to complete the survey of Gα for receptor activation-dependent conformational changes, model 
the observed structural changes, and measure intermolecular distances between the receptor and G protein 
to assemble a model of the complex based on these experimental constraints.   
 
Additional targets for SDSL in Gα 
Our lab has already completed an extensive SDSL study of Gα, but has primarily focused on a 
few structural regions, the N-terminus (Medkova, et al., 2002; Preininger, et al., 2003), the α5 helix 
(Chapters III and VI), and Switches I and II (Chapters IV and V).  Several other interesting structural 
elements remain to be explored.  The α3 helix connects the R*-binding α3/β5 loop to the nucleotide-
binding pocket at Switch III (Grishina & Berlot, 2000), and a point mutation in Switch III has recently 
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been shown to stabilize the nucleotide-free G protein (Pereira & Cerione, 2005).  In addition to potential 
R*-mediated conformational changes, this region plays an important role in G protein activation and 
interaction with effector proteins.  Interdomain interactions between Switch III and the αD/αE loop have 
also been shown to regulate basal nucleotide exchange in Gαs (Grishina & Berlot, 1998).  Similarly, 
several mutations at the interdomain interface affect basal and receptor-catalyzed nucleotide exchange 
rates (Marsh, et al., 1998; Warner, et al., 1998; Grishina & Berlot, 1998; Warner & Weinstein, 1999), 
although there is some controversy as to the role these interactions play in G protein activation (Marin, et 
al., 2001a).  Interestingly, 171R1 in Linker 2 at the interdomain hinge becomes immobilized upon 
binding R*, and mutagenesis of the linker regions has significant effects on nucleotide exchange 
(Heydorn, et al., 2004; Majumdar, et al., 2004; Kostenis, et al., 2005).  These regions, the α3 helix, 
Switch III, and the interdomain cleft, will be the most important future targets of SDSL studies of Gα to 
test for receptor activation-dependent conformational changes.  In addition, these sites have already been 
shown to undergo interesting structural changes crystallographically.  Switch III undergoes a significant 
structural rearrangement upon binding GTP and subtle differences in the relative orientation of the 
GTPase and helical domains have been observed in different G protein conformations (activated 
conformations adopt a more closed orientation).  Thus, the exploration of these regions with SDSL will 
surely provide fascinating insight into G protein dynamics. 
Another relatively straightforward, but important, experimental question is whether 
myristoylation of Gα has an impact on the conformational changes observed with EPR.  All of the studies 
described here were completed with non-myristoylated proteins, as these are much easier to express and 
give greater yields than the myristoylated proteins.  However, myristoylation certainly affects the 
structure of the N-terminus of Gα (Preininger, et al., 2003), and plays an important role in membrane 
localization.  At minimum, myristoylation should increase the percentage of G protein bound to the 
receptor by increasing the concentration on the membrane, providing a clearer picture of the spectral 
changes observed upon formation of the R*-G protein complex.  A more exciting possibility is that 
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myristoylation will influence the conformational changes observed in the G protein upon GDP release.  
At first, several of the most interesting single sites should be explored as myristoylated proteins, followed 
by a systematic examination if interesting results are found.  Although it is difficult to speculate about the 
effects of myristoylation on R*-mediated conformational changes, this lipid modification would provide 
an additional anchoring point for the protein, which may facilitate certain conformational changes.  
Interestingly, the effects of myristoylation on the basal and receptor-catalyzed nucleotide exchange rates 
seem to be unknown, so the influence of this moiety on receptor-G protein interactions remains relatively 
uncharacterized. 
 
Modeling the R*-bound, nucleotide-free conformation of Gα 
 Once receptor activation-dependent conformational changes have been identified, additional 
studies are required to characterize the nature of the conformational change in any given region.  Part of 
this analysis includes a systematic SDSL study of the region, from which a detailed model of the 
conformational change may be developed.  Another part relies on interspin distance measurements to 
quantify the magnitude of the structural changes.  These distance constraints can be combined with 
computational approaches to develop a sophisticated model of the R*-bound G protein conformation. 
Careful analysis of the mobility changes observed for spin-labeled side chains in and around the 
α5 helix suggests a 30° rotation and translation of the helix.  Preliminary distance measurements between 
187R1 and 333R1 before and after receptor activation are exactly consistent with this model; however, 
this single distance measurement is not sufficient to constrain a precise conformational change.  Several 
additional double cysteine mutants have been constructed, but the distances between the spin-labeled side 
chains have been measured with varying degrees of success (Table 4).  While some of these 
measurements may improve with repetition, it is likely that additional mutants must be made to measure 
enough experimental distances to define the nucleotide-free orientation of the α5 helix.  Furthermore, 
myristoylation may increase the number of R*-G protein complexes formed, thereby improving the 
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resolution between the signal from the free and bound G proteins, enabling a more accurate distance 
determination.  Once an adequate set of interspin distances has been collected, it can be used to constrain 
steered molecular dynamics simulations to generate models of the R*-bound conformation of the α5 helix 
(Isralewitz, et al., 2001).   
Care must be taken in the interpretation of interspin distances.  While an increase in the distance 
between two nitroxides may be due to a separation of their structural elements, it may also be due to 
changes in the rotamer conformation of the R1 side chain.  Ideally, distances should be measured between 
two sites where the single-site EPR spectra are the same before and after the conformational change.  
Where this is not possible, sites at the solvent-exposed surface of α-helices have predictable rotamer 
conformations (Mchaourab, et al., 1999; Langen, et al., 2000; Altenbach, et al., 2001), which can be 
accounted for in the modeling process.  Additionally, the use of multiple, overlapping pairs of labeled 
sites can help define the position of the R1 side chain.  This is particularly important when the EPR 
spectrum indicates tertiary interactions that may affect the side chain conformation.  Fortunately, the 
development of DEER EPR allows R1 pairs to be introduced at greater distances, increasing the options 
for spin-label placement and reducing concerns that closely-placed spin labels will alter the conformation 
of R1 relative to the singly-labeled mutant. 
 
Improving models of the R*-G protein complex 
Although enough data has been accumulated to begin to develop rudimentary models of the 
receptor-G protein complex that meet some of the important experimentally-derived structural constraints 
(Slusarz & Ciarkowski, 2004; Fotiadis, et al., 2004; Ciarkowski, et al., 2005), the currently available 
information about point-to-point interactions between the proteins remains sparse and the structural 
resolution of these models remains too low to answer questions about determinants of receptor-G protein 
specificity or the mechanism of activation.  Many experiments remain to be done in order to refine our 
current models of this complex.   
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Table 4 | Summary of double cysteine mutants for distance measurements  Each of the following 
double mutants has been constructed in the cysteine-depleted base mutant.  Experimental results are 
indicated by the following: (●) unsuccessful, (●) successful, and (●) undetermined.   
 
 
 
  CW DEER Notes 
Double mutants to examine the R*-mediated movement of the α5 helix 
187 333 ● ● 6 Å increase 
191 320 ● ● Poor signal:noise 
191 330 ● ● Too far for CW; DEER candidate 
191 333 ●  Too close for distance measurement 
191 334 ●  No change with R activation; binding? 
320 330 ● ● Poor signal:noise 
320 333 ● ● 2 Å decrease 
320 334 ● ●  
321 333 ● ● Distances not consistent with modeling 
300 333   Made construct 
305 330  ● Surprising 6 Å increase 
305 333   No expression 
Additional double mutants 
21 333   Made construct 
29 330   Expresses 
106 273   No expression 
106 330  ● 45 Å distance in HT 
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Particularly important information will come from intermolecular distance measurements 
between the receptor and G protein.  Two large libraries of single cysteine mutants have been generated in 
rhodopsin (Hubbell, et al., 2003) and Gαi1.  Initially, relatively few long-range distance measurements 
would be necessary to define the relative orientation of the receptor and G protein, which is a fundamental 
but unanswered question about the complex.  Once the proper orientation has been established 
experimentally, the model will suggest additional distance measurements that will be necessary to “pin 
down” intracellular loops onto the surface of the G protein.  Proceeding in such an iterative fashion 
should provide the experimental evidence that is critically important in refining the current models of the 
receptor-G protein complex. 
Any improvements in the models of the components of the complex will enhance our model of 
the complex itself.  The current R*-G protein models were assembled from an R* model based on the 
inactive crystal structure of rhodopsin and biophysical constraints, a crystal structure of the GDP-bound G 
protein heterotrimer, and NMR structures of C-terminal peptides of Gα and Gγ.  While the current models 
do not account for the conformational changes in the G protein that cause GDP release, the biophysical 
studies described in this work will provide the foundation for incorporating this information.  Similarly, 
the crystal structure of the fast-exchanging 56-333 mutant may provide a better approximation for the R*-
bound G protein than the currently available structures.  Success in developing a SDSL system to study G 
protein dynamics, and the insight to use rhodopsin as the receptor, affords a unique opportunity to provide 
critical structural information on the R*-G protein complex.  By far, the most exciting future direction of 
this work is modeling the interaction based on experimentally-derived distance constraints from DEER 
EPR.   
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Mapping Conformational Changes Along the Inactivation Pathway 
 
 The major focus of the SDSL studies of Gα has been the conformational changes leading to G 
protein activation.  Future work should use these same cysteine mutants to explore the structure and 
dynamics of Gα through GTP hydrolysis and reassociation of the heterotrimer.  Initially, EPR spectra for 
the Gα(GDP·AlF4−) and Gα(GDP·AlF4−)·RGS conformations should be compared to the GDP- and 
GTPγS-bound conformations that have already been recorded.  Although the crystal structures of 
activated Gα are virtually the same as the transition state, differences in the dynamics, particularly near 
the nucleotide-binding pocket, may be observed with EPR.  Presumably the transition state conformation 
would have decreased dynamics compared to the GTPγS-bound conformation, however, there may not be 
any differences at all based on the observation from the crystal structures.  While the effects of AlF4−-
binding are not necessarily obvious, RGS binding should certainly immobilize the Switch regions as it 
interacts with them to stabilize the transition state for GTP hydrolysis.  RGS binding may have a similar 
effect of dampening backbone motions throughout Gα as Gβγ binding does (300R1 and 320R1).  The 
reagents have been developed to perform these simple characterizations, and excitingly, unexpected 
structural changes may pop up in this analysis that would not have been identified otherwise. 
 Following these relatively straightforward measurements, more complicated studies could be 
performed.  Using time-resolved EPR measurements, it would be possible to follow changes in the 
dynamics of the protein during GTP hydrolysis.  The spin-labeled proteins could be loaded with GTP in 
the absence of Mg2+, and after recording a baseline spectra, the GTPase could be activated by the addition 
of Mg2+ through a stop-flow apparatus in the presence or absence of an RGS protein.  One advantage of 
these studies is that it is much easier to obtain high concentrations of a more homogeneous population of 
Gα conformers than the activation studies described in this work, enabling kinetic measurements where 
signal quality is sacrificed for rapid acquisition. 
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 Several mutations in Gα have been described that affect the GTPase activity of the protein, 
including G42V and G203A that stabilize a Gα(GDP·Pi) complex that has been characterized 
crystallographically (Berghuis, et al., 1996; Raw, et al., 1997).  These structures reveal a large 
conformational change in Switch II and less striking changes in Switch I.  Since these two different 
mutations stabilize a similar Gα conformation, it seems likely that this is a transient intermediate state of 
the wild-type protein during GTP hydrolysis.  A K180P mutation in Switch I seems to accelerate a 
conformational change in the Switch regions, but decreases the rate of GTP hydrolysis, suggesting that 
this transition is an obligatory step leading to bond breakage (Thomas, et al., 2004).  These mutations can 
be engineered into the cysteine mutants used in SDSL studies to test the hypotheses suggested by the 
crystal structures.  This biophysical approach will yield much more insight into the role of Switch 
dynamics in GTP hydrolysis than crystallography can.  Moreover, EPR is perfectly suited to address the 
impact of these mutations on Switch dynamics.  Certainly, the structural changes associated with G 
protein inactivation are not yet completely understood, and these should be one of the next targets of 
SDSL studies. 
 
Alternate Approaches to Study G Protein Dynamics 
 
Site-directed labeling 
 In a similar approach to SDSL, fluorescent labels may be incorporated into proteins to probe 
conformational dynamics.  For example, steady-state fluorescence measurements can monitor changes in 
environmental polarity, fluorescence anisotropy is related to the mobility of the fluorophore, and 
quenching reagents may be used to determine the solvent accessibility of the fluorophore (Mansoor, et al., 
1999).  A little surprisingly, this light-based technique has been used successfully to study the activating 
conformational changes in the photoreceptor, rhodopsin (Dunham & Farrens, 1999; Janz & Farrens, 
2004).  Recently, the interaction between arrestin and rhodopsin has been examined with site-directed 
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fluorescent-labeling (Sommer, et al., 2005), which provides encouragement for adopting this approach to 
study receptor-G protein interactions.  A SDFL approach may provide complementary information to the 
SDSL data that has been accumulated.  Additionally, the fluorescence of the bimane probe used in these 
studies is quenched by tryptophan residues, which suggests an additional means to test conformational 
changes within the protein by using cysteine-tryptophan double mutants.   
 As an alternative to using labels to monitor conformational changes in Gα, it should be possible 
to map protein-protein interaction surfaces by measuring the effects of complex formation on the 
accessibility of the cysteine residue to thiol-reactive molecules.  For example, cysteines that are buried in 
the R*-G protein interface would be protected from modification by thiol-reactive reagents upon R* 
binding.  Determining the extent that binding to R* protects residues from labeling would complement 
our results from SDSL studies.  Although the striking decreases in the mobility of spin-labeled side chains 
at the C-terminus of Gα is most likely due to direct contact interactions with R*, this experiment would 
offer additional evidence to support that conclusion.  Using reagents with different sizes and chemical 
properties would also help define a particular interface (i.e. a site that is accessible to small molecules, but 
not bulky reagents is more buried than a site accessible to both) (Hofmann & Reichert, 1985).  Certainly, 
this extensive library of Gαi1 cysteine mutants combined with the vast number of sulfhydryl-modifying 
reagents available opens nearly every region of Gα for exploration with a variety of creative experimental 
approaches.   
 
Hydrogen-deuterium exchange mass spectrometry 
 As mentioned previously, one experimental strategy to study the conformational flexibility of 
proteins is monitoring amide backbone hydrogen/deuterium exchange using mass spectrometry.  As a 
protein incubates in the presence of the heavy isotope of hydrogen, deuterium, hydrogen atoms in the 
protein exchange for deuterium atoms in the solvent, thereby increasing the mass of the protein.  Since 
hydrogens covalently bound to carbon atoms do not exchange and hydrogen atoms on side chains 
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exchange very quickly, only the increase in the mass due to the exchange of amide hydrogens is detected 
by mass spectrometry.  As a consequence of this chemistry, there is only one site available for labeling on 
each amino acid, except for proline.  Therefore, the hydrogen exchange rates can be measured for each 
amino acid over the length of the entire protein.  The labeling reaction is quenched by reducing the pH to 
2.5 and placing the reaction on ice.  The protein can be cleaved with pepsin, and the peptides are 
separated by reverse phase chromatography prior to injection on the mass spectrometer. 
 Since the rate of exchange is proportional to the solvent-accessibility of the backbone amide, this 
technique can provide a wealth of information about protein structure and dynamics as well as changes 
due to ligand binding, covalent modification, and protein-protein interactions.  Moreover, there is no 
limitation on the size of the protein, small amounts of protein are required, and membrane proteins are 
accessible to this technique (reviewed in Hoofnagle, et al., 2003). 
 Surprisingly, HXMS experiments have not been performed on heterotrimeric G proteins or 
complexes that contain them and a wealth of information on G protein dynamics would be available from 
very simple preliminary experiments.  As a first step, exchange rates can be compared between the GDP- 
and GTPγS-bound conformations of the Gα subunit alone.  These data could be compared to our own 
SDSL results, as well as the G protein crystal structures and the output from BEST analysis of them 
(Chapter VII).  Once the experimental conditions have been optimized with Gα alone, increasingly 
complex conformations can be studied as Gα binds Gβγ and the activated receptor.  These studies should 
define the interaction surfaces on all partners and identify regions where the dynamics are altered due to 
complex formation.  The clear advantages of this technique are the use of native proteins and the ability to 
study all proteins involved in the complex simultaneously.  When interpreted in terms of the rhodopsin 
and G protein crystal structures, these data should provide important information on the structure of the 
R*-G protein complex and might hint at structural changes leading to GDP release.   
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Mapping allosteric connectivity with computational approaches 
Collectively, the group of G protein crystal structures provides a rich data set for computational 
studies of G protein biophysics.  Moreover, the Gα subunit is particularly interesting in that it cycles 
through at least six limit conformations, Gα(GDP), Gα(GDP)βγ, R*·Gα(O)βγ, Gα(GTP), 
Gα(GDP·AlF4−), Gα(GDP·Pi), in addition to its interactions with a variety of regulatory proteins, 
including receptors, effectors, GAPs and GDIs, each of which specifically interacts with different surfaces 
of Gα or different conformations of the protein.  One of the fundamental problems in understanding the 
complex interplay between the occupants of the nucleotide-binding pocket and various regulatory proteins 
is the identification of the allosteric or intramolecular signaling pathways in Gα subunits.  Several elegant 
computational approaches have been developed to address these fundamental questions in signal 
transduction.   
Two methods are based on the hypothesis that, over the course of evolution, functionally 
important amino acids in proteins will not be mutated, while unimportant amino acids will vary.  In the 
evolutionary trace analysis (Lichtarge, et al., 1996b), a multiple sequence alignment is generated for a 
given family of proteins and the individual members of the family are clustered together with their closest 
relatives based on their relative sequence identity.  Then, a consensus sequence is generated for each 
cluster, and if an amino acid varies at a given position, it is left blank.  The consensus sequences for all of 
the clusters are then aligned to provide the evolutionary trace.  A residue is either conserved if it is the 
same in all of the consensus sequences, class-specific if it varies among the consensus sequences, or 
neutral if it is blank in any one of the consensus sequences.  The conserved and class-specific amino acids 
can then be mapped onto the crystal structure, and will identify functionally important areas of the 
protein.  When applied to heterotrimeric G proteins, the evolutionary trace identified subunit interfaces, 
receptor and effector interaction sites (Lichtarge, et al., 1996a).   
Statistical coupling analysis is an extension of the evolutionary trace (Lockless & Ranganathan, 
1999).  This method uses a very large multiple sequence alignment to identify statistical interactions 
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between any two amino acid positions in the protein, and is based on the additional hypothesis that 
functional coupling between any two sites in the protein should mutually constrain the evolution at those 
two sites.  In this approach, conservation is defined as the deviance of amino acid frequencies at a given 
position from their average abundance in all proteins in nature.  Statistical coupling is the extent to which 
an amino acid at one site changes in response to a perturbation at another site.  This analysis predicted 
long-range interactions with the ligand-binding site in the PDZ domain family, which were subsequently 
verified by mutagenesis (Lockless & Ranganathan, 1999).  When SCA was applied to the G protein 
superfamily, including the monomeric G proteins, a network of amino acids was identified that surrounds 
the nucleotide-binding pocket and links it to the effector-binding surface at the switch regions (Hatley, et 
al., 2003).  Interestingly, this connectivity is only observed in the GTP-bound conformation of the G 
proteins, but not in the GDP-bound conformation.  Since mutations in this allosteric network significantly 
affected the nucleotide sensitivity of the interactions between Gαs and Gβγ or AC, these residues likely 
form a core allosteric network conferring nucleotide-dependent switching in G proteins (Hatley, et al., 
2003).  
Unfortunately, the SCA approach is limited by the large sequence alignment that must be 
assembled for statistical analysis in order to identify coupling energetics, and it is unable to provide a 
physical explanation for the coupling between two residues, whether it be ligand specificity, structural 
stability, folding or intramolecular signaling.  An alternative method that follows anisotropic thermal 
diffusion through proteins has recently been described to identify intramolecular signaling pathways (Ota 
& Agard, 2005).  In the ATD method, a protein is energy minimized and equilibrated to 10 K with 
molecular dynamics, which essentially “freezes” each atom.  Then, a particular region of interest is 
“heated” to 300 K, and the propagation of the kinetic energy is followed by the deviation of atoms from 
their positions in the minimized structure in subsequent dynamics simulations.  Interestingly, the energy 
propagates along defined pathways that highlight the physical connectivity of intramolecular signaling 
pathways.  When this approach was applied to a PDZ domain family member, the results were consistent 
with the SCA pathway, but provided a more direct physical connection between the binding pocket and 
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distant residues (Lockless & Ranganathan, 1999; Ota & Agard, 2005).  This method would be very useful 
to trace the connectivity between bound nucleotides and protein-protein interaction surfaces in G proteins, 
particularly the receptor-binding surface.  Since the monomeric G proteins were included in the SCA 
analysis (Hatley, et al., 2003), connectivity to the receptor-binding site could not be addressed by this 
method.  The ATD technique provides an interesting new way to explore the current models of the 
receptor-G protein complex, and the interface between these proteins. 
Certainly the G protein system is an excellent example of how the allosteric connectivity between 
proteins is as important as the connections within a protein.  Since this intermolecular communication 
must occur through the sites of contact, it becomes an important theoretical question to ask if protein-
protein interaction surfaces can be identified based on other structural information.  One method is to 
analyze the surface of a protein in search of areas with favorable energy exchange when buried in a 
protein-protein interaction (Fernandez-Recio, et al., 2005).  This approach identifies optimal docking 
areas by finding the area with the lowest docking surface energy centered on each of a series of randomly 
assigned surface points (Fig. 56).  When the structure of Gαi1 from the heterotrimer crystal structure was 
examined with this algorithm, two potential protein-protein interaction surfaces were identified, the 
region around the α5 helix and the helical domain (Fig. 56).  Surprisingly, the Gβ-binding interface was 
not identified even despite the use of the heterotrimeric conformation of Gα as the input for the analysis. 
Computational tools for analyzing protein structure are becoming increasingly sophisticated.  
Although these tools cannot replace hard experimental data, they can be invaluable as “pre-experiments” 
that provide a glimpse of what to expect or “post-experiments” that aid in the analysis and interpretation 
of the experimental data.  Furthermore, a computational approach may provide data that would not be 
immediately accessible experimentally, and as these algorithms are increasingly used, the correspondence 
between the in silico result and the experimental result should continue to increase.  Heterotrimeric G 
proteins are an excellent proving ground for these applications as they help to address many of the issues 
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of interest to theoretical structural biologists, such as the role of protein dynamics in function, tracing 
allosteric connectivity in proteins, and the regulation of protein-protein interactions, among others.   
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Figure 56 | Optimal docking areas in Gαi1  In order to identify ODA, a network of points is assigned to the surface of the protein (colored 
spheres).  For each sphere, the lowest energy docking surface is chosen from a series of surfaces centered on each surface point.  The size and 
color of the surface points identifies the ODA (large red spheres) in this N-terminally truncated Gαi1 subunit from the Gi1 heterotrimer (1GP2).  
The colored meshes describe potential ligand-binding pockets in the G protein (An, et al., 2005).  Indeed, this analysis identified the nucleotide-
binding pocket (blue mesh).   
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CHAPTER IX 
 
PERSPECTIVE AND CONCLUSIONS 
  
As seems only fitting, the unanswered questions about the structural basis for function in 
heterotrimeric G proteins are framed in terms of what is not known from the many crystal structures of 
these proteins in a variety of conformations and complexes.  For example, the amino and carboxyl termini 
of Gα play key functional roles in mediating its interaction with regulatory proteins, yet limited structural 
information for these regions is available from crystallography.  Furthermore, answers to some of the 
most important questions in G protein signaling await a better understanding of the structure of the 
receptor-G protein complex, including agonist-mediated conformational changes in receptors, point-to-
point interactions between the receptor and G protein, the transition leading to GDP release, the structural 
determinants of R*-G protein specificity, and the functional role of receptor dimerization in G protein 
activation.  Although low resolution models have been described that address all of these issues, the 
strongest evidence in favor of any structural hypothesis comes once it has been captured on film. 
In the meantime, the biophysical approaches described in this work offer an excellent alternative 
approach to addressing issues relating to G protein function.  By far, the most exciting result of the SDSL 
of Gα is the identification and characterization of receptor activation-dependent conformational changes 
in the α5 helix that couple receptor binding to GDP release.  Previously, exploration of the R*-G protein 
complex was not technically possible and models of R*-catalyzed GDP release were based on the results 
of mutagenesis studies.  Even though a given mutation can alter the nucleotide exchange rate, the receptor 
does not necessarily use a similar mechanism.  For this reason, the importance of testing specific 
conformational changes with direct observation cannot be overstated.   
In addition to providing structural information for unknown protein conformations, SDSL reports 
dynamic information that is not necessarily evident from crystallographic analysis.  For example, a 
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comparison of the GDP- and GTPγS-bound crystal structures of Gα suggests that G protein activation 
immobilizes the Switch regions, while SDSL reports amplified backbone dynamics of Switch II in that 
conformation.  Similarly, the striking decreases in the mobility of residues 300 and 320 upon binding to 
Gβγ could never have been predicted from examination of the structures.  As more and more sites are 
selected for spin-labeling, equally interesting results will likely be identified relating to interdomain 
movements, effector binding, and GTP hydrolysis.  Unfortunately, SDSL is not adequate on its own to 
follow these allosteric connections through the protein, and computational approaches may help to 
explain these interesting experimental results. 
 The overall success of this approach is due, in large part, to the amount of detailed structural 
information available for G proteins.  The ability to model the R1 side chain into these crystal structures 
allows rather detailed mechanisms to be described based on relatively low resolution structural 
information.  As this study continues forward, results from biophysical approaches will be used to 
assemble detailed models of the R*-G protein complex.  Current models of the complex are based on the 
relatively few experimental constraints that are available, and are therefore dominated by the 
computational approaches that produced them.  Only a few intermolecular distance measurements would 
go a long way toward refining these models, and SDSL combined with DEER EPR is perfectly poised to 
provide that data.   
 In conclusion, the methodology and results presented here form a strong foundation for continued 
studies of the biomechanics of G protein signaling.  The most productive approach toward answering 
questions in this field relies on integrating all of the structural and dynamical information obtained from 
these varied experimental sources into a cohesive model of the allosterism that underlies the G protein 
molecular switch.     
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APPENDIX A 
 
Gαi1 MUTANT CONSTRUCTS 
 
 The first table summarizes the progress made in the SDSL project.  Prior to my joining the lab, 
the cysteine-depleted construct had been constructed and characterized, and 60% of the single cysteine 
mutant constructs listed had been created.  While in the lab, I made the remaining mutants, and at one 
time or another, attempted to express each of the mutants listed.  Thus, this table represents, to the best of 
my knowledge, the current status of the SDSL project. 
 The second table summarizes the constructs I generated to test a variety of hypotheses.  Most 
groups will be familiar to the reader based on the preceding chapters (uncoupling, cross-linking, salt 
bridge, distance measurements, and 5G).  However, several mutations were made in an attempt to 
improve the cysteine-less background used in the SDSL studies by removing additional cysteine residues 
and by substituting different residues at C325 to slow the very fast basal exchange rate in the Hexa I 
mutant.  One of the cysteines that remains in Hexa I contributes to a reasonable degree of background 
labeling, which can be avoided by labeling for short times with low concentrations of MTSSL.  Despite 
my best efforts, I was unable to convincingly identify the source of the background labeling.  Moreover, 
none of the subsequent constructs (Hepta I, Octa I, Nona I, or Deca I) express nearly as well as the Hexa I 
protein, and thus, we continued using this background for SDSL.   
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Table 5 | Single-site mutant constructs for SDSL studies of Gαi1  Sites 3, 214, 305, 325, and 351 (bold 
italic) are cysteines in the wild-type protein, but have been mutated in the cysteine-depleted background 
(along with 66).  The status of each mutant is indicated as follows:  (●) successful, (●) unsuccessful or 
incomplete, and (●) not determined.   
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3 S αN ● ● ● ● ● ● ● 
10 K αN ● ● ● ● ● ● ● 
13 V αN ● ● ● ● ● ● ● 
14 E αN ● ● ● ● ● ● ● 
15 R αN ● ● ● ● ● ● ● 
16 S αN ● ● ● ● ● ● ● 
17 K αN ● ● ● ● ● ● ● 
21 R αN ● ● ● ● ● ● ● 
29 K αN ● ● ● ● ● ● ● 
Incomplete biochemical 
characterization.  Missing 
data files for EPR spectra.  
Repeat measurements of 
R*-bound conformation.  
Published in (Medkova, et 
al., 2002; Preininger, et 
al., 2003). 
50 V α1 ● ● ● ● ● ● ●  
56 I α1 ● ● ● ● ● ● ● Dark spectrum 
106 Q αB ● ● ● ● ● ● ●  
154 Y αE ●        
171 Q αF ● ● ● ● ● ● ●  
172 Q αF ●        
175 Q αF ● ●       
179 V L2 (SwI) ● ● ● ● ● ● ●  
180 K L2 (SwI) ● ● ● ● ● ● ●  
182 T L2 (SwI) ● ● ● ● ● ● ●  
184 R β2 (SwI) ● ● ● ● ● ● ● No increase in exchange 
186 E β2 (SwI) ● ● ● ● ● ● ●  
187 T β2 (SwI) ● ● ● ● ● ● ●  
191 F β2/β3 ● ● ● ● ● ● ●  
192 K β2/β3 ● ● ● ● ● ● ●  
194 L β2/β3 ● ● ● ● ● ● ●  
205 R β3/α2 (SwII) ● ● ● ● ● ● ●  
206 S β3/α2 (SwII) ● ● ● ● ● ● ●  
209 G α2 (SwII) ● ● ● ● ● ● ●  
210 K α2 (SwII)         
211 W α2 (SwII) ●  ●   ● ●  
213 H α2 (SwII) ● ● ● ● ● ● ●  
214 S α2 (SwII) ● ● ● ● ● ● ●  
217 G α2/β4 (SwII) ● ● ● ● ● ● ●  
251 D α3         
273 L αG ● ● ● ● ● ● ●  
300 A α4 ● ● ● ● ● ● ●  
305 S α4 ● ● ● ● ● ● ●  
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Table 5 | Continued 
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312 K α4/β6 ●        
314 K α4/β6 ●        
318 E α4/β6 ● ● ● ● ● ● ●  
320 Y β6 ● ● ● ● ● ● ●  
321 T β6 ● ● ● ● ● ● ● Dark and GTPγS spectra 
322 H β6 ●        
323 F β6 ●        
325 A β6/α5 ● ● ●      
329 T β6/α5 ●        
330 K α5 ● ● ● ● ● ● ●  
331 N α5 ● ● ● ● ● ● ●  
333 Q α5 ● ● ● ● ● ● ●  
334 F α5 ● ● ● ● ● ● ●  
335 V α5 ● ● ●      
337 D α5 ●        
338 A α5 ●        
339 V α5 ● ● ●      
340 T α5 ● ● ● ● ● ● ● Dark spectrum 
341 D α5 ●        
342 V α5 ● ● ● ● ● ● ●  
344 I α5 ● ● ● ● ● ● ●  
345 K α5 ● ● ● ● ● ● ●  
349 K C ● ● ● ● ● ● ●  
351 I C ● ● ● ● ● ● ●  
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Table 6 | Miscellaneous constructs  
Construct Mutant Notes 
Improve cysteine-depleted background 
Hepta I C139V 
Hepta I C224V 
Hepta I C254A 
Hepta I C286A 
Four independent C mutations 
in Hexa I   
Hepta I Q333C 
Hepta I K345C C224V Hepta I 
Octa I C254A, C286A  
Nona I C254  
Hexa I C325M 
Hexa I C325V Slow basal exchange 
Uncoupling mutations 
Hexa I V342P 
Hexa I I343P 
Hexa I K345H 
Hexa I K345S 
Hexa I K349P 
Hexa I i348A 
 
Double cysteines for cross-linking experiments 
Gαi1 I56C  Q333C  
Gαi1 K192C  T340C  
Gαi1 K192C  D341C  
Gαi1 L194C  I344C  
Gαi1 Y320C  V342C  
Gαi1 T324C  V335C  
Hexa I K192C  D341C  
Gαi1 L194C  I344C With C351I mutation 
Gαi1 K192C  
Gαi1 L194C  
Gαi1 Q333C  
Gαi1 V335C  
Gαi1 V342C  
Gαi1 I344C With C351I mutation 
Salt bridge mutants (K192, D341) 
Gαi1 A, A  
Gαi1 D, D  
Gαi1 D, E  
Gαi1 D, K  
Gαi1 D, R  
Gαi1 E, D  
Gαi1 E, E  
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Table 6 | Continued 
 
Construct Mutant Notes 
Salt bridge mutants (K192, D341) 
Gαi1 E, K  
Gαi1 E, R  
Gαi1 K, A  
Gαi1 K, E  
Gαi1 K, K  
Gαi1 K, N  
Gαi1 Q, R  
Gαi1 R, A  
Gαi1 R, D  
Gαi1 R, R  
Double cysteine mutants for distance measurements 
Hexa I R21C  Q333C  
Hexa I K29C  K330C  
Hexa I Q106C  L273C  
Hexa I Q106C  K330C  
Hexa I T187C  Q333C  
Hexa I F191C  K330C  
Hexa I F191C  Q333C  
Hexa I F191C  F334C  
Hexa I F191C  Y320C  
Hexa I A300C  Q333C  
Hexa I C305  K330C  
Hexa I C305  Q333C  
Hexa I Y320C  K330C  
Hexa I Y320C  Q333C  
Hexa I Y320C  F334C  
Hexa I T321C  Q333C  
Mutations in the cysteine-less Gαi1 construct 
Deca I Q106C  
Deca I S206C  
Deca I C214  
Deca I C325  
Deca I N331C  
Deca I Q333C  
Deca I F334C  
Deca I C351  
Deca I C325, I344C  
Deca I C325, F334C Slow basal exchange 
Deca I C325, Q333C  
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Construct Mutant Notes 
Five-glycine loop insertion mutants 
5G L273C  
5G K330C  
5G F334C  
5G K349C  
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APPENDIX B 
 
BIOCHEMICAL CHARACTERIZATION OF SPIN-LABELED MUTANTS 
 
 Each new spin-labeled mutant Gα is characterized by measuring its basal and receptor-catalyzed 
nucleotide exchange rates as well as its ability to form stable R*-G protein complexes in ROS 
membranes.  Although the primary goal of this work is to explore G protein structure and dynamics with 
EPR spectroscopy, a secondary result has been the generation of a large number of Gα mutants with a 
correspondingly large amount of biochemical data (Figs. 57, 58).  Interesting patterns emerge when these 
data are mapped onto the Gαi1 crystal structure (Fig. 59).  Perhaps surprisingly, there is no correlation 
between the absolute or fold increase in the rates of R*-catalyzed nucleotide exchange and the extent of 
rhodopsin binding.  However, this may not be expected in a system where the two events, R* binding and 
GDP release, can be uncoupled from each other, as in the 5G mutant. 
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Figure 57 | Nucleotide exchange rates for spin-labeled mutants  Data represent the mean ± s.e.m. of 4-
6 independent experiments. 
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Figure 58 | Rhodopsin binding data for spin-labeled mutants  Data represent the mean ± s.e.m. of 3 
independent experiments. 
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Figure 59 | Mapping biochemical data onto the Gαi1 crystal structure  (a) The fold difference in basal 
nucleotide exchange compared to the cysteine-depleted base mutant are mapped onto the surface of Gαi1 
from the Gi1 structure (scale ± 4.5-fold).  A clear pattern is observed on the α5 helix.  (b) The effects of 
mutagenesis and spin-labeling at various sites have been mapped onto the surface of Gαi1 (scale 20-80% 
bound).  Compare this result with the ODA identified in Figure 56.   
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APPENDIX C 
 
COMPARISON OF SALT BRIDGE MUTANT EXCHANGE RATES  
 
 
 
 
 
 
 
 
 
Figure 60 | Summary of salt bridge mutant exchange rates  The basal and receptor-catalyzed exchange 
rates for wild-type Gαi1 are marked (black and red dashed lines, respectively).  Positively, negatively, and 
uncharged amino acids are colored blue, red, and black, respectively.  Data represent the mean ± s.e.m. of 
six independent experiments. 
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